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ABSTRACT

Capillary-channeled polymer (C-CP) fibers as an alternative support/stationary
phase for biomacromolecule separations on analytical and preparative scales have been
developed by Marcus research group. The combination of the fiber micro- and macrostructures and in-column orientation allows operation at comparably high linear velocities
(~100 mm s-1) without excessive system backpressure. The ability to move fluid efficiently
through the structure is complemented by the fact that the fiber physical structure is
effectively nonporous with respect to the size of proteins, therefor there is no significant
intrafiber diffusion. Ultimately, these factors combine for protein separations that are
devoid of appreciable van Deemter C-term broadening.
Polypropylene C-CP fibers have been employed for fast protein separations in
reversed phase (RP) mode. For hydrodynamic studies, important factors (injected mass and
volume) affecting overload in terms of peak height, width and shape (asymmetry) were
evaluated. For LC-MS application, a model mixture of ribonuclease A, cytochrome c,
myoglobin and lysozyme were prepared in phosphate buffered saline (PBS) and urine
matrices. The efficiency of the matrix removal was reflected in the near-identical
qualitative and quantitative responses in both UV-Vis and MS detection. Later, a new,
trilobal-shaped C-CP fiber was under developed to address the issue of poor A-term
performance of the previous eight-channeled form. The trilobal geometry provides better
packing homogeneity due to the fewer potential orientations of the symmetric fiber
geometry. Comparisons of separation efficiency and peak shape were made between the
two fiber shapes through several dynamic parameters.
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Poly(ethylene terephythalate) (PET) C-CP fiber was used as the stationary phase
for the separation of a synthetic protein mixture based on hydrophobic interaction
chromatography (HIC). Optimum resolution and fast analysis times were achieved
employing a steep gradient using higher linear velocities. The use of PET C-CP fibers in a
HIC protocol was examined to isolate exosomes from a human plasma sample. Initial
results demonstrated the ability to isolate exosomes with comparable yields and size
distributions and on a much faster time scale when compared to traditional isolation
methods, while also alleviating concomitant proteins and other impurities. And, 2D-HPLC
method for characterizing mAb concentration and aggregation level, combining ProA
purification, a novel injector-loop capture step (HIC processed by PET C-CP fiber), and
aggregation determination by SEC is described. Advantages are seen in terms of limiting
in-system mAb aggregation due to reduced low-pH solvent exposure, improved 2D
chromatographic resolution, better monomer/aggregate ratio fidelity, and enhance
quantitative figures of merit.
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CHAPTER ONE
INTRODUCTION

Capillary-channeled polymer (C-CP) fibers and current development
The merits of capillary-channeled polymer (C-CP) fiber stationary phases for
biomacromolecule separations on the analytical and preparative scales have been
investigated by Marcus research group.1-3 These 30- to 50-μm diameter polymer fibers are
made via extrusion from polypropylene (PP), polyester (PET), and nylon 6 materials
through an orifice with the desired shape.4,5 Fiber surfaces can be modified on-column
through simple adsorption or covalent ligand coupling to provide greater selectivity. Thus,
differences in native fiber chemistries, as well as facile surface modifications, provide a
platform for separations via reversed phase (RP),1-3,6,7 ion exchange (IEX),8,9 hydrophobic
interaction chromatography (HIC),10 and various affinity-based modalities.11-13 The close,
parallel packing of the fibers provide a unique transport medium. The combination of the
fiber micro- and macro-structures and in-column orientation allows operation at extreme
linear velocities without excessive system backpressures.14,15 Besides, very low intrafiber
porosity allows protein separations at extremely high linear velocities (100 mm s−1) without
negative effects of intraphase mass transfer (van Deemter C-term) broadening.16,17
Likewise, with high column permeability, faster flow rates minimize longitudinal diffusion
(van Deemter B-term).18 The lack of intraphase diffusion also allows for the use of high
gradient rates without the ill effects of band broadening.19,20 Moreover, another advantage
of C-CP fiber supports over other commercial sorbents is that they are quite stable over a
wide pH range and are fairly inexpensive (< $100 lb−1). The packing a C-CP fiber column
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shown in Figure 1.1 is a simple process that can be conveniently performed without any
special equipment.

Figure 1.1 The process of packing a C-CP fiber microbore column

LC-MS top-down proteomics and its current challenge
One of the largest fields of biomedical research is the field of proteomics. With the
realization that proteins can serve as markers for disease diagnostics, it is logical that
research has aimed to elicit the protein composition in diverse bio-media. With more
complexity than the human genome, the Human Proteome Project has attempted to map
the vast protein landscape.21 The search for biomarkers, interactions, and the thresholds of
the marker status (presence, absence, abundance), are practical goals of present research.
In order to identify and use proteins as biomarkers, a sample must be drawn from a relevant
physiological pool and prepared for analysis, examples include urine, serum, saliva, tissue
and sexual fluids.22
One challenge in LC-MS is the physico-chemical limitations of the separation step,
particularly for biomolecule analysis.23 For example, solvent flow rates that are optimum
for the separation may be too voluminous to efficiently ionize and desolvate the analyte in

2

an ESI source. Indeed, the identity of the LC solvent (based on volatility, acid/base
character, polarity, etc.) can disqualify it from use with MS detection. For example, ion
pairing agents used in RP-LC, such as trifluoroacetic acid (TFA), become ionization
suppressants in mass spectrometry,24 requiring post-separation remediation.25 Developing
methods that are reliable and maintain high sensitivity and speed can pose particular
challenges given the nature of protein separations on porous media.24 With reference to the
diversity of matrices where potential biomarkers may exist, the same chromatographic
method can in fact yield pronounced differences in analyte retention time.26 In such cases,
the specificity of MS detection far outweighs the general simplicity of performing the same
experiment with UV-Vis absorbance detection.
In practice, one must consider the palette of LC mobile phases and potential
additives that are acceptable. In addition, there are limited to the solvent loading (separation
speed). These aspects, in-turn, lead to restrictions on potential modes of chromatographic
separation. For example, separations that involve large changes in the ionic strength, pH,
non-volatile mobile phases are not directly interfaceable to ESI-MS; thus ion exchange and
hydrophobic interaction chromatography (IEX and HIC) are excluded.27,28 By the same
token, RP separations, where high concentrations of ion pairing agents are employed, are
problematic. Thus any proposed protein separation protocol must be designed with these
parameters in mind.
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Exosomes and its traditional purification methods
Extracellular vesicles (EVs) are small membrane-bound particles with various
functions and origins.29 So far, three major types of extracellular vesicles have been
characterized: apoptotic bodies (>1000 nm), microvesicles (150–1000 nm), and exosomes
(30–150 nm). Formed within the endocytic compartments, exosomes are released into the
extracellular space via fusion of multivesicular bodies with the cell surface membrane.30
They are produced by normal as well as malignant cells and are present in all human body
fluids, including blood, urine, cerebrospinal fluid and ascites.31-33 Exosomes are considered
potential biomarkers for diagnosis and prognosis of several diseases such as colorectal
cancer, prostate cancer, glioblastoma, or cerebrovascular disease.34 For functional and
biomarker analysis, it is essential to obtain a pure population of exosomes, excluding
matrix components such as proteins and genetic material.35,36
The most commonly used techniques to isolate exosomes from biomedia relies on
their physical properties of size and shape. Thus, exosomes are usually isolated by a
complex and lengthy procedure which includes differential centrifugation to remove
cellular fragments and large vesicles, ultracentrifugation at 100,000×g for 2–3 h, and
sucrose density gradient centrifugation to recover purified exosomes at densities of 1.1–
1.2 g mL−1.37,38 The primary drawback of this method is that it is time consuming. In
addition, this method yields a relative crude product, as contaminants, such as protein
complexes and co-sedimenting vesicles are pelletized along with exosomes. In addition,
the tendency of exosomes to form aggregates under centrifugal forces results in losses,
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which further complicates their recovery. Repeated ultracentrifugation steps can reduce the
quality of exosome preparations leading to lower exosome yield .32,33
Ultrafiltration is an alternative tool for exosome isolations.37,38 Unfortunately,
particle yields can be very low in pressure-driven concentrating devices in comparison to
sedimentation devices. Non-specific adsorption to both cellulose and Biomax®
(polyethersulfone) membranes result in an additional loss mechanism. Eventually, the
recovery of exosomes gradually decreases as the pores of membranes become blocked.4042

Exosomes can also be isolated via size-exclusion processes (either in spin-down or
chromatography formats), which have been shown to significantly reduce contamination
(proteins, etc.) in plasma-derived EVs when compared with centrifugation-based
methods,34,35 though the levels of contamination are still debated. In one case, the purity of
exosomes isolated via SEC was estimated by protein concentration analyses using Western
blot and bicinchoninic acid assays (BCA). It was found that a co-eluting band contained
serum proteins with the exosomes from the SEC columns, especially those proteins having
large molecular weights.
Immunoaffinity-based capture methods are another useful method for the isolation
of cell-specific exosomes.37,39,43,44 Exosomes may be captured based on antibody
selectivity, specificity, and the affinity/binding constant. Unfortunately, this process may
also exclude potentially important exosome populations. In addition, recent nanoarraybased immunoaffinity devices can require up to 60 h of processing time to isolate exosomes
from simple buffer solutions.36 Finally, many of these time-consuming multistep
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immunoaffinity-based processes and methods can damage exosomes and reduce their
overall collection efficiency.
More recently, several commercial protocols and techniques that claim to take less
time and lead to greater purification have been developed to isolate exosomes using
precipitation and isolation at lower centrifugation speeds.34,36 Results show that these
commercial precipitation reagents are more efficient and enable higher exosome
enrichment factors when compared with traditional ultracentrifugation; however,
subsequent imaging analysis was not possbile. In addition, these methods are not free from
protein contamination. Finally, there are concerns on how the precipitating agents or the
high rotation speeds used in these processes may affect the properties of the exosomes and
the efficiency of the immunochromatographic strips.

Two dimensional liquid chromatography
Over the last two-plus decades, two-dimensional liquid chromatography (2D-LC)
techniques have emerged as powerful separation platforms for affecting high peak capacity
separations.45,46 Recent advances have been motivated by greater fundamental
understanding of the potential and limitations of the technique. In this regard, ultra-high
pressure LC (UHPLC) hardware has enabled greater throughput of second-dimension
separations.47

The most commonly used modalities of 2D-LC separation include

comprehensive, selective comprehensive, and heart-cutting analysis.48 As early as 1978,
Erni and Frei introduced the so-called “comprehensive” 2D-LC technique,49 followed by
significant advances by Bushey and Jorgenson.45 Comprehensive 2D-LC (LC x LC)
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analysis reflects the fact that consistent fractions of the entire eluent of the first dimension
(1D) are transferred to the second dimension (2D), i.e., the entire 1D chromatogram is
sequentially-sampled into 2D, while heart-cutting mode reflects only selected fraction will
be transferred to 2D for additional chromatographic analysis.50-52 In comparison to 1D-LC,
2D-LC should achieve better separation efficiencies and greater overall peak capacities.53
According to Giddings, 2D-LC performance depends upon the orthogonality of the
respective LC modalites.54,55 The demonstrated potential for modern 2D-LC to outperform
1D-LC has attracted considerable attention from a variety of application areas, including
the pharmaceutical industry,56,57 polymer analysis,46,47 and the life sciences.58
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CHAPTER TWO
COUPLING OF CAPILLARY-CHANNELED POLYMER (C-CP) FIBERS FOR
REVERSED PHASE LIQUID CHROMATOGRAPHY AND ESI-MS FOR THE
DETERMINATION OF PROTEINS IN A URINE MATRIX

Introduction
One of the largest fields of biomedical research is the field of proteomics. With the
realization that proteins can serve as markers in disease diagnostics and treatment, it is
logical that research has aimed to elicit the protein composition in diverse bio-media. With
more complexity than the human genome, the Human Proteome Project has attempted to
map the vast protein landscape.1 The search for biomarkers, interactions, and the thresholds
of the marker status (presence, absence, abundance), are practical goals of present research.
In order to find and use proteins as biomarkers, a sample must be drawn from a relevant
physiological pool and prepared for analysis, examples include urine, serum, saliva, tissue
and sexual fluids.2 While each of these is a prime source for different proteins/markers,
there is increased focus on developing strategies for using urine as a universal test medium,
indeed spawning the field of urine proteomics; aka “urinomics”.3,4
The desire to increase the utility of urine as a test matrix is due to the fact that
collection is non-invasive and sample size in most cases is relatively large. Finally, normal
protein levels remain relatively stable in a subject, so changes observed reveal key
diagnostic information.5,6 Urine protein levels have been used to profile pediatric cystinuria
and diabetic nephropathy progression, among other diagnostics and health monitoring
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assays.7,8 Unfortunately, the overall protein content in urine is extremely low, and so
analyte enrichment methods become crucial in order to have any hopes of diagnosing
characteristic species. This situation is compounded by the fact that the heavy, salt and
small molecule-laden matrix is the antithesis of the ideal for ESI-MS.9-11 Other
complications exist due to the high solids content and potentially high viscosity of the urine
matrix. Thus, while being perhaps the ideal matrix in terms of clinical diagnoses, it is one
of the worst-case scenarios in terms of measurement science.12
Because of the challenges in protein monitoring and analysis due to the complexity
of samples,13,14 a separation step or multiple steps are standard practice in proteomics.15,16
Current methods include solid phase extraction (SPE), 2D gels, ligand binding assays,
precipitation steps and filtration steps.17-20 Each of these methods adds time to analysis,
adds to the potential of analyte loss, and perhaps contamination. SPE is often used as a
method of matrix removal, but can often be a bottleneck point in sample analysis
throughput. After SPE, the sample components are separated using capillary
electrophoresis (CE) or reversed phase liquid chromatography (RP-LC) prior to coupling
with ESI-MS for detection.15,16 In the first case, high throughput and resolution can be
obtained, at the cost of potential perturbations of the system due to the solution chemistry
taking place in both the separation and ionization steps. Liquid chromatography holds
general advantages in method development simplicity (at least for “small” molecules) and
the fact that multiple means of detection can be readily affected (e.g., in-line UV-Vis
absorbance).
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Often the challenges in LC-MS come from physico-chemical limitations in the
separation step, particularly for biomolecule analysis.21 For example, solvent flow rates
that are optimum in the separation may be too voluminous to efficiently ionize and
desolvate analyte in an ESI source. Indeed, the identity of the LC solvent (based on
volatility, acid/base character, polarity, etc.) can disqualify it from use with MS detection.
Ion pairing agents used in RP-LC, such as trifluoroacetic acid (TFA) become ionization
suppressants in mass spectrometry,11 requiring postseparation remediation.22 Developing
methods that are reliable and maintain high sensitivity and speed can pose particular
challenges given the nature of protein separations on porous media.21 With reference to the
diversity of matrices where potential biomarkers may exist, the same chromatographic
method can in fact yield pronounced differences in analyte retention time.23 In such cases,
the specificity of MS detection far outweighs the general simplicity of performing the same
experiment with UV-Vis absorbance detection. Based on the above discussion it is
pragmatic to move into the arena of urinomics, having the ultimate goals of high
throughput, sensitive, protein identification, to work from the detection process backwards
to the initial sample input. Of course, this approach is natural in all forms of separation
science as the means of separation and detection must be able to co-exist, hopefully under
conditions of optimum performance for each. As such, it is reasonable to acknowledge that
ESI-MS provides advantages in terms of sensitivity, flexibility, and information content
among the common detection strategies for proteomics. From that point, one must then
consider the palette of LC mobile phases and potential additives that are acceptable. In
addition, there are limitations as to the solvent loading (separation speed). These aspects,
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in-turn, lead to restrictions as to the potential modes of chromatographic separation. For
example, separations that involve large changes in the ionic strength, pH, non-volatile
mobile phases are not directly interfaceable to ESI-MS; thus ion exchange and hydrophobic
interaction chromatography (IEX and HIC) are excluded. By the same token, RP
separations where high concentrations of ion pairing agents are employed are problematic.
Thus any proposed protein separation protocol must be designed with these parameters in
mind.
We describe here the first extension of previous efforts in the use of capillarychanneled polymer (C-CP) fiber stationary phases into the realm of LC-MS analysis of
proteins. The fibers have been employed in fast LC separations of proteins using standard
UV-Vis absorbance detection.24-26 C-CP stationary phases are extruded from
polypropylene (PP), polyester (PET), and nylon 6 base polymers in the form of 30–50 mm
diameter fibers having eight channels running along their periphery.27 Packed in a column
format, the fiber channel walls interdigitate to affect a monolith of thousands of parallel
open channels. High column permeability coupled with very low intra-fiber porosity
provides a phase that permits protein separations to be affected at extremely high (>50 mm
s-1) linear velocities,28-30 without the ill-effects of van Deemter C-term (mass transfer)
broadening. The as-extruded fiber surface chemistries allow effective protein separations
in the RP, IEX, and HIC modes. The surfaces can be modified on-column through simple
adsorption or covalent ligand coupling to provide greater selectivity.31-35 Beyond their use
in analytical protein separations, very high throughput and yield have been realized relative
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to preparative chromatography. Finally, the C-CP materials have been applied with success
as SPE media for protein analytics.37-40
The adaptation of C-CP fiber protein separations is presented in terms of ESI-MS
detection. Test samples of a four-protein suite (ribonuclease A, cytochrome c, myoglobin
and lysozyme) were prepared in common phosphate-buffered saline (PBS) and synthetic
urine matrices. The principle challenge in this application is driven by the fact that C-CP
separations are optimized at high linear velocities, counter to the case for porous media.
This also goes against the general tendencies where ESI-MS sensitivity is inversely related
to the solvent volume flow rate. Therefore, an in-depth evaluation of column format and
operating parameters was required meet the apparent conflicting needs of the separation
and detection steps. The effects of microbore column diameter and volume flow rate are
evaluated with respect to the chromatographic quality as determined with UV-Vis
detection, with the final target being sensitive, high fidelity detection by ESI-MS. Narrow
(0.5 mm i.d.) bore columns operated at volume flow rates of up to 0.5 mL min-1 are readily
employed, with the separation characteristics and sensitivity being the same for the buffer
and mock urine matrices. It is believed that the coupling of RP-LC of proteins on C-CP
fiber phases and ESI-MS presents a number of attractive features in the field of proteomics,
and more specifically urinomics.

Materials and methods
Column construction
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C-CP fibers (40 mm diameter) were melt-extruded in the Clemson University,
School of Material Science and Engineering (Clemson, SC, USA). Polypropylene (PP4 by
in-house designation) was chosen based on previous evaluations from this laboratory in
terms of protein chromatography and SPE.26,29 Fibers were removed from the primary
bobbin using a rotary counter to acquire the desired column fiber density. The fibers were
heat shrunk using boiling water and then cleaned sequentially in water, acetonitrile and
methanol to remove any latent anti-static spin-coating. Clean fibers were pulled by hand
using a monofilament through lengths of PEEK tubing (Cole- Parmer, USA) of two
different inner diameters; 0.5 mm and 0.8 mm. Based on previous efforts, the number of
fibers in the respective columns (220 and 480) was initially chosen to acquire an interstitial
fraction of ~0.61,29 as determined by uracil injections. The columns were then flushed with
MilliQ water and ACN until a stable absorbance baseline at 216 nm was achieved.
Sample preparation and solution delivery
Stock protein solutions of 500 mg mL-1 each in ribonuclease A, lysozyme,
myoglobin, transferrin and cytochrome c from Sigma Aldrich (St. Louis, MO, USA) were
made up in MilliQ water (conductivity 18.2 mU cm-1, Millipore Water System, Billerica,
MA) + 0.1% TFA and kept frozen between uses. Mobile phase components of the same
MilliQ water at a 0.1% TFA (Sigma Aldrich, Milwaukee, WI, USA) composition, and
HPLC grade acetonitrile (ACN) (Fisher Scientific, Pittsburgh, PA, USA) and a 0.1% TFA
composition were prepared in lab. For studies using the different sample matrices, 100 mg
mL-1 protein solutions were prepared by dissolving proteins in 100 mM phosphate buffered
saline (PBS) and a synthetic urine matrix (194 g urea, 6 g calcium chloride, 11 g

19

magnesium sulfate and 80 g sodium chloride dissolved in 4 L of MilliQ Water).
Chromatographic gradient elution conditions varied, but all began at 100% aqueous 0.1%
TFA and ended at 100% ACN with 0.1% TFA. All data reported in graphic form are the
results of triplicate separations, with the error bars representing ~1 s from the mean value.
Equipment
Two instrumental apparatus were used in this work. Basic characterization of the
column hydrodynamics (e.g., interstitial fraction) was performed on a Dionex (Sunnyvale,
CA) Ultimate 3000 HPLC system with a multi-wavelength VWD-3400 RS UV/Vis
detector controlled by Chromeleon 7 software. The combined LC-MS experiments were
performed on a Thermo Scientific Surveyor+ LC-ESI-MS system. The system employs a
Thermo Scientific (Waltham, MA, USA) LCQ Advantage Max™ ion trap mass analyzer
(operating in the positive ion mode) and the accompanying Xcalibur™ data acquisition
software were used as the MS system. The instrument employs a universal Ion Max source
that was operated here in an ESI mode. MS system performance was optimized using
ribonuclease A as a standard compound, employing the Xcalibur™ auto-tune function. The
system software also controls the combined LC and MS functionality.

Results and discussion
Relationship between volume flow rate and mobile phase linear velocity
Tailoring of the RP protein separations for conventional ESI-MS detection brackets
the mobile phase operational space to slightly acidic solutions, preferably composed of
volatile solvents, and flow rates that should not exceed 0.5 mL min-1. All previous works
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with C-CP fiber columns have shown optimum separation qualities at the highest possible
linear velocities (Uo), and with fibers packed to an interstitial fraction (εi) of 0.6–0.65.26, 29
Of course the linear velocity is directly related to the volume flow rate. As flow rates
increase, so must linear velocity, which in the case of virtually non-porous stationary media
such as C-CP fiber, increases the rate of mass transfer, and ultimately the speed of
separation. Therefore, to achieve high linear velocities, but remain under the 0.5 mL min-1
solvent-load limit of the ESI, the inner diameter of the columns must be reduced, but not
to the extent of compromising the column loading capacity. The relationships between
volume flow rate and linear velocity for the 0.8mm i.d. column size used previously26 and
a 0.5 mm i.d. PEEK column are shown in Fig. 2.1. Uracil injections under non-retaining
conditions on columns of equal length and interstitial fraction (0.61) were used to calculate

Figure 2.1 Comparison of linear velocity responses to increased solvent volume flow rate
for 0.5 mm and 0.8 mm i.d. C-CP fiber columns. Columns of equal length (30 cm) and
packed to an interstitial fraction of ~0.61.
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the linear velocities. At the maximum volume flow rate of 0.5 mL min-1 the 0.8 mm i.d.
columns affect a linear velocity of ~30 mm s-1, while the column with half the inner
diameter yields a linear velocity of over 70 mm s-1, a value that approximates well those
that have shown excellent protein separation quality on other C-CP columns.25, 26, 29 Across
the entirety of the flow rate changes, the required back pressures increase linearly, with the
maximum back pressures for the columns being 450 and 600 psi for the 0.5 and 0.8 mm
i.d. formats, respectively. The fact that both the velocities and back pressures change in
proportion to the flow rates reflects the fact that the column packing remains consistent.
Applying flow rates below 0.5 mL min-1 is the best condition for coupling with ESI-MS
detection. Based on the ability to affect high linear velocities at low solvent loadings,
method development based on the 0.5 mm i.d. columns was pursued.
Effects of column length and interstitial fraction on separation characteristics
In general terms, chromatographic retention time differences (ΔtR) are proportional
to the length (L) of columns, whereas the diffusional broadening (van Deemter B term)
increases with L1/2, thus efficiencies of separations are in proportion to L1/2.41 Thus there
are trade-offs to be considered between the ability to affect rapid (short columns) and
efficient (long columns) separations. An additional benefit of longer columns is overall
loading capacity. Unlike packed-bed and monolithic columns, the lengths of C-CP fiber
microbore columns can be increased without stressing the backpressure limits of typical
HPLC systems.
To elucidate the effects of column length on separation characteristics, column
lengths of 5, 10, 15, 20, and 30 cm were evaluated. Fig.2.2a presents representative
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Figure 2.2 Effects of column length on the chromatographic performance of PP C-CP
fiber columns. (a) Chromatograms for three protein suite and (b) resultant resolution.
Analytes: ribonuclease A, cytochrome c and transferrin (10 mg mL-1 each, 5 mL
injection), mobile phase: 0.1% aqueous TFA to 100% ACN + 0.1% TFA, gradient rate:
10% B min-1, flow rate: 0.4 mL min-1, 216 nm absorbance detection.
chromatograms for the separation of three proteins, ribonuclease A, cytochrome c and
transferrin under constant gradient rate and linear velocity conditions as noted in the figure
caption. Visual inspection of the chromatograms suggests no significant change of
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retention time or peak character. Consistent in each, a small peak appears between
cytochrome c and transferrin, evolving from a shoulder on cytochrome c peak to a
completely isolated peak, with increasing column length. Based on individual protein
injections, this entity is a decomposition product of cytochrome c. Across this range of
column lengths, the resolution of the critical pairs (ribo A/cyto c and cyto c/transferrin)
increases from ~1.9 to 2.9 for the former, and ~3.4 to 3.7 for the latter. As in the case of
most protein separations, the retention times for the respective peaks depends on the
gradient program and the critical protein elution composition. In this case, the gradient
conditions remain unchanged, and so the ΔtR values are virtually unchanged. Interestingly,
the peak widths for the first two proteins decrease by 42% (ribonuclease A: from 0.163 to
0.101 min; cytochrome c: from 0.128 to 0.065 min) across the column lengths, while the
width of the transferrin increases by 17% (from 0.108 to 0.126 min). The decreasing widths
can be rationalized by a higher degree of bed homogenization at greater lengths (i.e., van
Deemter A-term variability is averaged out). The increased width for transferrin is not Bterm related as the retention times do not change appreciably, and so relatively slower
desorption kinetics seem to be coming in to play. This is not unexpected given the much
higher molecular weight and greater hydrophobicity (based on elution order) of this
protein. The trade-offs in peak characteristics here yield overall improvements in
chromatographic resolution with increasing column lengths seen in Fig.2.2b without
appreciable penalties with regards to throughput. In addition, it must be emphasized that
an only ~20% (from 350 psi to 450 psi) increase in backpressure is realized when
comparing the 5 and 30 cm-length columns.
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Previous work in this laboratory has shown that the optimum interstitial fraction
(εi) both for small molecules and for protein separation using 0.8 mm i.d. column was
~0.63.29 Higher interstitial fractions (greater column free space) lead to increased nonuniformity of the bed and lower ones led to impeded flow paths; resulting in broader peaks
in both cases. It would be hazardous to assume that this packing density would necessarily
be optimum for the 0.5 mm i.d. column moving forward. The effects of column interstitial
fraction were evaluated for 0.577, 0.585, 0.597, 0.610, 0.629 and 0.643. Representative
chromatograms for the three-protein suite are shown in Fig.2.3a. As noted above, because
the retention times are tied to gradient conditions, the tR values across the entire set of
chromatograms remain essentially unchanged. As was the case of the larger diameter
column, the packing density has a pronounced effect on the peak widths and shapes, with
greater tailing seen at low εi, and slight fronting at high εi. As a result, the obtained
resolution values shown in Fig.2.3b shows an optimum at 0.61 for both protein pairs. The
slight change in optimum packing density from the previous 0.8 mm i.d. columns, to a
higher value, seems to reflect the fact that there is less fiber-to-wall friction with the smaller
i.d. columns. As such, tighter packing can be affected without deleterious effects in the bed
homogeneity.
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Figure 2.3 Effects of column interstitial fraction (length = 30 cm) on the
chromatographic performance of PP C-CP fiber columns. (a) Chromatograms for threeprotein suite and (b) resultant resolution. Analytes: ribonuclease A, cytochrome c and
transferrin (10 mg mL-1 each, 5 mL injection), mobile phase: 0.1% aqueous TFA to 100%
ACN + 0.1% TFA, flow rate: 0.4 mL min-1, 216 nm absorbance detection.

Roles of gradient rate and volume flow rate on separation characteristics
As stated above, the retention times for protein elution are dictated by the critical
gradient composition required to allow protein desorption from the hydrophobic fiber
surface. It is important to note, though, that protein release is not a true on– off process.
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Due to the many points (and types) of interaction of proteins with any stationary
phase, elution occurs over a range of solvent concentrations. In order to study the role of
gradient rate on separation qualities, rates were varied at a constant flow rate of 0.4 mL
min-1 (~55 mm s-1). The RP gradients employed for these studies ranged from 0.1%
aqueous TFA to 100% ACN + 0.1% TFA, with the percentage B change per unit time
varied from 5 to 25% B min-1. Each gradient program had a one minute loading segment
before the initiation of the gradient. Gradients in this experiment were kept linear, that is,
at the initiation of the gradient, the rate was constant over the time period.
Fig.2.4a presents the chromatograms for the gradient separations of a four-protein suite
including ribonuclease A, cytochrome c, lysozyme and myoglobin. It is visually clear that
gradient rate has a profound effect on the separation as the efficiency increases with the
length of the gradient program. Based on the gradient conditions, the elution window for
the proteins is between 34 and 48% ACN. The resolution between these four peaks
significantly improves as the gradient rate is decreased from 25 to 5% B min-1. Of course,
both the peak widths and ΔtR values are effected by the changing gradient as presented in
Table 2.1. For porous-bead RP columns, if the gradient rate is too slow, the proteins would
diffuse and broaden the peak shape, reducing the resolution, as it takes longer for proteins
to elute in the mobile phase. However, this situation didn't happen using the C-CP fiber
column (0.5 mm i.d.). Here, the peak widths (w1/2) also increase by a factor of ~2X as the
gradient rate is reduced, as with porous bead RP columns, while the peak separation times
(ΔtR) increase by a factor of ~4X across the protein suite. The peak width response reflects
the fact that proteins actually elute over a range of solvent compositions, with the peak
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Figure 2.4 Effects of gradient rate on the chromatographic performance of PP C-CP
fiber columns. (a) Chromatograms for four-protein suite and (b) resultant resolution.
Analytes: ribonuclease A, cytochrome c, lysozyme, and myoglobin (10 mg mL-1 each, 5
mL injection), mobile phase: 0.1% aqueous TFA to 100% ACN + 0.1% TFA, flow rate:
0.4 mL min-1, 216 nm absorbance detection.
separation following the slower evolution of the gradient. As a result, the realized
improvement in resolution represented in Fig.2.4b is a factor of ~2X as the gradient rate is
reduced from 25 to 5% B min-1. Slower gradient rates provide better separation efficiency,
at the expense of longer process times and higher solvent consumption. Based on these
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considerations, a compromise gradient rate of 6.25% B min-1 was employed through the
remainder of the studies.
Table 2.1 Peak characteristics for four-protein (ribonuclease A, cytochrome c, lysozyme,
and myoglobin) separations as a function of gradient rate (% ACN increase per minute).
Constant flow rate of 0.4 mL min-1 (55 mm s-1).

After choosing the gradient rate, the relationship between flow rate (linear velocity)
and separation quality for the 0.5 mm i.d. column are demonstrated in Fig.2.5 through the
resolution of a four-protein separation (ribonuclease A, cytochrome c, lysozyme, and
myoglobin) taken under identical gradient conditions. At flow rates higher than 0.5 mL
min-1, a significant compromise in sensitivity is expected due to poor ionization efficiency
and limited sampling efficiency. The mobile phase flow rates of 0.1–0.5 mL min-1 equate
to linear velocities of ~12–70 mm s-1. Consistent with previous reports, the relative
retention times for the proteins presented in Table 2.2 are for the most part invariant with
flow, but there is a substantial improvement in the peak widths. Essentially, higher linear
velocities lessen the extent longitudinal broadening (van Deemter B-term). As indicated in
Fig.2.5, the resolution of the four peaks improves substantially as the velocity increases,
clearly demonstrating a lack of mass transport limitations (van Deemter C-term). It is also
encouraging to note that precision of the separations, as viewed in the reproducibility of
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the retention times and resolution are not sacrificed at high linear velocities. The values
observed for these quantities in fact vary on the order of 1–3% RSD for three replicates.

Figure 2.5 Effects of volume flow rate (linear velocity) on the resultant resolution of the
four-protein suite. Analytes: ribonuclease A, cytochrome c, lysozyme, and myoglobin (10
mg mL-1 each, 5 mL injection), mobile phase: 0.1% aqueous TFA to 100% ACN + 0.1%
TFA, 216 nm absorbance detection.
As the sensitivity of ESI-MS is inversely related to the solvent loading (flow rate),
it is reasonable to run protein separations on the C-CP fiber phases at modest flow rates,
while still achieving sufficient resolution. Likewise, lower flow rates pose less stress on
compression fittings used to mount the polymer column tubing. Based on the data
presented in Fig.2.5, the difference between resolution achieved by 0.4 mL min-1 and 0.5
mL min-1 is not significant. Therefore, it was decided to undertake the remainder of the
ESI-MS efforts at a flow rate of 0.4 mL min-1 (Uo = 55 mm s-1).
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Table 2.2 Peak characteristics for four-protein (ribonuclease A, cytochrome c, lysozyme,
and myoglobin) separations as a function of solvent volume flow rate. Constant gradient
rate of gradient rate 6.25% ACN min-1.

LC-ESI-MS detection
Having derived operational parameters that allow for a low solvent burden for a
conventional ESI source, while not compromising the inherent efficiency of protein
separations on C-CP fibers, the final experimental point of concern must be the matrixinduced effects on the ionization processes. As has been employed in virtually all RP
protein separations on C-CP fiber phases, trifluoroacetic acid (TFA) is a very common ion
pairing agent used in reversed phase chromatography to control mobile phase pH and peak
shape. However, TFA is a well-known ion suppressant in ESI-MS.11, 22, 42, 43 In order to
erase the ion suppressant effects of TFA, the ion pairing agent is replaced with weak acids,
such as formic acid (FA).22, 44 In order to keep the mobile phase pH the same, a 1.5% FA
was present instead of 0.1% TFA in solvents A and B. In doing so, sacrifices are made in
terms of the product resolution of the protein separation. In practice, the loss in resolution
moving from 0.1% TFA to 1.5% FA is quite minimal (less than 5%), without reoptimization of other parameters. Therefore, 1.5% FA was used in all ESI-MS experiments.
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Fig.2.6 demonstrates the ability to separate a four protein mixture (ribonuclease A,
cytochrome c, lysozyme, and myoglobin) at a concentration of 20 mg mL-1 each, in an
undiluted urine matrix for analysis by ESI-MS. The chromatographic quality obtained for
the UV-Vis absorbance detection mode (Fig.2.6a) can be compared to that in Fig.2.4a for
the same 6.25% B min-1 gradient with TFA as the pairing agent and solutes introduced in
a PBS matrix. Differences in retention time are due to the use of an accelerated gradient in
the early portions of the FA separation. The reduced signal-to-noise (S/N) performance in
the case of the FA separation is due to the necessity of 280 nm absorbance monitoring as
FA presents substantial background at 216 nm as used in the TFA case. Even so, it is quite
clear that the complex urine matrix poses no appreciable challenge to the separations on
the C-CP fiber phase. By the same token, the total ion chromatogram (TIC) of the same
separation (Fig.2.6b) exhibits little loss in chromatographic quality, which is due to the fact
that there is a mismatch between the diameter of the microbore column, the transfer
capillary, and the ESI source. There is a delay in the apparent retention times (~0.4 min)
due to the further transit between the absorbance cell and the ESI source. Very different
from the case of the absorbance detection, the TIC shows an appreciable injection peak due
to the elution of the urine matrix components which are un-retained on the polypropylene
fibers. A loss in S/N performance is seen in the TIC due to the very nature of the experiment
(all signals contributing), but the extracted single ion chromatograms (SIMs) of the
respective protein masses show very high S/N, reflecting the efficiency of the on column
desalting.
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Figure 2.6 Chromatographic traces (a) absorbance at 280 nm and (b) ESI-MS total ion
chromatogram (TIC) for the four protein mixture in an undiluted synthetic urine matrix
(20 mg mL-1 each, 5 mL injection). Gradient rate: 0.5 min hold in 1.5% aqueous FA, 0–
20% ACN + 1.5% FA in 1 min, 20–50% ACN in 4 min, flow rate: 0.4 mL min-1.
The ESI mass spectra extracted from the central portion of the respective protein
elution peaks are presented in Fig.2.7. Each peak's spectrum is determined by averaging
the spectra of the center of the elution peak, while subtracting the spectra of the neighboring
chromatographic baselines for an equivalent time period. The resulting spectra are
deconvolved within the Surveyor system software, charge states assigned and molecular
weights calculated. The figure includes labels of the most prominent of the nH+ charge
states for each of the proteins, with the assigned molecular weights correctly identified as
(a) ribonuclease A, 13 700 Da, (b) cytochrome c, 12 327 Da (c) lysozyme, 14 300 Da and
(d) myoglobin, 17 000 Da. The ability to deconvolve individual proteins from a
chromatograph increases the chances of identifying the analyte, augmenting the
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Figure 2.7 Extracted ESI-MS spectra representative of each of the four proteins for the
separation presented in Fig. 1.6. (a) Ribonuclease A, 9H+ charge for 1522 m/z; (b)
cytochrome c, 16H+ charge for 774 m/z; (c) lysozyme, 10H+ charge for 1432 m/z; (d)
myoglobin, 18H+ charge for 943 m/z.
information from a typical UV-Vis chromatogram, which gives little to no identification
or structural information. It should be noted that the charge states are higher in these spectra
in comparison to those of the proteins introduced by direct infusion. Proteins tend to
denature in hydrophobic environments, including the surface of the fibers and the nonpolar mobile phase components. It is well understood that a protein will exhibit higher
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charge states in ESI when denatured as more protonation sites are available. Early studies
comparing the extent of protein denaturing on C-CP fibers and C18 stationary phases on
porous silica supports reflected that lesser amounts of denaturation occurred on the fiber
phases.

Conclusions
This work has served to consolidate many past findings surrounding the use of CCP fibers as stationary phases in protein analytics. Polypropylene C-CP fibers employed
in microbore formats have demonstrated excellent efficiency for protein separations that
improves with mobile phase linear velocity. At the same time, the use of the fibers as solid
phase extraction media allows for very convenient desalting prior to ESI and MALDI-MS
analysis.38, 40 Here, for the first time, we demonstrate the direct coupling of C-CP fiber
separations with ESI-MS for the determination of proteins in a urine matrix. The operation
target for the effort was to perform efficient, rapid separations, at mobile phase
(acetonitrile: water) flow rates of >0.5 mL min-1, as dictated by the ESI source solvent
tolerance. To meet this limit, C-CP fiber columns of reduced diameter (0.5 mm) were
employed to lower the volume flow rates while maintaining linear velocities >50 mm s-1.
A full parametric evaluation was performed for three- and four-protein mixtures,
including variations in column length, interstitial fraction, gradient rate, and volume flow
rate using UV-Vis absorbance detection. The effects of the parameters on protein retention
times, peak widths, and ultimately resolution yielded separations that could be effected in
gradient times of less than 3 minutes, with resolving powers of greater than 2, for all of the
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critical pairs. While trifluoroacetic acid is the most common ion pairing agent in RP protein
separations, its effects in the ESI process cause severe suppression of protein MS
responses. Therefore, the method was modified with the use of formic acid as the pairing
agent. In this case, there was little effect on the chromatographic performance in the
separation of the same suite of proteins, now in a mock urine matrix. Direct coupling of
the separation to the ESI-MS resulted in high quality spectral performance that was not
subject to the chromatographic and ionization interferences that would be expected in the
presence of the urine matrix.
In the future, work would include employing these methods to quantify proteins in
complex matrices to further the application of C-CP fibers for proteomic analysis. It would
also be interesting to see the effect that temperature would have on C-CP fiber column
separations. A further reduction in back pressure would be expected, but it would be
interesting to see the effect on resolution, peak shape and separation time, as the solvation
strength should increase with temperature. Other studies should look into the transfer
kinetics and whether, in the case of C-CP fibers, the flow rate or the linear velocity is the
driving force of the separation efficiency. While the two parameters are clearly dependent
upon one another, it seems that even when the linear velocity is comparable, if the flow
rates are different, the separation time is also different. Questions into glycoproteomics and
whether the C-CP fibers have the capacity to separate glycoproteins to further
diagnostics.45,

46

Current trends in proteomics point to a desire to create single step

bioreactor/analyzers by immobilizing trypsin on the surface of a column to digest a protein
and simultaneously separate the digest products. Research in this group has shown promise
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in the field of surface modifications via lipid-tethered ligands (LTL).31, 47 It would be
conceivable to immobilize a trypsin enzyme to the LTL to digest proteins on column.
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CHAPTER THREE
DYNAMIC EVALUATION OF A TRILOBAL CAPILLARY‐CHANNELED
POLYMER FIBER SHAPE FOR REVERSED PHASE PROTEIN SEPARATIONS
AND COMPARISON TO THE EIGHT‐CHANNELED FORM

Introduction
RP‐LC has been one of the most commonly used separation modes in HPLC1.
Dominated by stationary phases of acyl‐bonded, porous silica beads, RP‐HPLC is capable
of separating analytes in complex mixtures based on hydrophobicity, hydrogen‐bonding
affinity, and extent of functional group ionization2. One of the most useful areas of RP
separations is in the biological sciences, including analysis of complex materials and the
purification of bio‐analytes (the caveat here being the potential loss of enzyme/protein
activity)3, 4. RP‐HPLC coupled with UV absorbance or ESI–MS detection has been used to
separate and identify nucleic acids in forensic samples5, nucleotide metabolites in blood6,
proteins in complex mixtures7, and for peptide analysis8, clearly demonstrating the
method's comprehensive role in the separation of biological analytes9.
Despite the clear prevalence among all HPLC stationary phases, alkyl‐silica micro‐
particulates are not without disadvantages in terms of biomacromolecule separations, such
as whole, intact proteins. Most of the surface area in these supports lies within the porous
silica particle, leading to high binding capacities and chromatographic efficiencies for
small molecules, particularly with the advent of sub‐2 μm supports (i.e. UHPLC). In many
respects, these developments challenge the need to affect greater efficiency and higher
throughput in biomacromolecule LC as slow intraphase mass transfer leads to band
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broadening. In the extreme, proteins may be excluded from the pore volumes, making the
added surface area inconsequential. Silica‐based phases are also known to be unstable
under high pH conditions10 and prolonged exposure to phosphate buffers common to
biological sciences11. These issues reduce column lifetime and increase the preponderance
of ionizable silanol groups that lead to decreased column efficiencies and poor recoveries.
In response to these shortcomings, stationary phases of greater chemical stability
and enhanced mass transfer and hydrodynamic properties have been developed.
Historically monolith stationary phases have been on the forefront of these efforts12.
Monolith columns are based upon the polymerization of monomers to create a through‐
pore network, allowing for the application of high flow rates at moderate backpressures13,
while providing a surface that is more conducive to biomolecule separations. With the
development of UHPLC, sub‐2 μm superficially porous phases have been applied for rapid
and efficient biomolecule separations14-17. In comparison to conventional totally porous
particles of the same size, superficially porous phase show improved mass‐transfer kinetics
that allow more rapid separations of macromolecules.
Marcus and coworkers have developed capillary‐channeled polymer (C‐CP) fibers
as an alternative support/stationary phase for biomacromolecule separations on the
analytical and preparative scales18-20. The combination of the fiber micro‐ and macro‐
structures and in‐column orientation allows operation at extreme linear velocities (∼100
mm/s) without excessive system backpressures19, 21. Upon packing, the fibers interdigitate
and form collinear channels that act similarly to single‐micron open tubular columns with
regards to mass transfer and hydrodynamic properties22, 23. The ability to move fluid
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efficiently through the structures is complemented by the fact that the fiber physical
structure is effectively nonporous with respect to the size of proteins, therefore there is no
intrafiber diffusion. Ultimately, these factors combine for protein separations that are
devoid of appreciable van Deemter C‐term broadening21, 23.
Throughout all the works with C‐CP fiber phases, the dominant band broadening
mechanisms can be attributed to the van Deemter A‐term effects23,25,26, reflective of
inhomogeneities in the column fiber packing. To this point, C‐CP fibers have been extruded
with eight, nonuniform channels that run the length of the fiber. The present work looks to
an alternative fiber shape that is trilobal in nature. On a first‐principles basis, and supported
through preliminary computation modeling, fibers of this shape should provide more
uniform packing in comparison to the eight‐channeled version. Fibers extruded from
polypropylene (PP) starting materials are employed here as the RP mode has been the most
widely applied for protein separations. The new “Y‐shaped” fiber (denoted as PPY) is
compared to the traditional eight‐channeled fiber (denoted in previous works as PP4)27.
Figure 3.1 shows SEM images of cross sections of PPY and PP4 packed columns.
Comparisons are made in terms of RP chromatographic performance for the two fiber
shapes for protein separations, with the packing density of the PP4 fibers chosen based on
the best performance reported in previous works27. Results of this study suggest that this
shape is an obvious evolution in the production of next generation C‐CP fibers for high
throughput protein separations.
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Figure 3.1 SEM images of C‐CP fiber packed columns. PPY on the left was packed at εi
= 0.405 and PP4 on the right was packed at εi = 0.616. Micrographs a and b taken at
X110 magnification, c and d taken at X350 magnification
Materials and methods
Chemicals and sample preparation
HPLC‐grade ACN and MeOH (Fisher Scientific, Pittsburgh, PA, USA), milli‐Q
water (DI‐H2O, deionized water; 18.2 MΩ‐cm, purified with Millipore, Merck, Germany)
purification system, and TFA (Sigma–Aldrich, Milwaukee, WI, USA) were used in sample
and mobile phase preparation. BSA (BSA), ribonuclease A (ribo A), cytochrome c (cyto
c), myoglobin (myo), lysozyme (lyso), and transferrin (trans) were purchased from Sigma–
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Aldrich. Stock solutions were prepared with 2 mg/mL of each protein in DI‐H2O and
diluted to the working concentrations of the day of the analysis.
Column construction and evaluation
Polypropylene C‐CP fibers were manufactured by the Department of Materials
Science and Engineering at Clemson University. The extrusion process employs spinnerets
having 120 fibers in the yarn for the eight‐channel and 35 fibers in the yarn for the trilobal
version. Once extruded and drawn, the average perimeter was ∼200 μm per fiber for the
eight‐channel fiber format and ∼120 μm per fiber for the trilobal version. SEM was used
to examine the fibers and their packing uniformity. A variable‐pressure scanning electron
microscope (Hitachi, SU6600, Japan) was operated in the variable pressure mode at 30 Pa,
and the accelerating voltage was set to 20 kV.
Columns were packed with C‐CP fiber using previously described methods28.
Polyether ether ketone (PEEK) tubing used as the column body was purchased from Cole‐
Parmer with a 0.76 mm internal diameter, with columns prepared at lengths of 300 mm.
The packing of the PP4 columns was held constant at a value of two rotations, representing
a total of 480 fibers and an interstitial fraction (εi) of 0.616, and used as a benchmark
throughout21,23. PPY fiber columns of different εi were prepared by pulling different
numbers of fibers through the tubing.
Before all studies, fresh columns were washed with ACN and then DI‐H2O until a
stable baseline absorbance was observed at 216 nm, reflective of the removal of any anti‐
static coatings applied in the fiber extrusion process. Data for the van Deemter
characterization was collected using two markers compounds under nonretaining
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conditions. Uracil (20 µg mL-1) was used with a mobile phase of 5% ACN (by volume) in
H2O with 0.1% TFA, and BSA (20 µg mL-1) was used with a mobile phase of 50% ACN
(by volume) in H2O with 0.1% TFA. Column permeability was determined for each column
using Darcy's Law with ACN, DI‐H2O, and MeOH as solvents.
Instrumentation and methods
All chromatographic measurements were performed on a Dionex Ultimate 3000
HPLC system (LPG‐3400SD quaternary pump and MWD‐3000 UV–Vis absorbance
detector; Thermo Fisher Scientific, Sunnyvale, CA) controlled by the Chromeleon 7
software system. Auto‐injection, rather than manual mode, provided better reproducibility
and lower plate heights, supported by van Deemter plots for the various column types.
Solvent gradients, flow rates, and loading amounts were optimized using a 20 μL injection
of a four‐protein suite, ribo A, cyto c, lyso, and myo. All data were collected in triplicate
for each set of experimental conditions with solvent baseline absorbance subtracted based
on gradients with no protein injection.

Results and discussion
Initial van Deemter evaluation of trilobal and eight‐channeled fiber columns
The fiber packing density in C‐CP columns is the most critical parameter in terms
of hydrodynamic quality as it affects the permeability/interstitial fraction and the
uniformity of the packing and flow paths. As a starting point for the comparative analysis
with the PP4 version, columns constructed using nine and ten rotations of the PPY fibers
yielded physical structures that were stable and easily prepared. The most common method

47

to determine column efficiently is to calculate the number of theoretical plates achieved
under a given set of conditions. Plate number is defined as
𝑡𝑟
𝑁 = 16( )2
𝑤
where N is the number of theoretical plates, tr is the retention time, and w is the width of
the peak. Plate number (N) is more practically calculated by based on data system outputs
as
𝑁 = 5.545(𝑡𝑟 /𝑤0.5 )2
where w0.5 is defined as the peak width at half height.
Increases in plate height are the result of zone broadening processes. The
subclassifications of peak broadening are described in the van Deemter equation1.
𝐻 =𝐴+

𝐵
+𝐶∗𝑢
𝑢

H is defined as the height of each theoretical plate, and u is the linear velocity of the mobile
phase. The efficiency of a column is inversely related to the H value. The A‐term represents
factors that lead to variations in flow paths, and the effects are minimized by improving
packing/flow uniformity. B‐term broadening is related to longitudinal diffusional and is
inversely proportional to the linear velocity of the mobile phase. C‐term broadening is
caused by limitations in solute mass transfer to/from the stationary medium and/or poor
adsorption/desorption kinetics29. C‐term broadening is the limiting factor to high‐speed
macromolecule separations on porous media as zone broadening increases with linear
velocity for species having low diffusion coefficients.
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It is common to look to alternative hydrodynamic models of band broadening
(typically the Knox and Giddings models) as parametric influences are interdependent30-32.
According to Giddings coupling theory, the effects of eddy dispersion and transverse
diffusion should be combined to account for an actual attenuation of band dispersion
according to:
𝐻=

𝐴
𝐸
1+ 𝑢

+

𝐵
+𝐶∗𝑢
𝑢

The Knox equation is the most widely used variant of the van Deemter equation32 and
assigns an empirical one‐third power dependence for the A term on linear velocity:
𝐻 = 𝐴𝑢1/3 +

𝐵
+𝐶∗𝑢
𝑢

In previous studies using butylparaben (MW = 194 Da) as the marker compound,
the latter two models performed similarly, both better than the van Deemter equation23. In
this study, the column efficiencies of the two differently shaped polypropylene C‐CP fibers
were determined. Figure 3.2 displays three different sets of van Deemter plots (including
two rotations of PP4, nine and ten rotations of PPY fibers), using uracil (20 μg/mL, solid
circles) and BSA (10 μg/mL, open circles) as the unretained markers compounds. As
measured with/without column, by 20 μL uracil injections, the interstitial fractions were
calculated as εi = 0.616 (ten rotation PP4 fibers), εi = 0.457 (nine rotation PPY fibers) and
εi = 0.405 (ten rotation PPY fibers).
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Figure 3.2 van Deemter plots for the standard PP4 and two PPY columns of different
interstitial fraction. Unretained markers a) uracil (closed circles) injected in 5%
ACN:H2O with 0.1% TFA and b) BSA (open circles) injected in 50% ACN:H2O with
0.1% TFA. Linear velocities correspond to mobile phase flow rates of 0.1–0.8 mL/min
The general trends observed for both solutes are consistent with previous C‐CP
fiber column evaluations23,25, reflecting the fact that the overall performance is A‐term
limited, with very minor contributions by C‐term broadening at what would be considered
as very high linear velocities33,34. This demonstrates that C‐CP fiber columns can maintain
efficient performance at high linear velocities (up to 55 mm/s here); a crucial quality in
terms of throughput. The minor visual slope is relatively flat when compared monoliths
operating at the same linear velocity. In general, the uracil marker has a slightly higher
slope (C‐term) with increased linear velocities as compared to the BSA marker, indicative
of intraphase diffusion24. Overall, the trilobal fiber shapes provide better hydrodynamic
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efficiency than the PP4 format. The minimum H = 0.11 mm value determined for the PPY
phase compares very well with other phases. For example, Chen and coworkers achieved
plate heights of 0.1 mm on superficially porous silica using carbonic anhydrase as the
marker protein at a linear velocity 12 mm/s35. Fang and coworkers also used carbonic
anhydrase on PS‐DVB monoliths in capillary LC formats (100–200 μm id) yielding plate
heights of 0.030–0.060 mm at similar linear velocities34. Of course, such columns have
very low volume throughput and mass loading capacities.
Reduction of the raw data presented in Figure 3.2 into numerical form was
accomplished through Matlab (MathWorks, Natick, MA, USA) fitting into the van
Deemter, Knox, and Giddings equation parameters. As listed in Table 3.1, subtle
differences in the graphic data become clearly delineated. Consistent for both solute sets,
the packing quality of the higher density (lower εi) PPY appears better than the other two
columns, having lower A‐term values. This is expected as the packing uniformity of the
trilobal shape appears to be better than the eight‐channel (Figure 3.1). Additionally, there
is less void space in the ten‐rotation compared to the nine‐rotation trilobal, holding fibers
more firmly in place with respect to each other. An appreciable difference is seen in the A‐
term coefficients between the uracil and protein solutes, with the macromolecule values
being much lower. In principle, these values should not be different, but likely reflects the
“randomness” of solute access to the minute fiber pores; the uracil having access and the
protein, not. With respect to the extracted B‐term coefficients, there is no appreciable
difference among the column types, within each of the solutes. A clear improvement is
seen when moving from the small molecule to protein values; as would be expected.
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Perhaps the most interesting comparison for the three columns is in the C‐term coefficients.
If one considers that the C‐term is only related to intraphase hold‐up, then one might expect
the PP4 and PPY fibers to be different as they are extruded and drawn under different
conditions, affecting the fiber porosity. This is clearly the case as the PPY fibers show
order‐of‐magnitude lower C‐terms for both solutes than the PP4, reflective of more
strenuous drawing conditions for the trilobal fibers.
Table 3.1 Extracted van Deemter, Knox, and Giddings parameters for PP4 and PPY
columns using uracil and BSA as markers

Based on datasets of uracil injection, the Knox, and Giddings equations show better
fits than the van Deemter equation. The improvements likely result from linear velocity
influence associated with A‐term (Knox equation) and the inclusion of an additional
parameter (Giddings equation). However, a comparison among the three hydrodynamic
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models produces no real differences in terms of the capacity to fit the respective data for
BSA, resulting in goodness‐of‐fit (R2) values of > 0.993 in all cases.
Column permeability characteristics
Given the desire to perform protein separations under native sample conditions that
can be quite viscous, and the general benefit of C‐CP fiber operations at high mobile phase
linear velocities, it is important to characterize the pressure/flow relationships of the
trilobal phase. The three most common solvents employed in RP chromatography (H 2O,
ACN, and MeOH) were used to measure the permeability of the PP4 and ten‐rotation PPY
columns corresponding to volume flow rates of 0.1–0.8 mL/min. The backpressure of the
PP4 column is slightly lower (∼15%) than for the PPY column. For example, the
backpressures for PP4 with 40 mm/s linear velocity are 12.5, 5.0, and 8.5 psi/cm,
respectively, (water, ACN, and MeOH), while for PPY are 12.6, 5.9, and 10.0 psi/cm. In
practical terms, higher linear velocities (beneficial for protein throughput) are realized for
the PP4 due to the higher permeability. In addition, the qualitative (linear) responses reflect
no evidence of bed structure perturbations as the flow rates are increased.
Table 3.2 contains the specific permeability of the two types of fiber columns for
each mobile phase. The PPY fiber columns have a lower specific permeability than the PP4
columns due to higher packing density, which is expected and consistent with SEM images
(Figure 3.1C and D). Both of the permeability values are superior to most monolith
columns, which have permeability measurements 104–105x smaller than C‐CP fibers36. As
described in previous reports20,27, the high permeability has benefits, including high
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throughput, short analysis time, and reduced susceptibility to clogging problems with
viscous samples such as cell culture media or body fluids.
Table 3.2 Comparison of PP4 and PPY column permeability using three solvent systems
(calculated using Darcy's Equation)

Roles of packing density (εi) on resolution and mass loading capacity
In general terms, the shape of the fibers influences the performance of the column
through the specific surface area and the quality of the packing. As shown in Figure 3.1,
the cross‐sectional SEM images taken with 110 and 350x magnification, the PPY column
visually suggests better channel homogeneity in comparison to PP4. As fiber packing
densities increase, the PP4 fibers having eight capillary channels with thin walls have more
propensity for collapsing and creating less‐uniform free space. Greater benefits would be
expected in fine‐tuning the packing density of the PPY fibers.
To compare the separation characteristics between standard PP4 and PPY fibers,
columns were assembled with εi values ranging from 0.387 to 0.612 for PPY and the
standard 0.616 value for PP4. A four protein mixture (ribonuclease A, cytochrome c,
lysozyme, and myoglobin) was separated using a constant 0.5 mL/min flow rate and a 15
min gradient 100% H2O with 0.1% TFA to 100% ACN with 0.1% TFA21,27. It is understood
that operation of the different columns at the same volume flow rates, does impact the
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resultant linear velocities, but in each case, the velocities are within the flat portions of the
van Deemter diagrams for proteins. Representative chromatograms for the four‐protein
suite are shown in Figure 3.3A. As seen, each chromatogram shows complete resolution of
the proteins with similar peak shapes. As would be expected, based on being extruded of
the same base material (polypropylene), the same protein elution order is observed. The
somewhat higher operational velocity for the successively lower εi PPY columns is
apparent in slightly shorter retention times for the most‐retained myoglobin. Finally, the
PP4 column show greater tailing than the PPY fibers. One particular point of difference
between the shapes is apparent in the associated asymmetry factors (As) listed for the
myoglobin band in each chromatogram. The asymmetry is greatest for the PP4 and the
highest εi PPY columns, with a gradual decrease to a minimum for the εi = 0.405 PPY
column.

Figure 3.3 (A) Comparison of chromatograms for standard PP4 and PPY columns of
different interstitial fraction. (B) Resolution of three critical pairs in the protein mixture.
Conditions: flow rate = 0.5 mL/min, 15 min gradient (0.1% aqueous TFA to 100% ACN
+ 0.1% TFA,). Peaks: a) ribonuclease A, b) cytochrome c, c) lysozyme and d) myoglobin
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The resolution (n = 3) for both PP4 and the various PPY columns are presented in
Figure 3.3B, clearly identifying εi = 0.405 as the optimal interstitial fraction for PPY.
Indeed, the observed value is ∼10% higher than for the PP4 column. However, with similar
packing densities, the separation efficiency for PP4 is better than PPY of the same
interstitial fraction. The trends across the PPY columns are similar to previous
studies21,23,27, where higher interstitial fractions (greater column‐free space due to less
dense packing) lead to increased nonuniformity of the column bed. Tighter packing leads
to impeded flow paths as channels can start to collapse. These packing characteristics result
in a resolution maximum for the εi = 0.405 PPY column. Overall, based on the Rs and As
considerations, that would be the optimum packing density.
The second component to packing density is the change in available fiber surface
area to affect the protein separations. The four‐protein mixture composed of 0.04 to 0.40
μg total mass of each protein was injected using the previously described gradient
conditions. Representative chromatograms (SI Figure A-2a for PP4 and SI Figure A-2b for
εi = 0.405 PPY) are presented as indicated for the individual protein loadings. In the case
of column overload, the peak retention time would not change, but would exhibit tailing37.
The retention times do indeed remain the same, but profound tailing is observed for the
PP4 column as the mass load is increased, with not so much for the PPY.
There are greater extents of tailing for the PP4 column in general, with the response
to increased loading, particularly above the level of 0.2 μg. Beyond the hydrodynamic
aspects to the broadening/asymmetry that should be solute mass‐independent, the overload
aspects would naturally be attributed to differences in available fiber surface area to affect
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the separations. In fact, this is not the case, as the theoretical available fiber surface area
for is 288 cm2 for PP4 and 277 cm2 for PPY. Thus, there are issues of accessible surface
area as the higher interstitial fraction PP4 column does not provide as efficient mass
transport to the fiber surfaces. One of the most common attributes of C‐CP fiber phases is
the fact that solute mass transport to the surface (i.e., protein loading) increases with the
shear rate of the mobile phase through the capillary network23,26,38. This finding is
consistent with those earlier studies as the interfiber spacing of the PPY fiber column is far
smaller than the PP4 column.
Roles of mobile phase flow rate and gradient rate on separation characteristics
Dynamic parameters of flow rate and gradient rate were studied using PPY (εi =
0.405) and PP4 (εi = 0.616) columns. The four‐protein mixture was used and peak
resolution performance was compared between the two columns under the same operating
conditions.
A range of mobile phase flow rates (0.2 mL/min to 0.6 mL/min) was compared
using the same 15 min gradient (aqueous 0.1% TFA to 100% ACN with 0.1% TFA) as
used in the previous section. Representative chromatograms of the PPY column separations
are shown in Figure 3.4A, while the computed resolution for both the PP4 and PPY
columns are plotted in Figure 3.4B (solid line represents PP4 and dashed PPY). As seen in
Figure 3.4A, retention times change dramatically as the flow rate is increased, a trait
common to all C‐CP fiber separations19,21,39. More importantly, the obtained resolution on
both columns improves substantially as mobile phase flow rate is increased (Figure 3.4B),
by virtue of the narrower elution bands at higher linear velocities while the actual time
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differential for the respective bands remains constant at ∼0.5 min in all cases. Notably,
both curves parallel each other in their responses and seem to be approaching a limiting
resolution value with increased flow rate. This suggests that the resolution gains from
increasing the flow rate will eventually approach negligible returns in terms of
chromatographic performance. A final factor to consider is the potential overlaps due to
the band broadening at the baseline of each peak; i.e. peak asymmetry.

Figure 3.4 (A) Comparison of chromatograms as a function of volume flow rate for the εi
= 0.405 PPY column. (B) Resolution of three critical pairs in the protein mixture.
Conditions: injection volume = 20 μL, 15 min gradient (0.1% aqueous TFA to 100%
ACN + 0.1% TFA).
To assess the role of gradient rate on separation qualities, rates were varied at a
constant solution flow rate of 0.5 mL/min. The gradients composition change was 0.1%
aqueous TFA (solvent A) to 100% ACN + 0.1% TFA (solvent B), with the percentage B
change per unit time varied from 4.17 to 16.67% B min−1 (equivalent to 24 to 6 min gradient
times). Each program had a 1 min loading segment before the initiation of the linear
gradient.
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As depicted in the representative chromatograms of Figure 3.5A, the eluting peaks
respond as expected to increasing gradient rates (from top‐to‐bottom). Higher gradient
rates yield narrower peaks, appearing at shorter retention times, and with greater
absorbance responses. Retention times decrease as those critical elution values are reached
in shorter amounts of run time, with the narrower elution windows improving response
characteristics. Interestingly, if only solvent composition was a factor, then the resolution
at different slopes would be maintained. This does not seem to be the case as the
cytochrome c and lysozyme peaks begin to merge into one another, indicating that the
desorption process is kinetically limited. Simply, the gradient can pass through the elution
band before the protein itself can release. This kinetic aspect is apparent in the
corresponding plots of resolution versus gradient rates for both the PP4 and PPY fiber
columns presented in Figure 3.5B (solid line represents PP4 and dashed PPY). It is visually
clear that gradient rate has a slight inverse effect on the separation, as the efficiency
increases with the length of the gradient program. The loss in efficiency is less than would
be anticipated on porous phases, as a quadrupling the gradient rate results in <50% (and
most less) decreases in resolution. This is considered to be an excellent trade‐off in
performance for throughput. There is a similar response seen in the w0.5 values, though,
with the bands eluting from the PPY column being narrower. As such, the Rs values plotted
in Figure 3.5B are all higher for the PPY column than for the PP4. As a final point of
comparison, the gradient had a pronounced effect on the peak asymmetry for the PP4
column, but not on the PPY where the As values clustered between 1.0–1.1 across the
board. The lower extent in asymmetry seen with faster gradients for the PP4 data suggests
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that the release kinetics are improved for that system, but they did not influence the
situation for the PPY. Consistent with previous works, the benefits of higher shear in the
case of the C‐CP fiber separations are to lessen the degree of unfolding, thus narrowing the
range of elution windows for proteins. In this case, the lower shear of the PP4 separation
benefits from higher gradient rates, but there was not kinetic benefit for the PPY.

Figure 3.5 (A) Comparison of chromatograms as a function of gradient rate for the εi =
0.405 PPY column. (B) Resolution of three critical pairs in the protein mixture.
Conditions: injection volume = 20 μL, flow rate = 0.5 mL/min, (0.1% aqueous TFA to
100% ACN + 0.1% TFA)
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Comparison of protein separations between trilobal and eight‐channeled fiber columns
Having evaluated the parametric factors affecting the quality of the PPY fiber
separations, a more stringent test of the respective fiber shapes was undertaken with a more
complex, six‐protein mixture. In terms of the phase chemistries and hydrodynamics,
columns of the two fiber types (PP4 and PPY) are optimally operated under virtually the
same separation conditions. Using the optimized conditions, the mixture was analyzed at a
mobile phase flow rate of 0.6 mL/min, and a 5% B min−1 (20 min) gradient slope. The test
solution contained 100 μg/mL each of ribo A, cyto c, lyso, myo, BSA, and trans, with an
injection volume of 5 μL employed for separations on the PP4 (εi = 0.616) and PPY (εi =
0.405). Visual inspection of the chromatograms for the two columns of (Figures 3.6A and
B), it is clear that both peak shape and column efficiency is superior on the PPY fiber phase,
resolving all six proteins with lessened peak tailing. On the other hand, in the case of the
baseline width‐derived resolution (Rs (wb)), obtained by taking a tangent from the peak
front and back to the baseline, the superior performance of the trilobal geometry becomes
apparent, with the average improvement being ∼12%.
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Figure 3.6 Comparison of chromatograms for synthetic six‐protein suite (ribo A, cyto c,
lyso, myo, BSA, and trans, 100 μg/mL each) separation on (A) PP4 (εi = 0.616), and (B)
PPY (εi = 0.405) columns. Conditions: injection volume = 5 μL, flow rate = 0.6 mL/min,
20 min gradient (0.1% aqueous TFA to 100% ACN + 0.1% TFA). Peaks: a) ribo A, b)
cyto c, c) lyso, d) myo, e) BSA, and f) trans
The improved separation quality is due to the improved uniformity of the PPY fiber
columns at higher packing densities. The fact that C‐CP fibers have negligible C‐term
broadening implies that the only limitation to the mass transfer kinetics is the rate of
desorption from the stationary phase. As the mobile phase changes with time, faster flow
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rates will cause faster desorption and will result in sharper peaks. At the same flow rate of
2 mL/min, the PPY column has a linear velocity of ∼160 mm/s in comparison to the PP4
column that has a linear velocity of only ∼110 mm/s, a 46% difference. PP4 columns do
not operate nearly as well as PPY columns at higher packing densities due to collapse of
the fragile eight‐channeled fibers, increasing the variation in the average channel diameter.
The channels on PPY are much larger and much more resistant to channel collapse
allowing for higher packing densities without sacrificing packing uniformity.

Conclusion
Two differently shaped C‐CP fibers, the well‐characterized eight‐channeled PP4
and newly developed trilobal PPY, have been compared to determine the potential of the
latter fiber as an improved stationary phase in biomacromolecule separations. It was
anticipated that the greater structural integrity in terms of fiber shape retention and better
packing uniformity for the PPY would result in improved chromatographic characteristics.
Overall, the quality of protein separations on the PPY fibers paralleled those of the eight‐
channeled version in terms changing separation parameters (linear velocity, gradient rates,
etc.). Column efficiencies were determined for a variety of interstitial fractions using two
separate markers, uracil and BSA as marker compounds. Both fiber shapes exhibited
excellent mass transfer kinetics, indicating a lack of C‐term broadening even at high linear
velocities. In terms of chromatographic performance, lower plate heights, greater
resolution, lower amounts of peak asymmetry, and greater tolerance to protein mass
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loading was realized for the PPY column. In all cases, enhanced performance can be
attributed to higher fiber densities and packing uniformity for the PPY fiber columns.
This study sets the groundwork for the development of a superior next generation
of C‐CP fibers. The basic structure of the PPY fibers seen in Figure 3.1 suggests the
capacity to affect greater packing densities with increased channel uniformity than realized
with the PP4 fibers. As seen, general fiber‐to‐fiber size uniformity is clearly a problem, but
its influence can only be determined post extrusion optimization. Smaller, more uniform‐
sized, PPY fibers, will lead to further improved packing homogeneity as the variability in
the microchannel structure decreases. The current limitation is the ability to apply uniform
pressure in the melt extrusion process, to yield greater primary fiber uniformity before the
drawing‐down process to affect smaller sizes. This is the focus of current efforts, which
are expected to pay large benefits for C‐CP fibers extruded from the different base polymer
materials, thus allowing greater versatility in the modality of the protein separations.
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CHAPTER FOUR
OVERLOAD EFFECTS IN REVERSED PHASE PROTEIN SEPARATIONS USING
CAPILLARY‐CHANNELED POLYMER FIBER COLUMNS

Introduction
For decades, new stationary phases holding advantages in terms of efficiency, high
throughput, and low‐cost have attracted great interest, including porous and non‐porous
beads, monoliths and membranes.1-8 In addition to the more common support/stationary
phases, there have been attempts to develop fiber‐based chromatographic stationary phases
for protein separations.9-14 Natural and synthetic polymer fibers have found use in a variety
of chromatographic modes, including materials such as cellulose (cotton), polystyrene
sulfonate, polypropylene (PP), and polyester (PET).
In a general sense, overload chromatography taking place under non‐linear
conditions, is of high relevance in preparative separations.1-8 However, many studies have
revealed that column overloading is very common in separations of proteins on the
analytical scale via reversed phase liquid chromatography (RP‐LC).15-20 No matter the
physical and chemical properties of such stationary phases, including commercially
available columns, only very small amounts of protein sample can be injected before
distorted peak shapes appear due to non‐linear processes. As a general rule, this situation
occurs at solute concentrations of 10−4 to 10−3 g per mL of bed volume.8 As examples,
column efficiency decreases dramatically (~20 and ~50%) from 0.5 to 1.0 μg injections of
model molecules using commercial XTerra C18 (3.5 μm, 15 cm × 0.46 cm I.D.)21 and
Kinetex C18 (2.6 μm, 5 × 0.46 cm I.D.),20 porous, silica‐based columns.

68

In an effort to understand general retention and overloading mechanisms, some
basic factors have been studied under different RP‐LC separation conditions, including
various buffers having different ionic strength and pH.22, 23 Despite the extensive works of
Guiochon and co‐workers on sorption isotherms of overload band profiles under various
RPLC conditions19, 24-28 and McCalley's continuing efforts to understand overloading effect
of basic compounds in RP‐LC,17, 20, 21, 29-32 the study of sample overloading effects on peak
shape, peak width and efficiency is still relevant for different analytical‐scale LC platforms.
Theoretical approximations and experimental data have shown that overloading effects
increase as the ionic strength of the mobile phase is reduced.15, 19, 28 Unusual peak shapes
have been attributed to mismatches between the solute, the injected sample matrix, and the
mobile phase pH/composition. Fornstedt et al.22 investigated the overloading of pH‐
matched samples with two types of columns, hybrid silica C18 columns (Phenomenex
Gemini and Kromasil Eternity) and purely polymeric (polystyrene/divinylbenzene and
poly[hydroxymethacrylate]) columns without C18 ligands. They found that peak distortion
was not related to the initial pH mismatch between sample solution and mobile phase.
As an alternative point of view, several papers suggest that the gradient deformation
while moving down the column would lead to the distorted peak shape. As described by
Ladisch and co‐workers,33, 34 the concentration of the organic additive in the mobile phase
is assumed to be a high enough for it to lie in the nonlinear region of its own adsorption
isotherm, that is, interaction with the stationary phase. For example, acetonitrile (ACN;
considered as modulator in reversed phase chromatography) would have deformation of its
concentration distribution within the column. Thus, anomalous behavior and unexpected
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shapes of protein elution peaks would occur because of the deformed gradient, even below
injection masses where protein overload should occur. Continuing,35, 36 modulator sorption
(deformed gradient shape) was suggested to significantly affect peak shapes and retention
times, both in reversed phase and hydrophobic interaction chromatography.
Furthermore, it was observed that the overloading effects appeared on different
types of columns with C18 ligands, independent of the base matrix (silica, hybrid silica, or
polymeric). Additionally, overloading effects are also found with non‐ligated polymeric
phases, which do not contain C18 ligands or silanols.22, 23, 37-39 However, results showed
that peak tailing, which appears on traditional C18 stationary phases under conditions of
sample volume overload, were not observed on nonderivatized polymeric phases. Thus,
perhaps not surprisingly, different mechanism and phenomenon of overload effect exist
between the various supports and stationary phases. Ultimately, the disparity in overload
characteristics exhibited on analytical‐scale columns with respect to protein separations is
a complex composite of the physical attributes of the support phase, the chemistry of the
stationary phase, the solvent system, and the specific proteins under study.
Marcus and co‐workers have investigated the merits of capillary‐channeled
polymer (C‐CP) fiber stationary phases13, 14, 40 for protein separations under RP‐LC, ion
exchange chromatography and affinity chromatography41-47 conditions. These 30‐ to 50‐
μm diameter polymer fibers are made in a melt‐spin process by extrusion from PP, PET,
and nylon 6 base materials through an orifice with the desired shape. Fiber surfaces can be
modified on‐column through simple adsorption or covalent ligand coupling to provide
greater selectivity.41-43,

45-47

The close, parallel packing of the eight‐channeled fibers
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provides a unique transport medium. Very low intrafiber porosity,48 allows protein
separations at extremely high linear velocities (100 mm s−1) without negative effects of
intraphase mass transfer (van Deemter C‐term) broadening.49-52 Likewise, with high
column permeability, faster flow rates minimize longitudinal diffusion (van Deemter B‐
term).52 Ultimately, packing inhomogeneity dominates peak broadening (van Deemter A‐
term). Beyond their use in analytical protein separations, very high throughput and yield
have been realized relative to preparative chromatography.51-53 Recently, an RP‐LC
method was developed specifically for coupling the C‐CP fiber separations with
electrospray ionization mass spectrometry (MS) detection.54 Based on results of those
studies, and the relatively low specific surface area of C‐CP fibers (2–5 m2 g−1), it is
imperative to understand potential overloading effects on the “analytical” chromatographic
quality of the C‐CP fiber columns in protein separations.
In this effort, we investigate the overloading effects in terms of analytical RP‐LC
protein separations on PP C‐CP fiber columns. Using bovine serum albumin (BSA, MW ≈
66 kDa) as a model protein, quantification of chromatographic peak heights, widths and
shapes allows assessment of the basic loading characteristics of protein on the fiber phases
as a function of mass load, injection volume, mobile phase flow rate, column length, and
mobile phase pH. Column efficiency, expressed in terms of plate count (N), was evaluated
based on the standard peak area height and half‐height approaches, as well as the Dorsey‐
Foley method.55 A mixture of proteins ranging from 13.7 to 81 kDa was employed to
characterize the resulting chromatographic separation quality as a function of load and
elution parameters. In this case, peak capacity (P) was used as the quantitative metric across
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a range separation conditions. Although the overall response of the C‐CP fiber columns to
increased solute loading is qualitatively similar to other stationary/support phases, those
hydrodymamic characteristics that are unique to this phase also provide novel, unexpected
means of minimizing overload effects.

Materials and methods
Chemicals reagents and materials
Stock protein solutions (2 mg mL−1 each) were prepared from ribonuclease A (Ribo
A), α‐chymotrypsinogen A (Chymo A), BSA, holo‐transferrin (h‐Tf), lysozyme (Lyso),
myoglobin, and cytochrome c (each purchased from Sigma Aldrich, St. Louis, MO, USA)
in 150 mM phosphate‐buffered saline (PBS) and kept frozen between uses. Further
dilutions were prepared in PBS, PBS + 0.1% trifluoroacetic acid (TFA) or MilliQ water
+0.1% TFA, based on the different experimental purposes. PBS buffer was made from 8.18
g NaCl, 1.42 g Na2HPO4, 0.24 g KH2PO4 and 0.20 g KCl in 1.0 L MilliQ water
(conductivity 18.2 MΩ/cm, NANOpure Diamond Barnstead/Thermolyne Water System,
Dubuque, IA, USA) and adjusted pH to 7.4. All salt compounds were purchased from
Fisher Scientific (Pittsburgh, PA, USA). A 30 μg mL−1 reagent‐grade uracil solution (2, 4‐
pyrimidinethiol, Acros Organics, Morris Plains, NJ, USA) was prepared in MilliQ water.
The HPLC grade ACN and methanol were purchased from EMD (Billerica, MA, USA).
Formic acid and TFA were purchased from Sigma Aldrich (Milwaukee, WI, USA). Mobile
phase solutions, including MilliQ water + TFA, ACN + TFA, were prepared in the
laboratory as needed.
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Instrumentation
Two instrumental apparatus were used in this work. Basic characterization
experiments involving changes in solute concentration and injection volume using the BSA
model protein were performed on a Dionex Ultimate 3000 HPLC system consisting of an
LPG‐3400SD pump, a WPS‐3000TSL autosampler and a VWD‐3400RS UV–vis
absorbance detector, operated by Chromeleon 6.8 software. Characterization in terms of
multi‐protein separations were performed on a Dionex (Sunnyvale, CA) Ultimate 3000
HPLC system with a 5‐μL injection loop and a multi‐wavelength VWD‐3400 RS UV/Vis
detector controlled by Chromeleon 7 software.
Column construction
Based on previous demonstrations of high efficiency for RP protein separations and
compatibility with MS detection, C‐CP fiber columns constructed of PP4 (40 μm cross‐
sectional diameter) were chosen for these studies.49, 50 The fibers were melt‐extruded by
the Clemson University, School of Material Science and Engineering (Clemson, SC, USA).
Details about packing C‐CP fiber columns have been presented previously.49, 56 The size
of PP fiber used in this study is 3 denier per filament (dpf); that is, 3 g per 9,000 m of single
fiber. The perimeter determined through electron micrographic imaging of cross sectioned
fibers is 199 μm. Thus, the specific surface area of the PP fibers is calculated to be ~0.6 m2
g−1.45, 49
Briefly, fibers are removed from the primary bobbin using a rotary counter to
translate the pre‐determined optimum packing density to a rotation count. The fibers were
heat‐shrunk in boiling house water and then cleaned sequentially in DI‐H2O and ACN to
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remove any residual antistatic spin‐coating. Clean fibers are pulled by hand using a
monofilament through a length of PEEK tubing (~0.5‐mm inner diameter and 30‐cm
length, Cole‐Parmer, USA). Based on previous efforts, the number of fibers in the PEEK
column (one rotation, ~220 single fibers) was employed to attain an interstitial fraction of
~0.62,50 as confirmed by uracil injections. Prior to use, assembled columns were flushed
with MilliQ water and then ACN until stable absorbance at 216 nm (i.e., background) was
maintained.
As a benchmarking exercise, one can calculate a characteristic or hydrodynamic
particle size for the assembled C‐CP fiber bed via Eq.1,8
𝜂𝐹𝐿

∆𝑃 = K0 𝜋𝑟 2 𝑑2

(1)

𝑝

where ΔP is change in pressure (Pa), η is mobile phase viscosity (Pa·s), F is flow rate (m
s-1), L is column length (m), K0 is column permeability (m2), r is column radius (m) and dp
is particle diameter (m) as determined at an ACN flow rate of 0.1 mL min−1. Based on these
pressure/particle size relationships, a hydrodynamic particle size of 1.6 μm was calculated.

Results and discussion
Mass and volume overloading in protein separations
There are two forms of overload that are generally experienced in LC systems; mass
and volume. Fundamental considerations on mass and volume overloading have been
discussed in detail and some general consensus has long existed.8, 57-61 As a signature
response under mass overloaded conditions, the front of an eluting peak becomes sharp
while pronounced tailing is exhibited. In addition, the breakthrough time of the peak front
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is shortened; this is regarded as a “fronting” situation. On the other hand, as injection
volumes increase to an overload situation, centroid positions move to longer times as extra
column broadening takes on the primary role in the broadening. The combination leads to
rectangular peaks with flat tops, most prominently for those peaks eluting early in a
separation. Beyond these straightforward phenomena, it is important as well to realize that
the fundamental solubility of specific solutes within the mobile phase and the partitioning
between mobile and stationary phases also have a bearing on the overloading
characteristics of columns.
As a direct measure of the overloading of proteins on PP C‐CP fiber phases, elution
characteristics were determined using BSA as the model protein with the injected masses
increasing from 0.1 to 1.4 μg, with the sample volumes and solute concentrations
continuously varied. Constant protein elution conditions were maintained, employing a
gradient of 100% water +0.1% TFA to 100% ACN + 0.1% TFA in 15 min with a 0.5 mL
min−1 flow rate. Based on the chromatographic responses depicted in Figure 4.1, retention
times are shorter with both larger injection volumes and sample concentrations, both sets
of responses being reflective of overload conditions. In the case of the varying injection
volumes at a constant concentration of 20 μg mL−1 (Figure 4.1a), there is a clear increase
in peak heights with the peak front moving forward in time, with a smaller displacement
of the trailing edge to longer times as well. The peak shape evolves from a predominately
Gaussian shape to one that has a flat top; as such there are aspects of both volume and mass
overload. Interestingly, as the peak evolves to a flat top, there remains a trailing‐edge
shoulder moving towards shorter retention times, somewhat reflecting the shift of the non‐
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overloaded peak. This latter phenomenon has not been observed in previous studies of the
C‐CP phases. A few groups have attributed this kind of peak distortion as being caused by
pH mismatch of the initial mobile phase and sample solution, resulting in variations in
surface charges of proteins.15, 17, 28 This possibility will be discussed in subsequent sections.

Figure 4.1 Influence of injection volume and protein concentration on BSA elution
profiles; total mass varied from 0.1 to 1.4 μg. (a) Injection volume increase from 5 to 70
μL, sample concentration: 20 μg mL−1. (b) Sample concentration increase from 5 to 70
μg mL−1, injection volume: 20 μL. Mobile phase: 100% H2O + 0.1%TFA to 100% ACN+
0.1%TFA in 15 min, Flow rate: 0.5 mL min−1, UV Absorbance @216 nm, PP4 column
length = 30 cm.
Tests of purely mass overloading effects yield the expected responses as depicted
in Figure 4.1b. In this case, the injection volume was held constant at 20 μL, with the
concentration increased by a factor of 12×, from 5 to 70 μg mL−1, equivalent to 0.1–1.4 μg
BSA on‐column. Clearly, the eluting peak height increases with concentration, while
retaining a sharp front that moves toward shorter retention times. The classical triangular
shape emerges with the onset of overload, as the trailing edge terminates at the same time
across the concentration suite. Qualitatively, peak tailing is less problematic using PP fiber
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column than silica‐based phases because the purely polypropylene phase has fewer
secondary interactions. However, as showed in Figure 4.1 a, b, peak fronting appears and
elution time shortens as loading mass increases. Causes such as asymmetric voids at the
head of the column, channeling within the column, or a less dense bed structure along the
walls of the column than in the middle, allows one to project the fronting process. From an
equilibrium perspective, the fronting is a direct reflection of a plot of the solute's retention
factor (k’) as a function of its mobile phase concentration, as is borne out in the applicable
adsorption isotherm for that solute/stationary phase system.8
In terms of the primary contributing factors to the peak distortions experienced on
the C‐CP fiber columns, it must be acknowledged that van Deemter A‐term broadening is
by far the dominant mechanism under non‐overloaded conditions.50, 62 Generally speaking,
when flow rate increases, induced convective flow gradually becomes the dominant
transport process over diffusional effects in the HPLC column. Additionally, the van
Deemter A‐term contributions become dominant and constant, peak broadening effects are
invariant at high flow rates.10, 63 That is, column inhomogeneity is the primary limiting
factor. Breaking down the peak characteristics of the elution peaks in Figure 1 in terms of
constant injected solute mass is quite enlightening. Figure 4.2 presents the peak heights,
peak areas, and peak widths at 50% height (w0.5) as a function of injected protein mass
corresponding to the variable volume (Figure 4.1a) and concentration (Figure 4.1b)
experiments. The peak height responses for the two experimental modes are fairly uniform
as seen in Figure 4.2a, with slightly higher yields in the variable volume case. As expected,
there is a linear response in the peak absorbance as the injected solute mass increases from
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0.1 to 0.8 μg mass injections. Beyond that point, the responses plateau to values of 60–70
mAU. This sort of response is an indication of mass overload effects of a column, as the
solute elution window is broadened. A simple response function constructed across the
solution makeup of Figure 4.1b, without a column present, yields linearity up to
concentrations of 70 μg mL−1, or 1.4‐μg injected mass. This would equate to a column
loading of <0.05 mg protein per g of fiber, a value which is far below the experimental
values of ~1.5 mg g−1 observed in frontal analysis on C‐CP fiber columns.46, 52, 64 Thus, to
no surprise, chromatographic overload in the analytical sense is observed long before
physical overload is realized in preparative‐type separations.
There is a natural question in any situation where less than expected absorbance
values are realized (e.g., Figure 4.2a) as to the potential reduction in protein recovery under
those conditions. In terms of LC employing absorbance detection, the most relevant metric
in this regard is the integrated absorbance (mAU*min) across the eluting peak. As seen in
Figure 4.2b, the integrated absorbance responses in both sets of experimental conditions
do indeed linearly‐follow the mass of BSA injected on‐column. There is no degraded
recovery in either instance, thus effects (reduced peak height values) are purely a product
of the broadening of the solute band as the concentration is increased. There is a very
pronounced difference in the sensitivity (slope) of the response functions presented in
Figure 4.2b for the cases of the variable‐concentration/volume experiments. What appears
to occur is that greater loading efficiency occurs under conditions of a constant BSA
concentration (variable‐volume), and that increasing solute concentrations may limit the
amount of protein that can be loaded under these conditions. This would seem to suggest
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Figure 4.2 Influence of injection volume and protein concentration on BSA elution
profile characteristics; total mass varied from 0.1 to 1.4 μg. (a) Peak height (mAu), (b)
peak area (mAU*min), and (c) peak width (w0.5, min). Data extracted from triplicate
injections of the sort depicted in Figure 1 with errors bars representing the ranges of
determined values. Operation parameters as described in Figure 4.1.
some sort of kinetic limitations as proteins “seek” available sites on the fiber surface.
Clearly, the underlying effects here bear study, and will be addressed in subsequent
sections of this report.
The responses of the w0.5 values as a function of injected mass (Figure 4.2c), for the
two experimental approaches, clearly point to the peak broadening effects of volume
overload being more extensive for the C‐CP fiber column than mass overload. Although
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the peak widths increase fairly monotonically as a function of mass in the constant volume
(variable concentration) experiments, those for the variable volume experiments increase
tremendously. For this particular column, having an interstitial fraction of ~0.62, the
column void volume is ~36 μL, with an extra‐column volume of ~9.3 μL. It is imminently
clear that injection volumes approaching the void volume lead to pronounced broadening
as the equal‐mass peak width values increase greatly beyond the 0.4 μg value (20 μL
volume). As a general rule, injection volumes of >15–20% of the column void volumes are
deleterious on packed‐bed columns. Ultimately, once this condition is reached, extra
column volumes, where there is no stationary phase material, are filled with the injected
analyte solution. As such, tremendous amounts of broadening come into play.
In the realm of analytical protein separations, overload effects are only
consequential once the separation quality of a system is compromised. Column efficiency,
as expressed in the number of theoretical plates (N), was determined using three different
approaches: (i) area height (Eq. 2), (ii) half‐height (Eq. 3), and (iii) Dorsey‐Foley (Eq. 4)
methods. These approaches are implemented according to
𝑁𝐴𝐻 = 2 ∗ 𝜋 ∗ (𝑡𝑟 ∗ 𝐻/𝐴)2

(2)

𝑁𝑊 = 5.54 ∗ (𝑡𝑟 /𝑤0.5 )2

(3)

𝑁𝐷−𝐹 = 41.7 ∗ [𝑡𝑟 /𝑤0.1 ]2 /[𝐴𝑠 + 1.25]

(4)

where tr is the retention time of the eluted peak, H is the maximum peak height, A is the
peak area, w0.5 is the peak width at 50% of peak height, w0.1 is the peak width at 10% of
peak height, and As is the peak asymmetry factor.55 Although such approaches are strictly
relevant for isocratic separations, the fact that the tests were run under identical gradient
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conditions makes them useful for the purposes of comparison. We compared the various
efficiency calculations to determine which method best fits the fiber‐based stationary
phase. The first two approaches are most commonly used in analytical‐scale separations,
while calculation of column efficiency using the Dorsey‐Foley procedure, which takes
peak tailing into account, is much more commonly used in preparative chromatography.39
In instances where column overload is taking place, and severe peak distortions are
common, the area height method tends to produce relatively accurate and reproducible
column efficiency as the integrated response is taken into account.27
As a means of assessing column overload, a plot of apparent plate count versus
sample amount injected, is characterized by two parameters: the limiting plate count (N0)
and the column sample loading capacity (ω0.5).57 The limiting plate count is the theoretical
number of plates that are observed when a small amount of sample is injected, such that
loading follows a linear isotherm modality. In the present experiments, this equates to the
plate count obtained from the injection 0.1 μg of BSA. The column sample loading
capacity, the sample amount that causes a 50% reduction in plate count, is regarded as a
measure of the maximum amount of sample that can be injected onto that column before
the onset of analytically‐relative overloading is taking place. McCalley et al. showed that
N0 values, under constant conditions of column length and mobile phase flow rate and
composition, are almost independent of column type (manufacturer); however, different
column types exhibit significant differences in their ω0.5 values.65
Table 4.1 summarizes the column efficiencies for the two experimental approaches
(variable‐volume and ‐concentration) based on the three computational approaches. In
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addition, the extent of performance degradation is reported for each case as the quotient
N/N0. Implicitly, the half‐height method of plate count determination follows more closely
changes in the peak width, w0.5, with the Dorsey‐Foley having more to do with the extent
of fronting/trailing. (The values presented reflect the average of three injections at each set
of conditions, where the variability in each was <4.1 %RSD). As presented in Table 4.1,
the half‐height approach consistently yields the highest plate counts, among the three
calculations, for the instances of N0 (lowest loading) determinations. The responses of the
plate counts based on the BSA elution characteristics for the variable‐volume data set
decrease steadily by a factor of ~20× using the area height and Dorsey‐Foley formula, but
only a factor of ~10× via the half‐height approach. A somewhat opposing situation exists
in the variable‐concentration data wherein the half‐height plate counts decrease by ~10×,
but those for the area height and Dorsey‐Foley only degrade by ~3×. These contrary
responses point clearly to what is seen visually in Figure 4.1; overloading the C‐CP fiber
column by increased volumes (of constant concentration) greatly affect the shapes and
symmetry near the base of eluting peaks. On the other hand, increasing the loading via
solute mass (constant volume) increases the breadth of the peaks and not so much the
shapes, so the half‐height values are more greatly affected. When calculating the column
efficiency under overload conditions, peak asymmetry is of greater relevance via increased
volumes as showed in the chromatograms. The Dorsey‐Foley method is more appropriate
with increased volumes while area height and Dorsey‐Foley methods are both suitable with
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Table 4.1 Column Efficiencies (N) as Determined by Different Methods and Measured
Peak Asymmetry Under Variable‐Volume (5–70 μL) and Variable‐Concentration (5–70
μg mL−1) Injection Conditions

solute mass (constant volume) as reflected in Table 4.1 in their virtually‐identical N/N0
values. Based on these relationships, and the fact that most analytical situations involve
injections of constant volumes and different solute concentrations, column efficiencies in
subsequent experiments are calculated via the area height method. As a final observation
of the Table 4.1 data, there is a popular conception that overloading effects only occur once
some specific amount of solute is injected.15 However, in our study, measurable changes
in retention time and efficiency can still be observed even for levels of ~0.05 μg of model
proteins on 0.5 mm I.D. columns; thus, it is believed that column overload is a continuum
process, rather than an event which takes place only once a certain mass/volume is injected.
Although the above data and discussions seem to point clearly to a situation where volume
overload has far more detrimental effects that mass, it is not explicitly clear that it is the
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absolute volume from those experiments, as volume and solute mass were inextricably tied
together. In order to decouple these effects, protein injection volumes were varied while
maintaining a constant total mass of 0.6 μg (below the onset of mass overload displayed in
Figure 4.2a). Based on the chromatograms in Figure 4.3, there is no appreciable effect seen
when using increased injection volumes. Neither fronting nor tailing problems appear.
Thus, we consider that volume‐based peak broadening is not problematic so long as the
total mass is below the onset of mass overloading, even with relatively large sample
volumes. In fact, the highest volume depicted in Figure 4.3 exceeds the total volume of the
fiber column employed. This is an advantageous situation in that a separate sample
enrichment step (e.g., solid phase extraction) to reduce injected sample volumes may
become unnecessary, enabling high throughput and sensitivity for LC‐MS detection, for
example. Along these lines, each of the following studies is performed at a fixed injection
volume of 5 μL to remove volume‐based overloading effects, concentrating on mass
overload effects.

Figure 4.3 Influence of injection volume (5–60 μL) on chromatographic responses all
containing 0.6 μg of BSA. Operation parameters as described in Figure 4.1.
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Role of protein molecular weight/ size on overload characteristics
Practical aspects of column overload take on different meanings in moving from
“small molecules” to proteins. For small molecules (e.g., <500 Da), the surface area
excluded by a retained solute is related to molecular mass. For proteins, there is a high
level of diversity of three‐dimensional projections, with the size/shape of the molecule
changing dynamically based on solution phase chemistry and surface hydrophobicity. In
comparison to porous commercial silica‐based phases, polymeric phases generally suffer
from poor column efficiency, because of their low porosity and phase ratios, in terms of
small molecules separations.27 However, the accompanying low intra‐phase porosity and
high column permeability are advantages in terms of mass transfer in the separation of
macromolecules, including proteins.
In order to gain some understanding of the influence of molecular weight /size on
C‐CP fiber overloading effects, four proteins, Ribo A (13 kDa), chymotripsinogen A (25
kDa), BSA (66 kDa), and Tf (80 kDa), were studied across a variety of injected masses via
increased concentration at constant volume (5 μL injection). According to the protein data
base71, these proteins represent a range of three‐dimension footprints, respectively: 30 × 38
× 53 Å3, 49 × 67 × 66 Å3, 118 × 118 × 121 Å3, and 67 × 67 × 138 Å3. Of course, these
parameters are determined via x‐crystallography in the single crystal state, and so the
actually sizes as they are in contact with the fiber surfaces in the HPLC process will
certainly be different. The multi‐protein suite provides a basis to study the roles of solute
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mass, mobile phase flow rate, column length, and potential buffer mismatches in gradient
separations.
As observed in Figure 4.4a, the elution peak heights (adjusted for their relative
molar absorptivities at 216 nm) for Chymo A, BSA and Tf follow the general trends
observed for BSA (Figure 4.2a) in terms of mass overloading. In each case, there is a
gradual, though not strictly proportional, increase up to loading masses of ~1 μg, beyond
which the responses reach a plateau. There is an appreciable difference seen though for the
smallest of the proteins, Ribo A. In this case, the suppression of the absorbance response
is less pronounced. A much more uniform set of responses in seen in reference to the peak
widths of the respective proteins as a function of loading mass (Figure 4.4b). In this case,
there is very little change in breadth with increased loading, until a mass of ~0.5 μg is
reached. Beyond that point, there is a dispersion of the responses which bare no particular
dependence on the proteins’ molecular weights, crystallographic dimensions, or molar
absorptivity.
Seeing no obvious relationships, we compared the N/N0 ratio and peak capacities
(P) across the protein suite to see if peak shape and column efficiency effects could be
related to molecular weight/size. As showed in Table 4.2, the column efficiency normally
deceased as the total mass increased. However, according to the data calculated from area
height method, there is no significant protein mass/size effect observed. However, the loss
of column efficiency over 1 μg seems less with Chymo A in comparison to other three
proteins. Based on size exclusion chromatography, Chymo A shows more tendency for
aggregation in acidic aqueous solutions, which hinders the UV detection and decreases the
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Figure 4.4 Potential influences of protein identity/molecular weight on elution
characteristics; total mass varied from 0.1 to 1.8 μg. (a) Peak height (mAu), (b) peak
width (w0.5, min). Data extracted from triplicate injections with errors bars representing
the ranges of determined values. Operation parameters as described in Figure 4.1.
peak intensity (both peak height and peak width).66 Although the mass/size range of the
proteins evaluated here does not go so high as to include antibodies, the lack of appreciable
effects up to the 78 kDa Tf is highly encouraging. Certainly, in the case of microporous
media, there would be a diversity of responses across the protein spectrum, including
different extensts of C‐term broadening and recoveries.66
As the final metric, peak capacity (P) is most commonly used as an estimate of
gradient elution performance versus plate counts, given by the relationship
𝑃 = 1 + 𝑡𝑔 /[1.699 ∗ 𝑤0.5 ]
where tg is the gradient time. This equation strictly applies only to Gaussian‐form peaks,
and so for tailing or overloaded peaks will give an optimistic value of the peak capacity.
As listed in Table 4.2, peak capacities for the C‐CP fiber microbore columns decrease
uniformly as sample loading mass are increased, though the ranges from P = 15–80, are
certainly adequate for many top‐down proteomic approaches.
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Table 4.2 Column Efficiencies (N) (Determined by the Area Height Method) and
Computed Peak Capacities Under Gradient Conditions as a Function of Protein
Identity/Molecular Weight

Roles of flow rate and column length on overload characteristics
For the purpose of understanding how operation conditions, including mobile phase
flow rate and column length effect the overload characteristics, the HPLC instrument with
manual injection was employed. BSA was again used as the model protein, with total
injection masses covering 0.05–1.8 μg via varied concentrations and a constant 5 μL
injection volume. Fundamentally, when solute sizes are of the same order of magnitude as
stationary phase pore diameters and smaller, peak broadening is exaggerated at high mobile
phase linear velocity (Uo), because of slow intrastationary phase mass transfer. As
predicted by the van Deemter curve, we would expect peak widths to increase as U o is
increased. However, protein elution peak widths on the C‐CP fiber phases are
approximately inversely related to Uo.49,

50

These responses reflect the fact that (after

desorption from the C‐CP fiber surface) rapid protein transport down the column
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minimizes longitudinal diffusion and proportionally shorter time frames to pass through
the detection volume.
The effects of varied flow rate were evaluated from 0.2 to 0.5 mL min−1, equating
to linear velocities of ~12–70 mm s−1 (maintaining the backpressure below 700 psi). Figure
4.5a,b depicts the role of injected solvent mass at the different mobile phase flow rates.
Clearly, at each individual mass loading the inverse relationship between flow rate and
peak half‐width is revealed. As with the previously presented studies, overload‐related
effects become apparent at BSA masses of > 0.5 μg. Beyond this level, is becomes very
obvious that the effects leading to band broadening are exacerbated at the lower volume
flow rates. The slope of peak width change rate using 0.2 mL min−1 is much steeper than
using 0.5 mL min−1. The peak width values range from 0.4 to 1.0 min, with decreasing

Figure 4.5 Influence of mobile phase flow rate on BSA elution characteristics; total mass
varied from 0.1 to 1.8 μg. (a) peak width (w0.5, min) and (b) peak height (mAu). Data
extracted from triplicate injections with errors bars representing the ranges of
determined values. Other operation parameters as described in Figure 4.1.
velocities, when the 1.8 μg total mass was injected. In the case of a fixed number of solute
molecules passing through detector volume in shorter periods of time, the peak height
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should increase with linear velocity (under the assumption of constant peak area). As
shown in Figure 4.5b, the peak heights realized for the 0.5 mL min−1 are the highest among
the various flow rates at each solute concentration. In addition, the responses remain more
linear with increasing protein concentration at the higher flow rates, thus the recoveries are
appreciably improved, and/or lack of overload effects are dramatically lessened, using high
linear velocities. Table 4.3 provides quantitative data pertaining to the area height plate
numbers and the extent of degradation of the relative efficiencies (N/N0), along with the
changes in BSA elution times across the injected mass, solution flow rate matrix. As
expected from the responses of Figure 4.5a,b, the plate counts are maximized at the highest
flow rate. A more subtle benefit is that the degradation of the efficiencies are far less
impactful at 0.5 mL min−1, at least at mass loadings below the onset of major effects at 0.5
μg, injected. Finally, to go along with the benefits of reduced overload effects, Table 4.3
tabulates the elution times for the BSA. It is clear that while mass overload does indeed
lessen retention times regardless of flow rate by virtually the same amounts, retention times
are reduced with increasing flow rates across the board. Thus improved analytical
throughput is also realized.
The amount of surface area available to affect chromatographic separation is
obviously a key aspect in the overall amount of protein that can be processed effectively.
In order to vary the amount of stationary phase material, without changing the
hydrodynamics of the column, different length columns (5, 10, 20, and 30 cm) were used
and compared while operating under the same flow and gradient rates (The increase in
backpressure across this set of columns is only ~20%.) Figure 6a illustrates the peak heights
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Table 4.3 Column Efficiencies (N) (Determined by the Area Height Method) and BSA
Solute Elution Times Under Gradient Conditions as a Function of Mobile Phase Flow
Rate.

are clearly similar with 0.05 μg (~18 mAU absorbance intensity), while the maximum
height limitation is 30, 50, 100, and 140 mAU, correspondingly. As shown in Figure 4.6a,
increases in column length result in two primary benefits. First, the mass of protein injected
prior to onset of saturation (plateauing of the absorbance, increases with column length;
increasing from 0.25 μg to a value of ~1.0 μg. In addition, the absolute value of the eluting
peak height increases with column length. To complement the enhanced loading/recovery
at longer column lengths, the overload effects on the peak half‐widths is appreciable as
depicted in Figure 4.6b. Perhaps it is intuitive that the onset of increasing peak widths
occurs at lower masses for shorter columns. Perhaps counterintuitive, the bandwidths are
much shorter for the longest columns. In this case, the very high mobile phase velocities
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of C‐CP fiber columns does not add broadening with increased column lengths, allowing
the true effects of the overload phenomena to be seen.

Figure 4.6 Influence of C‐CP fiber column length on BSA elution characteristics; total
mass varied from 0.1 to 1.8 μg. (a) peak height (mAu) and (b) peak width (w0.5, min).
Data extracted from triplicate injections with errors bars representing the ranges of
determined values. Other operation parameters as described in Figure 4.1.
Table 4.4 presents the quantitative overview of the columns of different length, in
terms of area height‐calculate plate counts, normalized column efficiency (N/N0), and peak
capacities. Obviously, there are pronounced improvements in each of the quantities with
the increases in column length. At the lowest injection mass, the number of plates generated
by ~3× with the increase of length from 10 to 30 cm (~11,000 to ~33,000 plates). This
upper plate count is outstanding in the realm of protein HPLC. The rates of performance
degradation with increasing solute mass are far more severe for the shorter columns. One,
perhaps surprising, aspect of the elution characteristics with increasing column lengths is
the fact that the elution times (~8 min) varied by less than 3% (though increasing with
mass) for any of the injection masses, again reflecting the highly efficient hydrodynamics
of the C‐CP fiber columns. The final point of comparison, of relevance to gradient
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separations of proteins, is the peak capacities. Here, as would be expected based on the
peak width data (Figure 4.6b), longer columns definitely provide higher P‐values,
particularly prior to the eventual onset of overload effects. According to basic gradient
elution theory, it can be assumed that the peak capacity is proportional to the square root
of plate number (N) and column length (L),59, 60 which is consistent to the peak capacity
data in Table 4.4. All subsequent studies were performed on 30 cm long C‐CP fiber
columns.
Table 4.4 Column Efficiencies (N) (Determined by the Area Height Method) and
Computed Peak Capacities Based on BSA Solute Elution Under Gradient Conditions as a
Function of C‐CP Fiber Column Length

Roles of mobile phase and sample solution pH on overload characteristics
In most biomolecule separations in the RP mode, such as proteins or peptides,
solvent pH is considered to be a key factor in the product peak shape, resolution and
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retention time. Solution pH effects the ionization state, hydrophobicity, and tertiary
structure of proteins, while also effecting the surface chemistry of the stationary phase. As
a result, pH mismatches due to different solvent composition of the sample and the eluent
solvent, can deform the eluted peaks and reduce the separation system performance.67, 68
On a first principles basis, the sample injection creates an unretained pH plug that travels
along the column, with protein stock solutions usually prepared in PBS solution (pH = 7.4).
The pH inside the plug will be that of the sample solution pH, while the pH outside the
plug will be that of the mobile phase.28, 62 We look here to the effects of the pH of these to
volumes on the overloading characteristics of C‐CP fiber columns.
The first set of experiments involved changes in the primary sample solution, to
determine whether an initial pH mismatch between sample and mobile phase would be
critical reason for peak broadening and peak split. Three initial solvent systems, PBS buffer
(150 mM, pH = 7.40), PBS + 0.1% TFA (pH = 2.90) and water +0.1% TFA (pH = 2.04)
were used to prepare protein samples. As in the previous studies reported here, 0.05–1.75
μg mass loadings were injected via increased concentrations, with the same elution
conditions employed throughout. As presented in Figure 4.7a, there are no substantial
differences between the peak height responses across the sample solvent makeups, this
includes both the absolute values as well as the onset of saturation above ~0.75 μg of BSA.
By the same token, differences among the extent of protein peak broadening are virtually
non‐existent, with the half‐widths increasing to the same extent with increased solute
loading. Assessment of the column efficiencies in terms of the area height‐derived plate
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counts and the normalized efficiencies as a function of BSA mass injections, showed no
appreciable differences among the three injection solvents.

Figure 4.7 Influence of protein injection media (PBS, PBS + 0.1% TFA and H2O + 0.1%
TFA) on BSA elution characteristics; total mass varied from 0.1 to 1.8 μg. (a) peak height
(mAu) and (b) peak width (w0.5, min). Data extracted from triplicate injections with
errors bars representing the ranges of determined values. Operation parameters as
described in Figure 4.1.
TFA is a very common ion pairing agent in RP protein separations, affecting the
degree of ionization as well as changing their relative hydrophobicity. At the same time,
pairing agents can affect the degree of ionization of latent reactive groups on the stationary
phase (e.g., OH groups). In the case of the PP C‐CP fibers, the latter function is not at play.
The influence of mobile phase pH on overloading effects was assessed by adding various
volumes of TFA when preparing the mobile phase solvents A and B, 0.01% (pH 3.56),
0.05% (pH 2.56), 0.1% (pH 2.04), and 0.15% (pH 1.89). (As a point of reference, the
isoelectric point of BSA in H2O at 25°C is 4.7.) As depicted in Figure 4.8a,b, the peak
height and peak width of the 0.05, 0.1, and 0.15% TFA in the mobile phase result in
virtually the same values along with the increased loading mass. In other words, beyond
the lowest TFA concentration, the pH of the mobile phase imposes no influence in the
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appearance of chromatographic overloading effects. It is hypothesized that the mobile
phase with 0.01% TFA does not have sufficient efficiency to induce solvent ionic. As
described by Ståhlberg and Guiochon, for a charged molecule solute, a low ionic strength
carrier solution disturbs the retention mechanism resulting in overload effects, resulting in
early‐eluting, deformed peaks.28,

37

The appearance of overload is also manifest in

compilations of area height‐computed plate numbers, and the trends in efficiency (N/N0)
with increasing protein concentration. In the cases of the 0.05–1.5% TFA additives, the
absolute values and trends are very similar, with increasing values with TFA content. At
the lowest protein loading, the 1.5% TFA yields a plate count of ~20,000.

Figure 4.8 Influence of mobile phase solvent pH as set by TFA content on BSA elution
characteristics; total mass varied from 0.1 to 1.8 μg. (a) peak height (mAu) and (b) peak
width (w0.5, min). Data extracted from triplicate injections with errors bars representing
the ranges of determined values. Operation parameters as described in Figure 4.1.

Conclusions
In this work, we measured the loading effects on protein separation using
polypropylene C‐CP fiber stationary phases. Several parameters and assumptions about
overloading theory were evaluated and confirmed using BSA as the model protein, with
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varied sample mass and volume and mobile phase conditions. The quantitative impact of
overload were evaluated in terms of three means of computing column efficiency (plate
number). Of the methods employed, the area height approach yielded the best
representations of the various effects. Gradient separations of a four‐protein suite allowed
practical evaluation of the performance in terms of efficiency as peak capacity. Peak
capacities of >70 were realized for 15 min. Gradients, with values of >50 realized even
with the onset of overload effects. Observed perturbations in peak shapes tend to follow
conventional observations of mass/volume overload, but no evidence of pH mismatch or
modulator effects is seen. It is notable that in the case of C‐CP fiber columns, increased
mobile phase flow rates and column length result in increased loading capacity. This is
attributed to the more favorable mass transfer rates at higher flow rates, also resulting in
better peak shape (less tailing) and symmetry. In general, this work has served to
quantitatively confirm many past findings surrounding the use of C‐CP fibers as stationary
phases for fast analytical protein separations.50
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CHAPTER FIVE
EVALUATION OF PROTEIN SEPARATIONS BASED ON HYDROPHOBIC
INTERACTION CHROMATOGRAPHY USING POLYETHYLENE
TEREPHTHALATE CAPILLARY-CHANNELED POLYMER (C-CP) FIBER PHASES

Introduction
The separation of biomacromolecules is a required function in many chemical and
biological science fields.1 In the brief history of high performance liquid chromatography
(HPLC), reversed phase liquid chromatography (RPLC) has emerged as the most widely
used technique for the analysis and purification of a wide variety of substances.2 However,
the strong interaction between proteins and highly hydrophobic stationary phases, on the
one hand, and the use of organic modifiers as eluent constituents, on the other, can be
detrimental to the native structure of the proteins. In particular, proteins are subject to
unfolding and denaturation, and can lose some or all of their biological activity.2-4 Thus,
there is a need for milder chromatographic processes to affect separations, thus the growth
of hydrophobic interaction chromatography (HIC).1,4
In comparison to RPLC, the main advantage of HIC for separating proteins is the
milder interactions between the proteins and the stationary phase, the biomolecules retain
activity during separation under physiological pH conditions, ambient mobile phase
temperatures, and no requirement for deleterious organic solvents. Retention and
selectivity in HIC can be modulated by the type and characteristics of the stationary phase,
load salt identity, parameters of the gradient (initial and final salt concentration, gradient
time), flow-rate, pH, temperature and the potential addition of mild organic modifiers.4-7
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The concept of protein HIC for retention and discrimination was first put forward
by Tiselius in 1949, and he coined the term “salting-out chromatography” by analogs to
the well-known bulk protein separation process.8 Subsequently, Hjertén called this mode
of separation hydrophobic interaction chromatography.9 In HIC, proteins lose their
hydration shell in the highly-concentrated salt solution (mobile phase A) and are expelled
to the mildly-hydrophobic surface of the stationary phase. Mobile phase B is an aqueous
solvent containing no or low salt concentration, eluting proteins by allowing a reassembly
of the water shell and release of proteins to pass down the column.10 The retention in HIC
is dictated by the hydrophobic interaction between amino acid residues of the proteins and
the non-polar functional groups located at the surface of the stationary phase.6,11 Therefore,
the elution order enables one to generally rank the proteins on the basis of their relative
hydrophobicity.5
The mild operating conditions, combined with short separation times and high
recovery, make HIC the technique of choice for many applications, increasing the
prevalence in the field of protein separations.1,2 HIC has found wide application in
biotechnology, both as an analytical technique and as an industrial purification process.
Most commonly, a gradient from high-to-low salt concentrations is used, for instance, in
the separation of closely related proteins,4,12 monoclonal antibodies,13,14 and antibody drug
conjugates (ADCs).8,15,16 In addition, the method has also been employed in the separation
of peptides when the recovery in RPLC is unsatisfactory. In conclusion, HIC provides very
good levels of purification, enrichment, and quick separations are achieved with little
product degradation.17,18
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Traditionally, HIC stationary phases consist of a hydrophobic (short alkyl chain)
ligand on a base matrix, which typically consists of porous beads with diameters ranging
from 2 to 50 μm.11,19 Common base matrices include agarose, methacrylate, polystyrene–
divinylbenzene and silica.20,21 For analytical applications, the bead size of the adsorbent is
in the lower range (2–10 μm). As a general rule, the strength of hydrophobic binding of the
ligand increases with the length of the organic chain.22 The most common ligands include
butyl and octyl alkanes which are linked to the base support. Phenyl (and other aromatic)
groups are also used with good results due to mixed hydrophobic and aromatic (π-π)
interactions, which can further strengthen the hydrophobic interaction. Fernandez and coworkers have studied the effects of stationary phase composition and loading on protein
conformation in HIC systems using hydrogen-deuterium exchange mass spectrometry
(HXMS).23 Resin ligand type, density and backbone chemistry each play important roles
in HIC systems.
Recently, the introduction of monolith columns has simplified considerably the
preparation of high-resolution supports by a one-step polymerization of the monomers
directly in the column tube. Elimination of the cumbersome packing procedure makes it
easy to prepare these columns with inner diameters 0.05–6 mm. The adsorbents of HIC are
mainly hydrophilic polysaccharide gels, such as Sepharose, dextran or modified silica
gels.6 The hydrophobic ligands can be covalently attached to the adsorbents in the same
manner as traditional beads. Use of monoliths in HIC, as with other forms of HPLC, brings
certain advantages, in particular throughput.
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Fibrous stationary phases, both natural and synthetic, have been investigated
somewhat sporadically over the last 30-plus years, for small molecule and protein
separations. In the case of proteins, these phases hold promise from the points of view of
throughput, native surface diversity (i.e., types of separation modes), and very low cost.
Marcus has reviewed the fundamental rationale and applications of fibrous support phases
in HPLC.24,25 Of particular note are several applications in the small molecule space by
Jinno and co-workers26-28 and those of Ladisch and co-workers29-31 in protein separations.
In the former case, a variety of fibers were employed, predominately in terms of solid phase
extraction and as stationary phases in capillary electrochromatography.26-28 The Ladisch
group extensively studied both the roles of fiber chemistry and the physical structure of
fabric constructs on the retention and hydrodynamic transport of proteins.29-31 While todate, no commercial implementations of fibrous stationary phases have emerged, there are
many fundamental and practical aspects of fiber phases that warrant continued
investigation.
We describe here for the first time the use of polyester (poly(ethylene
terephthalate), PET) capillary-channeled polymer (C-CP) fiber stationary phases into the
realm of HIC separation of proteins. C-CP stationary phases are extruded from diverse base
polymers in the form of 30–50 μm diameter fibers having eight channels running along
their periphery,32,33 providing efficient protein separations at velocities of up to 75 mm
s−1.34,35 The PET fibers have been employed predominately in analytical LC separations of
proteins using an RP mode,36,37 and have also been used as a substrate for surface
modification to produce anion exchange and affinity chromatography phases.38,39 In a
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previous study, nylon 6 C-CP fibers, consisting of an alkyl backbone with hydrophilic
amide groups, were used as the stationary phase for the HIC separation of a synthetic
protein mixture.40 In this study, the implementation of native PET C-CP fibers in HIC
protein separations is presented. In terms of HIC, the basic structure of PET (consisting of
an aromatic ring, an ester linkage, and carboxylic acid end groups), provides a promising
surface in terms of its relative hydrophobicity. Test samples of a four-protein suite
(ribonuclease A, α-chymotrypsinogen A, lysozyme and holo-transferrin) were prepared in
common phosphate-buffered saline (PBS) at various ammonium sulfate concentrations.
The dynamic loading capacity of the fibers was determined through the use of isotherms,
with the potential roles of mobile phase velocity studied as well. Reproducibility and
column stability was verified through 10 complete load/elute cycles without the need of
any clean-in-place (CIP) processing. The operating parameters of mobile phase
composition, including salt concentration, percentage and identities of organic modifier,
and solvent pH were varied to study their effects on the protein separation process. Finally,
the separation efficiency of a commercially available HIC column (TSKgel Phenyl-5 PW)
and the PET fiber column were compared with six protein mixtures using the respective
column’s optimal operating conditions. Finally, the loading characteristics of the two
column types were compared. Based on these results, use of the native PET C-CP fibers in
an HIC mode provides a number of practical advantages, primarily aspects of throughput,
separation efficiency, and cost of materials.

Material and methods
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Column construction
PET C-CP fibers were obtained from the Clemson University, School of Materials
Science and Engineering. Previous cross sectioning and electron micrographic imaging of
these fibers yielded perimeters of 241 μm, which equate to specific surface areas of ∼0.3
m2 g−1 on the basis of the assumption of a completely non-porous fiber structure versus the
size of proteins.41 The method for packing C-CP fiber microbore columns was as described
by Marcus et al..42 Fibers were removed from the primary bobbin using a rotary counter to
acquire the desired column fiber density. The fibers were heat shrunk using boiling water
and then cleaned sequentially in water, acetonitrile and methanol to remove any latent antistatic spin-coating. 450 PET fibers were pulled through polyether-ether-ketone (PEEK,
0.76 mm i.d., IDEX Health & Science LLC, Oak Harbor, WA) tubing with interstitial
fraction of ∼0.62, determined by non-retained uracil injection. After packing, the columns
were washed with ACN and then deionized water until a stable baseline was observed on
the UV–Vis absorbance detector (216 nm and 280 nm).
Chemicals and instrument
Stock protein solutions of 4 mg mL−1 each in cytochrome c, myoglobin,
ribonuclease A, lysozyme, α-chymotrypsinogen A, α-chymotrypsin and transferrin from
Sigma Aldrich (St. Louis, MO, USA) were made up in 150 mM phosphate buffered saline
(PBS) and kept frozen between uses. Deionized water was prepared by a Milli-Q water
system (conductivity 18.2 mU cm−1, Millipore Water System, Billerica, MA). PBS buffer
was prepared by dissolving NaCl (8.0 g), KCl (0.2 g), Na2HPO4 (1.44 g), and KH2PO4
(0.24 g) in deionized water to a final volume of 1.0 L. Ammonium sulfate ((NH4)2SO4,
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98% purity) was purchased from Sigma Aldrich (Milwaukee, WI, USA). HPLC grade
isopropanol (IPA) and acetonitrile (ACN) were purchased from Fisher Scientifc
(Pittsburgh, PA, USA).
A TSKgel® phenyl – 5 PW column (7.5 × 75 mm column, 10 μm particle size,
TOSOH Bioscience) was purchased from Sigma Aldrich (Supelco, Spring Township, PA,
USA). All chromatographic processes and HIC protein separations were performed on a
Dionex (Sunnyvale, CA) Ultimate 3000 HPLC system with a multi-wavelength VWD3400 RS UV/ Vis detector controlled by Chromeleon 7 software.
Liquid chromatography method
The dynamic binding capacity (DBC) of the PET columns (column length:
300 mm, i.d.: 0.76 mm) was determined through breakthrough (frontal) analysis as
described previously,43,44 using lysozyme as the test protein. After the column was cleaned
and equilibrated with 1.8 M (NH4)2SO4 solution (prepared in 10 mM potassium phosphate
buffer, pH = 7.4, designated as buffer A), lysozyme at the chosen concentration in buffer
A was introduced to the column in a continuous fashion. UV absorbance at 280 nm was
monitored as a means of detecting breakthrough and quantifying the amount of protein
retained on-column. When the UV absorbance of the eluting solute reached a plateau,
indicating column saturation, buffer B (10 mM potassium phosphate buffer, pH = 7.4) was
introduced to the column to elute the protein. The amount of lysozyme retained was
determined by integration of the breakthrough curve (equal area method). A blank
experiment was performed using empty PEEK tubing to determine the system hold-up
volume/time. The DBC at 10 and 50% breakthrough values was calculated at the point that
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the absorbance of the eluting solution reached 10 and 50% of its maximum value (plateau).
The DBC data as a function of loading concentration was fit with the Langmuir and
Freundlich models. In addition, 10 total load/elution cycles were performed to measure the
column stability and separation reproducibility.
The analytical quality of the protein separations in the HIC mode was assessed
using inverse salt gradient (high-to-low concentration) separations of a four-protein
mixture. For each experiment, 5 μL of the protein mixture containing transferrin, αchymotrypsinogen A, ribonuclease A and lysozyme (0.25 mg mL−1 each) was injected and
the chromatogram was recorded at 216 nm. The gradient baseline absorbance was obtained
by running the gradient with no protein injected. The absorbance baseline was subtracted
from protein separation chromatograms. All data reported in graphic form are the results
of triplicate separations, with the error bars representing ±1 s from the mean value.

Results and discussion
Dynamic binding capacity
As described in the literature, downstream purification processing continues to be
a primary challenge in the production of bio-therapeutics.45,46 Innovative HPLC stationary
phases with high loading capacity and fast elution properties are still attractive.
Comparisons regarding dynamic binding capacity, recovery and mass transfer properties
are made with HIC media suited for large scale separations.12,47 The advantages of
operating a separation under conditions which affect high throughput and recovery are
ultimately desirable, these are some of the most positive attributes of C-CP fiber phases.35
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To assess the kinetic attributes of protein loading, a constant concentration of
lysozyme (1 mg mL−1) in buffer A (1.8 M (NH4)2SO4 solution, pH 7.4) were fed into
columns at various flow rates (0.1 – 0.5 mL min−1) (∼8 – 40 mm s−1 linear velocity) until
the absorbance at 280 nm reached a plateau. Elution of the bound protein was achieved by
passing buffer B (10 mM potassium phosphate buffer, pH = 7.4) through the column.
Figure 5.1 presents representative lysozyme breakthrough curves on the PET fiber column
at various flow rates/linear velocities. The breakthrough curves are plotted on the basis of
the load solution volume, instead of a time scale, to better-reveal any kinetic limitations.
As seen in the scale expansion (2–3 mL loading volume range), there is a very slight bias
in the volume reflecting the 50% sample load, at the slowest flow rate (0.1 mL min−1,
10.4 mg mL−1), yielding an only ∼2% higher binding capacity than the highest velocity
(0.5 mL min−1, 10.2 mg mL−1) though the latter occurred at a 5× higher velocity/shorter
time scale. In quantitative terms, this represents a 500% improvement in throughput;
0.027 mg min−1 at 0.1 mL min−1, increasing to 0.14 mg min−1 at 0.5 mL min−1. Herein, lies
the advantage of C-CP fibers which affect virtually no mass transfer resistance in
comparison to traditional stationary phases.32
It is also interesting to note that the volume displacement at the 10% breakthrough
between the different velocities and the 50% level are virtually the same, thus the mass
transfer/adsorption kinetics are not sacrificed at the higher linear velocities. As well, the
breakthrough curves show steep slopes for towards the saturation point, no matter the load
speed, which represents the maximum usage and uniformity coverage on stationary phase
surface. Beyond the 50% C/Co level, there is a distinct break in the slope of each curve,
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Figure 5.1 Lysozyme loading breakthrough curves on the PET fiber column at constant
protein loading concentration and various mobile phase flow rates. (Column length:
30 cm, loading solution: 1 mg mL−1 lysozyme in 1.8 M (NH4)2SO4, pH 7.4, absorbance
detection: 280 nm).
reflecting some kinetic limitations in terms of filling the remaining open portions of the
surface. The negligible difference on dynamic binding capacity reflects the low mass
transfer resistance of the PET fiber stationary phase at high flow rates. Finally, the
backpressure of PET fiber column is comparably low to HIC columns made by silica beads
or monolith gels due to the high column permeability.48 For example, the pressure range
for the PET C-CP fiber column is around 100–800 psi using 0.1 – 1.0 mL min−1, while a
range of 1500–5000 psi is required for silica bead HIC columns. The combination of the
nonporous (relative to the size of proteins) polymer phase and high column permeability
yields very efficient mass transfer characteristics.
To understand the effect of loading concentration on breakthrough characteristics,
various concentrations (0.025–1 mg mL−1) of lysozyme in buffer A (1.8 M (NH4)2SO4
solution, pH 7.4) were fed into columns at 0.4 mL min−1 (∼32 mm s−1 linear velocity). (The
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uppermost, 1 mg mL−1, value is limited by the solubility of the protein in the load buffer,
but is still relevant in terms of most protein separation scenarios.) It is worth mentioning
that this flow rate, equivalent to about 3 column void volumes per minute, is comparatively
much higher than those normally used for frontal analysis in common porous stationary
phases run at u = 1–2 mm s−1.49,50 Representative breakthrough curves (UV absorbance at
280 nm) are shown in Figure 5.2 (normalized for maximum absorbance). Plotting on a time
axis depicts the expected temporal response; as the concentration is increased,
breakthrough occurs at shorter times/volumes. However, the total loading capacity at
saturation for the lowest lysozyme concentration (0.025 mg mL−1, ∼21.8 mg mL−1 loading
capacity) shows no significant difference from the highest concentration (1.0 mg mL−1,
∼23.4 mg mL−1 loading capacity). The consistent protein DBC at low protein feed
concentrations is especially important for industrial applications, since most of the desired
proteins present in cell lysates exist at low concentrations.
Typical adsorption isotherms reflect the amount of adsorbate bound to the surface
of the adsorbent (q, mg g−1) as a function of the concentration (C, mg mL−1) under
equilibrium conditions and constant temperature.51 Therefore, adsorption isotherms are
most commonly constructed from static (equilibrium) binding capacity measurements.52,53
Alternatively, the concept can be extended to dynamic binding capacity characteristics
obtained from frontal analysis,35 and applied here to obtain the adsorption isotherms. The
experimental data employed in the adsorption isotherms shown in Table 5.1 (fitting curves
showed in Supplementary material (SM) Fig. 5.1) is the result of previous breakthrough
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Figure 5.2 Lysozyme loading breakthrough curves on the PET fiber column at various
protein loading concentrations and a constant mobile phase flow rate. (Column length:
30 cm, loading solution: lysozyme in 1.8 M (NH4)2SO4, pH 7.4, flow rate: 0.4 mL min−1,
absorbance detection: 280 nm).
curves (Fig. 5.2). The Langmuir (homogeneous surface) and Freundlich (heterogeneous
surface) isotherm models were used to fit the 10% and 50% DBC data points. The classic
Langmuir isotherm is the most common model used by chromatographers to explain
surface adsorption.54 Its equation is expressed below
𝑞 = 𝑞𝑠

𝑏𝐶
1 + 𝑏𝐶

where C is the protein feed concentration (mg mL−1), q is the binding capacity (mg g−1) of
the column at the protein concentration C, qs (mg g−1) is the maximum DBC at infinite
protein loading concentration and b (mL mg−1) is the adsorption-desorption equilibrium
constant on the surface.55 The Freundlich isotherm was originally proposed for the
adsorption of polar compounds onto polar adsorbents and later applied to heterogeneous
surface adsorption,51 the equation of which is presented as:
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𝑞 = 𝑎𝐶 1/𝑛
where a (mL g−1) is the Freundlich coefficient which is an indicator of equilibrium
adsorption capacity and n is the Freundlich exponent which is smaller than unity and
reflects how the isotherm deviates from the linear model.56
The equation fitting parameters and correlation coefficients (R2) for the two
isotherm models are listed in Table 5.1. Clearly seen, fitting to the Freundlich isotherm
produced very satisfactory R2 values of 0.998 (10% DBC) and 0.999 (50% DBC), whereas
the values for the Langmuir model are not quite as good. In addition, DBC data gained
from low - medium protein concentrations (below 0.8 mg mL−1), better fit both models.
Based on the assumption that the Langmuir model should be applied to monolayer binding
conditions,57 it is suspected that multilayer binding of lysozyme protein appears at the
higher protein concentrations. As described previously, qs represents the maximum DBC
at infinite protein loading concentration. Thus, the maximum binding of PET column is
very high, ∼93 mg g−1 under these “analytical scale” separation conditions (0.8 mm i.d.
column, 0.03 g fiber weight). For preparative separations, much larger scale C-CP fiber
columns could be readily implemented through larger column diameters and/or longer
columns. The higher permeability of the columns is advantageous in either case. Similar
close-to-linear isotherms were previously reported for the adsorption of FITC-PEG lipids
(0.005–3.0 mg mL−1) on PP C-CP fibers.39 The similarity of the adsorption behavior in
these studies can possibly be attributed to the hydrophobic nature of the interaction between
the adsorbate and the fiber surfaces.33
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Table 5.1 Isotherm fitting parameters for lysozyme loading on PET C-CP fibers via
various loading concentrations.

The ability to consistently recycle columns after saturation is a key attribute in
terms of practical column lifetime. In many instances, some form of clean-in-place (CIP)
step is required, both to remove undesirable contaminants such as“unrecovered” proteins
and peptides in analytical separations or host cell proteins (in downstream processing).52
The ability to maintain consistent, high efficiency and recovery is more challenging in
preparative-scale applications where complete column saturation may occur. Even though
the matrix here is simple PBS, column saturation is achieved in the dynamic loading studies
employed here. In lieau of performing any CIP operations, 10 complete load/elute cycles
were executed with only buffer B elution (10 mM PBS, pH = 7.4). The corresponding
load/elute transients are presented in Figure 5.3, stacked from first-to-last from bottom-totop. As seen in each case, the PET fiber bed is saturated. The consistency shown here is
quite impressive in terms of both the load and elution steps, with the load masses (via
breakthrough volumes) differing by only 0.3%RSD and the recoveries (via the integrated
areas under the elution curves) by only 1.1%RSD for the 10 replicates. The PET column
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shows excellent column stability and separation reproducibility in the HIC mode, even
without a CIP step.

Figure 5.3 Chromatographs of 10 successive lysozyme load/elution cycles on the PET CCP fiber column. (Column length: 30 cm, loading solution: 1 mg mL−1 lysozyme in 1.8 M
(NH4)2SO4, pH 7.4, flow rate: 0.4 mL min−1, absorbance detection: 280 nm).
Effects of mobile phase composition on HIC separations: salt concentration, organic
additives and pH
Several factors contribute to the complex effects on protein separation in the HIC
mode, including the stationary phase (ligand type, ligand density, and backbone
chemistry),1,4,6 salt type and concentration,3,58 temperature, buffer pH and additives to the
buffer.12,59 Three processing parameters, salt concentration, organic additives, and buffer
pH have been evaluated here to address their effects on HIC protein separations.
In the HIC method, the inverse salt gradient elutes proteins possessing a wide range
of hydrophobicity from mildly hydrophobic stationary phases. Most commonly, a 1.5–2 M
ammonium sulfate mobile phase is used as the initial loading buffer (mobile phase A). In
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some instances, low proportions of water-miscible alcohols are added to the elution buffer
(mobile phase B), weakening the protein-ligand interactions and decreasing retention
times.8,13 The non-polar portions of the solvent molecules (often isopropanol) compete
effectively with the bound proteins for the adsorption sites on the HIC stationary phase
causing the displacement of the protein. Although there is a risk that proteins could be
denatured or inactivated by exposure to high concentrations of organic solvents, organic
modifiers are often advantageously employed in HIC method development to tune
selectivity and improve peak shape.60,61 Finally, buffer pH can have effects on both the
polarity of the stationary phase and the solute, effecting retention elution characteristics.
Various combinations of salt load concentration (1.4–2.0 M (NH4)2SO4) and
organic additives (0%–40 % ACN or IPA) in buffer B were evaluated. A four-protein suite
containing ribo A, lyso, chymo and transferrin (0.25 mg mL−1 each, 5 μL injection) was
separated using the PET column under the different mobile phase conditions. This
combination of proteins represents a wide range of hydrophobicities and molecular
weights. A constant flow rate of 0.5 mL min−1 (Uo = 40 mm s−1) and a 15 min gradient time
from 100% buffer A to 100% buffer B was utilized throughout. Representative
chromatograms using the 2.0 M (NH4)2SO4 load conditions with ACN as the elution
modifier are plotted in Figure 5.4. Individual peak identification was accomplished via
single-protein injections. Very clearly, the retention time of each four proteins decreases
as the ACN content is increased. Comparing the peak shapes and resolution between the
solutes, it is clear that the organic modifier is most beneficial for the more hydrophobic
molecules. When proteins are adsorbed onto any (stationary) phase surface, they tend to
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Figure 5.4 HIC chromatograms with various acetonitrile additive percentage in elution
buffer. Analyte: 1) ribonuclease A, 2) lysozyme, 3) α-chymotrypsinogen A and 4)
transferrin (0.25 mg mL−1, 5 μL each). Loading buffer: 2 M (NH4)2SO4 solution, elution
buffer: 10 mM PBS with organic additive, gradient rate: 10% mobile phase B min−1, flow
rate: 0.5 mL min−1, absorbance detection: 216 nm).
denature. Thus, almost any means of reducing retention times is beneficial in maintaining
native structure. Clearly the peak shape of transferrin (peak 4) changes most dramatically
from a broad and flat response to the more-regular triangular peak with increased ACN
concentration, consistent with other HIC phases.8,13,15
Table 5.2 reports the realized resolution, choosing lysozyme and αchymotrypsinogen A as the critical pair, as a function of the initial (at injection) salt
concentration and the percentage of ACN added to the elution solvent. As shown in the
table, applying 1.9 M (NH4)2SO4 as the initial buffer A results in the highest separation
resolution. The resolution increases at high salt concentrations because of the steeper salt
concentration gradient (for the fixed gradient time), accordingly this increases the
selectivity between the solutes. There must be caution, though, as using high salt
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concentrations could lead to situations of slow or non-eluting proteins since it could
stimulate protein precipitation (salting out) and/or irreversible adsorption on the stationary
phase. The maximum resolution appears when ∼ 15% ACN in buffer B was used, which
is consistent with other papers.8,61 However, with more than 20% ACN, regardless of the
salt content, the resolution decreases gradually due to broadened peak widths; likely caused
by protein denaturation. This presumes some possible structural changes depending on the
proportion of ACN, which affect conformation and contact area of the proteins with
stationary phase.8,61 In fact, the small shoulder following the transferrin peak at the highest
ACN concentration provides some evidence of denaturation.
Table 5.2 Resolution between α-chymotrypsinogen A and lysozyme peaks as a function of
different salt loading concentrations and percentages of acetonitrile in buffer B. Gradient
rate: 10% B min−1, Flow rate: 0.5 mL min−1.

Likewise, the effect of increasing IPA concentration in mobile phase B was studied
and compared to the effect of ACN. Table 5.3 presents the effects of IPA on the HIC
chromatographic profiles and separation efficiency (representative chromatograms are
showed in SM Fig. 5.2). Resolution values for the lysozyme: α-chymotrypsinogen A pair
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are listed in Table 5.3 using the isopropanol addition and (NH4)2SO4 concentration as the
variable parameters. The changes in resolution follow the same pattern as the acetonitrile
addition in Table 5.2, however, the separation efficiency is worse than when using ACN
as mobile phase modifier. Additionally, the maximum resolution appears when ∼20% IPA
(instead of ∼15% ACN) was used in buffer B. Consistent with the ACN addition (Table
5.2), the1.9 M (NH4)2SO4 load composition shows the best resolution. As described in the
literature, IPA tends to be a less denaturating solvent than ACN.8,61 That said, there does
appear to be some indication of transferrin denaturation as there is a distinct shoulder on
that peak at the 25% IPA additive concentration.
Table 5.3 Resolution between α-chymotrypsinogen A and lysozyme peaks as a function of
different salt loading concentrations and percentages of isopropanol in buffer B.
Gradient rate: 10% B min−1, Flow rate: 0.5 mL min−1.

It is worth mentioning that the ACN additive in solvent B provides narrower peaks
and better resolution than using IPA as the modifier. This is presumably due to the more
efficient solute mass transfer kinetics, thanks to its lower viscosity in comparison to IPA.
IPA can be limiting in general due to poor mechanical stability of most HIC columns at
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high solvent viscosities. The retention differences observed with ACN and IPA is probably
related to their solvating nature. IPA being a protic solvent, might participate in the Hbonding system of water and the protein itself, while the aprotic ACN probably has weaker
solvating potential. In both cases, the selectivity between the proteins changed with the
addition of organic additives. In addition, the resolution shows no differences between IPA
and ACN conditions when higher than 30% organic solvent is applied (due to the protein
denaturation). Overall, addition of organic modifiers to the mobile phase should be
evaluated carefully in the early stages of method development, since not only selectivity,
but also the recovery of hydrophobic protein species might be altered.
The effect of mobile phase pH on protein retention in HIC systems can be very
complex.62,63 Hjertén et al. found that while basic proteins such as lysozyme exhibited high
binding when the buffer pH was close to its pI, human serum albumin had a lower capacity
factor as the pH increased.9 Sanz et al. studied pH and temperature effects on tripeptidase
purification and showed that an optimal pH could be identified to obtain the highest purity
and yield.64 In this study, the mobile phase pH was varied between 5 and 7.5, below the pI
of the respective test proteins: ribonuclease A = 9.6, lysozyme = 11.35, and αchymotrypsinogen A = 8.75. Chromatographic data, including peak width, retention time
difference, and resolution values for the protein pairs, are listed in Table 4 (Representative
chromatograms are showed in SM Fig. 5.3)). The elution order was determined by single
protein injection: 1) ribonuclease A (13.7 kDa), 2) lysozyme (14.4 kDa), and 3) αchymotrypsinogen A (25.6 kDa), also consistent with increased molecular weight. When
increasing the mobile phase pH, an increase in protein retention is expected due to
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increased hydrophobic interactions thanks to a shift to a more neutral state of the protein
(closer to their pI). However, in this study, no consistent trends are revealed. For example,
the retention time of lysozyme gradually decreases with lower pH (more acidic), while it
increases for ribonuclease A peak. Indeed, the resolution listed in Table 5.4 illustrates
completely different trends between the lyso:chymo and ribo:lyso pairs. Similar to RP
protein separations, shaper peaks appear when using a more acidic mobile phase. In
addition, the small satellite peaks between chymo and lyso disappear at the lower
conditions, suggesting that protein aggregation or conformational changes become less
prominent in the mildly acidic solvent.
Table 5.4 presents peak width and retention time differences and their roles on the
critical pair resolution. As shown, the peak width of each peak decreases as the mobile
phase pH is lowered from 7.5 to 5.0. Mentioned in reversed phase application papers,65
peak broadening generally worsens under more basic solvent conditions. Thus,
chromatographers usually apply 0.1% trifluoroacetic acid (or other acids) in the aqueous
mobile phase (pH = 2.04) to obtain narrow peak shape due to ion suppression. It is
generally found that the retention of proteins changes more dramatically at pH values above
8.5 and/or below 5 than in the range pH = 5–8.5 in the HIC mode.62,63 The findings here
suggest that pH is not an important control parameter in the optimization of HIC
separations of protein using PET fiber columns. The most likely reason for the lack of pH
dependence is the lack of readily ionizable silanol groups on the PET surfaces versus silica
materials, thus protein structure/hydrophobicity would be the primary differences at
various pH conditions and not the surface chemistries.

124

Table 5.4 Peak characteristics for three-protein (ribonuclease A, α-chymotrypsinogen A
and lysozyme) separations as a function of mobile phase pH. Constant flow rate of
0.5 mL min−1 (40 mm s−1) and gradient rate of 10% mobile phase B min−1.

Effect of mobile phase flow and gradient rates on separation efficiency
Ultimately, whether operating in the analytical or preparative modes,
chromatographic performance (including peak shape, analysis time and resolution)
becomes a prominent figure of merit when evaluating phases.66 For preliminary
characterization, separations of a three-protein mixture containing ribonuclease A,
lysozyme and α-chymotrypsinogen A were performed on the native PET C-CP fiber
columns in the HIC mode.
In order to study the role of gradient rate on separation quality, gradient rates were
varied at a constant flow rate of 0.5 mL min−1 (∼ 40 mm s−1). The linear, inverse salt
gradients employed for these studies ranged from 1.8 M (NH4)2SO4 solution (buffer A,
pH = 7.4) to 10 mM PBS with 20% ACN (buffer B, pH = 7.4), with the percentage B
change per unit time varied from 5 to 16.67% B min−1. Each gradient program had a one
minute hold segment in between the injection and the initiation of the gradient. Figure 5.5a
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presents the chromatograms for the gradient separations of the three-protein suite. It is
visually clear that gradient rate has a profound effect on the separation as the efficiency
increases with the length of the gradient program, as would be anticipated. The quantitative
figures of merit are presented in SM Table 5.1. On the other hand, the peak shape is more
symmetric with less tailing when fast gradient rates are applied. As presented in the table,
both the peak widths (w0.5) and ΔtR values are affected by the changing gradient, with the
resolution reflecting the cooperative effects of the two.

Figure 5.5 a) HIC chromatograms and b) critical pair resolution as a function of
gradient rate. Analytes: ribonuclease A, lysozyme and α-chymotrypsinogen A
(0.25 mg mL−1, 5 μL each). Loading buffer: 1.8 M (NH4)2SO4 solution, elution buffer:
10 mM PBS with 15% ACN, flow rate: 0.5 mL min−1, absorbance detection: 216 nm. All
chromatograms were subjected to absorbance baseline subtraction based on the same
gradients without protein sample injection.
On a first principle’s basis, the ∼3.3× change in gradient rate would yield
comparable changes in the ΔtR values, and this is indeed seen in the table. For example,
ΔtR between ribonuclease A and lysozyme increased from 0.717 min (16.67%B min−1) to
2.21 min (5%B min−1). The same is not true for the peak widths, which reflect the fact that
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proteins elute over a range of solvent compositions. Changes from the fastest to slowest
gradient rates do not increase the peak widths in proportion, as the widths only increase by
a factor of ∼2.8. As represented in Figure 5.5b, an improvement in resolution is realized
as the gradient rate is reduced from 16.67 to 5% B min−1. Slower gradient rates provide
better separation efficiency, at the expense of longer process times, higher solvent
consumption, and reduced sensitivity. Based on these considerations, a compromise
gradient rate of 10% B min−1 was employed through the remainder of the studies.
After choosing the gradient rate, the relationship between flow rate (linear velocity)
and separation quality for the PET column was evaluated. Representative chromatograms
and the resulting critical pair resolution values are presented in Figure 5.6a and b,
respectively. The mobile phase flow rates of 0.2–0.6 mL min−1 equate to linear velocities
of ∼16 – 48 mm s-1. As showed in Figure 5.6a, the retention time of protein peaks decreases
with increasing solvent flow rates. Consistent with all previous C-CP fiber protein
separations,67,68 the differences in retention time (ΔtR) remain the same for all of the
proteins. The constant ΔtR is the result of the critical elution strength of each protein, while
the decrease in net retention times is caused by the faster post-release transit speeds at
higher flow rates/velocities.
As seen in Fig. 5.6a and quantified in SM Table 5.2, the ability to operate C-CP
fiber columns at high linear velocities to affect more narrow peaks is quite clear. The
combination of consistent ΔtR values, and narrowing of elution widths of course yields
pronounced improvements resolution for each of the protein pairs as displated in Fig. 5.6b.
For example, the retention time difference (ΔtR) between lysozyme and chymotrypsinogen
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peaks varies from 1.11 min to 1.14 min as flow rate increases, while the peak widths
decrease by approximately 25%. Here the C-CP format differs from any sorts of porous
support phases. Essentially, higher linear velocities lessen the extent longitudinal
broadening (van Deemter B-term), while at the same time there is a virtual lack of any
mass transport limitations (van Deemter C-term). It is also encouraging to note that the
precision of the separations, as depicted in the virtually non-existent error bars in Fig. 5.6b,
is not sacrificed at high linear velocities. The values observed for these quantities in fact
vary on the order of 1–3% RSD for triplicate injections. Based on the data presented in Fig.
5.6b, there are likely diminishing returns in going too far higher linear velocities as the

Figure 5.6 a) HIC chromatograms and b) resolution with various flow rates. Analytes:
Ribonuclease A, Lysozyme and α-chymotrypsinogen A (0.25 mg mL−1, 5 μL each).
Loading buffer: 1.8 M (NH4)2SO4 solution, elution buffer: 10 mM PBS with 15% ACN,
gradient rate: 10% mobile phase B min−1, absorbance detection: 216 nm.
adsorption/desorption kinetics of the proteins may eventually become limiting. It must also
be said that there is a tradeoff in analytical sensitivity with the present UV-VIS detection
systems which are sensitive to solute concentration, and not solute mass. This too has been
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a consistent observation in fast C-CP fiber separations. In general, there are no appreciable
advantages to operation at linear velocities of >100 mm s−1 with the present HPLC system.
Comparison of protein separations between a commercial HIC and the PET fiber column
Hydrophobic interaction phase separations of protein mixtures on PET C-CP fibers
were optimized and evaluated in previous sections. In order to benchmark the performance
of the fiber column to industry standards, the protein separation performance was compared
to a TSKgel Phenyl – 5 PW column. According to the product information, TSKgel Phenyl
– 5 PW stationary phase is based on a polymethacrylate polymer bead immobilized with a
phenyl functional group; a chemical similarity to the PET fibers. As in the case of the PET
fibers, this phase should result in limited secondary interactions between the proteins and
the support, theoretically minimizing peak tailing, broadening, or even splitting.
Using the suggested conditions provided by the commercial manufacturer, a 1.0 mL
min−1 flow rate and 30 min gradient slope from 1.8 M (NH4)2SO4 (PBS, pH 7.0) to 7%
isopropanol (PBS, pH 7.0), a solution of six proteins was analyzed. The solution contained
0.25 mg mL−1 of 1) cytochrome c, 2) myoglobin, 3) ribonuclease A, 4) lysozyme, 5) αchymotrypsinogen A and 6) α-chymotrypsin in PBS, as presented in the the TSKgel Phenyl
– 5 PW protocol handbook. The C-CP fiber columns were operated under two scenarios,
those used for the commercial column and those determined above. When examining the
HIC protein separation using the same conditions (Fig. 5.7a and b), it is clear much shaper
peaks (narrower peak widths and higher peak heights) appear when using the PET fiber
column. Based on the physical structure of the phases, narrower peaks likely reflect lesser
C-term peak broadening. As shown in Fig. 5.7a, the six protein peaks occupy the majority
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of the 30 min gradient range using the TSKgel column, while all of the proteins elute
between ∼7.5–17.5 min retention times using PET fiber column (Fig. 5.7b). Interestingly,
the elution order of α-chymotrypsinogen A and α-chymotrypsin is reversed between
TSKgel and PET fiber column, which could be caused by stronger π-π interactions with
TSKgel Phenyl – 5 PW stationary phase. It would be unreasonable to expect that the PET
fiber column should operate optimally at the same conditions as the commercial column.
Based on the efforts described above, the optimized operation parameters were applied for
the PET fiber separation; 0.6 mL min−1 flow rate with a 10 min gradient from 1.4 M
(NH4)2SO4 (PBS, pH 7.0) to 10% acetonitrile (PBS, pH 7.0). As shown in Fig. 5.7c, all six
proteins were baseline resolved in 10 min, with quite acceptable peak shapes and
recoveries.
The quantitative peak elution characteristics of the three separations are inserted in
to each figure, including retention times, peak widths, and the resolution for adjacent pairs.
The shortened elution window for the C-CP fiber versus the commercial column run under
the same mobile phase conditions was noted above. Taken a step farther, operation under
the optimized conditions yields an elution window of ∼2 – 8 min. Comparison of the peak
widths (w0.5) between the TSK Phenyl – 5 PW and PET fiber columns, shows a pronounced
decrease, with the like-condition fiber widths being ∼4X less broad, and the optimized
fiber column being a factor-of-2 less more. It is interesting to note, that there is a far greater
disparity in protein peak widths on the packed-bed column, than the fiber format. Here,
differences in solute size/mobility in the porous bead phase may come into play. Finally, it
is clear that each of the columns/operation modes can adequately affect the separation of
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Figure 5.7 Comparison of HIC chromatograms between the TSKgel Phenyl – 5 PW and
PET fiber columns. Analytes: 1) Cytochrome c; 2) Ribonuclease A; 3) Lysozyme; 4)
Myoglobin; 5) α-chymotrypsinogen A and 6) α-chymotrypsin (0.25 mg mL−1, 20 μL
injection volume). a) TSKgel Phenyl – 5 PW column using manufacturer conditions,
Loading buffer: 1.8 M (NH4)2SO4 solution, elution buffer: 10 mM PBS with 7% IPA, flow
rate: 1.0 mL min−1, gradient time: 30 min, absorbance detection: 216 nm. b) PET fiber
column, same analytes and operation conditions as a. c) PET C-CP fiber column, same
analytes. Loading buffer: 1.4 M (NH4)2SO4 solution, elution buffer: 10 mM PBS with 10%
ACN, flow rate: 0.6 mL min−1, gradient time: 10 min. All chromatograms were subjected
to absorbance baseline subtraction based on the same gradients without protein sample
injection.
this suite of six proteins. However, the peak widths are <∼ 0.1 min for PET fiber column
operating under its optimum conditions. In terms of making a global comparison of the
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efficiencies of the three cases, the average resolution values are 3.5, 4.0, and 7.2 across
Fig. 5.7a, b, and c. In summary, the PET fiber column (using the optimized 10 min gradient
time) shows better separation efficiency in this study, as well as providing faster analysis
times without sacrificing resolution.
In order to gain a more quantitative appreciation of the loading characteristics of
the commercial can C-CP fiber phases, the peak widths of two proteins, αchymotrypsinogen A and lysozyme, were measured across a range of sample
concentrations, from 0.01 to 4 mg mL−1 (20 μL injection volume). To normalize the
performance to the commercial column, flow rates of 1.0 mL min−1 and 30 min gradient
times were applied in this study. One important factor of column quality is the peak width
change with increased protein loading, suggestive of overloading conditions. The four data
sets are plotted in Fig. 5.8. Clearly seen, as predicted from Fig. 5.7, the peak widths for the
fiber columns are much smaller than TSKgel Phenyl – 5 PW column for both proteins,
even at lowest sample concentration (0.01 mg mL−1). That said, there is very little increase
in peak width across this relatively-wide (40X) range in concentrations for either column
type. The relative immunity to column overload of the C-CP fiber column versus the
commercial column is frankly surprising as the specific surface area of the fibers is ∼1–2 g
m–2, which is much smaller in comparison to most commercial packed bed columns lying
in the 50–400 g m–2 range.69
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Figure 5.8 Comparison of peak widths between TSKgel Phenyl-5 PW and PET fiber
columns with varied loading concentrations. Loading buffer: 1.8 M (NH4)2SO4 solution,
elution buffer: 10 mM PBS with 7% IPA, flow rate: 1.0 mL min−1, gradient time: 30 min.
Conclusions
In contrast to reversed-phase liquid chromatography, HIC is less detrimental to
potential changes in protein structures and is therefore more commonly used in industrial
scale purification as well as on the bench scale when the conformational integrity of the
protein is important. We demonstrate for the first time, high separation efficiency and
loading capacity using native PET C-CP fibers as the stationary phase in an HIC mode.
Dynamic binding capacity testing with lysozyme as the test solute showed potential
attractive features in terms of protein throughput. Model parameters and correlation
coefficients show near-perfect fitting with the Freundilich equation (across all loading
concentrations) and the Langmuir equation (for low - medium concentrations). A full
parametric evaluation was performed for three- and four-protein mixtures, including
variations in salt concentration, organic modifier, solvent pH, flow rate and gradient rate.
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In terms of organic modifiers, acetonitrile (ACN) and isopropanol (IPA), best separation
efficiency was found when using ∼15 – 20% of ACN. The combination of a non-porous
polymer surface of the fiber phases and high column permeability yields very efficient
mass transfer characteristics, as exhibited by narrowing of peak widths with increases in
mobile phase linear velocity. Optimum column efficiency is achieved at faster flow rates
(linear velocities) and moderate gradient times.
Finally, direct comparisons with a commercial HIC phase (TSKgel Phenyl – 5 PW
column) and the PET fiber phase under the manufacture’s specified HIC conditions and
those optimal for the C-CP fiber columns were highly informative. A six-protein mixture
demonstrated by the commercial manufacturer was employed. In each sort of metric, he
PET C-CP fiber column provides better separation efficiency (resolution) in much shorter
analysis times, particularly under the fiber column’s preferred method. Clearly, there are
further assessments to be done against other columns and with far more complex analytical
challenges. While not necessarily of primary concern, it must be pointed out that the capital
costs associated with assembly of the fiber columns are <$20 USD, while the purchase of
commercial versions are typically >$1500.
Future studies regarding pH effects on HIC protein separation should address
extremes in pH range, such as below 5 or above 8. Along those lines, protein
conformational changes, denaturation, and aggregation will be evaluated. Besides the use
of single electrolytes, multicomponent electrolyte mixtures may be used as an additional
tool. Ultimately, the use of C-CP fiber phases operating in an HIC mode will be evaluated
as the second-dimension separation phase in two-dimensional LC (2D-LC) separations.
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Here, high velocity separations coupled with rapid gradient rates and short re-equilibration
times of the fiber surfaces could be used to appreciable advantage.
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CHAPTER SIX
ISOLATION AND QUANTITATION OF EXOSOMES ISOLATED FROM HUMAN
PLASMA VIA HYDROPHOBIC INTERACTION CHROMATOGRAPHY USING A
POLYESTER, CAPILLARY-CHANNELED POLYMER FIBER PHASE

Introduction
Extracellular vesicles (EVs) are small membrane-bound particles with various
functions and origins.1 So far, three major types of extracellular vesicles have been
characterized: apoptotic bodies (>1000 nm), microvesicles (150–1000 nm), and exosomes
(30–150 nm). Formed within the endocytic compartments, exosomes are released into the
extracellular space via fusion of multivesicular bodies with the cell surface membrane.2
Exosomes are produced by normal as well as malignant cells and are present in all human
body fluids, including blood, urine, cerebrospinal fluid and ascites.3-5 Exosomes are
considered potential biomarkers for diagnosis and prognosis of several diseases, such as
colorectal cancer, prostate cancer, glioblastoma, or cerebrovascular disease.6 For
functional and biomarker analysis, it is essential to obtain a pure population of exosomes,
excluding matrix components such as proteins and genetic material.7,8
Studies of exosomes have been largely performed using supernatants of cultured
cells.5,9,10 This is because the origin of exosomes is known in a cell culture and the chemical
composition of culture media may be controlled in order to facilitate isolation of exosomes
without as many contaminating proteins, lipids and sugars. However, any potential use of
exosomes in clinical diagnostics requires isolation from far more complex millieu. Given
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the importance of human plasma as a reservoir of disease biomarkers, it is necessary to
optimize the methods to isolate exosomes from plasma,7,8,11 where plasma is a highly
complex and viscous fluid with free protein concentrations of 60–80 mg mL−1, which
interferes with currently-applied exosome isolation methods.5,12 In addition, the precise
source of each exosome present in plasma is unknown, as plasma contains a mixture of
exosomes derived from many different cell types in varying proportions.13 A final
complicating factor in their efficient isolation is that plasma exosomes are coated with
proteins, glycoproteins or glycolipids that are likely to lead to their aggregation and
potential loss upon subsequent centrifugation.14,15
A few attempts have been made to optimize exosome isolation from human
plasma.6,8,11,13 The most commonly used techniques to isolate exosomes from biomedia
relies on the physical properties of size and shape. Thus, exosomes are usually isolated by
a complex and lengthy procedure which includes differential centrifugation to remove
cellular fragments and large vesicles, ultracentrifugation at 100,000×g for 2–3 h, and
sucrose density gradient centrifugation to recover purified exosomes at densities of 1.1–
1.2 g mL−1.13,15 The primary drawback of this method is that it is time consuming. In
addition, this method yields a relative crude product, as contaminants, such as protein
complexes and co-sedimenting vesicles are pelletized along with exosomes. In addition,
the tendency of exosomes to form aggregates under centrifugal forces results in losses,
which further complicates recovery. Repeated ultracentrifugation steps can reduce the
quality of exosome preparations leading to lower exosome yield.4,5
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Ultrafiltration is an alternative tool for exosome isolations.10,13 Unfortunately,
exosome yields can be very low due to non-specific adsorption to the membranes and
blocked pores.11,12,16
Exosomes can also be isolated via size-exclusion processes (either in spin-down or
chromatography formats). These methods have been shown to significantly reduce
contamination (proteins, etc.) from plasma-derived EVs when compared with
centrifugation-based methods,6,7 though the levels of contamination are still debated. A
primary challenge exists as exosome elution bands are usually extremely broad due to the
naturally wide size distributions, thus causing low throughput and low recovered exosome
concentrations.12 In one case, the purity of exosomes isolated via SEC was estimated by
protein concentration analyses using Western blot and bicinchoninic acid assays (BCA). It
was found that a co-eluting band contained serum proteins with the exosomes from the
SEC columns, especially those proteins having large molecular weights. Under sacrifice of
total analysis time and yields, researchers have found that coupling an SEC process with
ultracentrifugation shows benefit for higher-purity recovery of exosomes.11,17 In addition,
it was shown that there is a tendency for proteins and exosomes to interact, specifically
leading to their co-eluting products.16
Immunoaffinity-based capture methods are another useful method for the isolation
of cell-specific exosomes.10,13,18,19 Exosomes may be captured based on antibody
selectivity, specificity, and the affinity/binding constant. Unfortunately, this process may
also exclude potentially important exosome populations. In addition, recent nanoarraybased immunoaffinity devices can require up to 60 h of processing time to isolate exosomes
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from simple buffer solutions.8 Finally, many of these time-consuming multistep
immunoaffinity-based processes and methods can damage exosomes and reduce their
overall collection efficiency.
More recently, several commercial protocols and techniques that claim to take less
time and lead to greater purification have been developed to isolate exosomes using
precipitation and isolation at lower centrifugation speeds.6,8 Results show that these
commercial precipitation reagents are more efficient and enable higher exosome
enrichment factors when compared with traditional ultracentrifugation; however,
subsequent imaging analysis was not possible, and exosomes were not free from protein
contamination. Finally, there are concerns on how the precipitating agents or the high
rotation speeds used in these processes might affect the properties of the exosomes and the
efficiency of the immunochromatographic strips.
While many options for exosome isolation exist, there continues to be great interest
in developing alternative methods. One possible alternative approach is chemical
separation and processing platforms akin to those employed in high performance liquid
chromatography (HPLC). Most of the common LC stationary phase materials, such as
porous silica beads, are not practical, as exosomes would likely be excluded from the
internal pore structures, and clogging would be a major operational problem. This study
describes the expanding use of capillary-channeled polymer (C-CP) fibers as stationary
phases for the isolation and recovery of exosomes from human plasma.20 C-CP fibers have
been employed by Marcus and coworkers as stationary phases for protein separations via
reversed phase, ion exchange, hydrophobic interaction, and affinity chromatographies.21-25
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The fibers are melt-extruded from commodity polymers (nylon 6, polypropylene, and
poly(ethylene terephthalate) (polyester,PET)), and have a unique cross-sectional profile
consisting of eight “legs” on the periphery. When packed in column formats, the fibers
inter-digitate to create thousands of 1–4 μm-wide channels that provide high permeability
to fluid flow. The nonporous nature of the fiber surfaces (at least on the size scale of
proteins) means that intraphase diffusion of solutes is prohibited.26 This combination of
macro and micro characteristics results in the ability to affect protein separations at
exceedingly high linear velocities (∼100 mm s−1) without the mass transfer limitations
common to porous phases.27 In total, these attributes make the utilization of these C-CP
fibers for exosome isolation a promising alternative to traditional methodologies.
Previously, PET C-CP fiber columns were used to isolate unpurified exosomes
from cell supernatants and urine matrices based on a hydrophobic interaction
chromatography (HIC) separation modality.20,28 The procedure, first developed for protein
separations,29 is readily implemented to isolate exosomes from host cell proteins and
concomitant components present in cell culture media, phosphate buffer, and urine. The
fidelity of the fiber-based exosome isolation process has been verified via scanning
electron microscopy, transmission electron microscopy, nanoparticle tracking analysis, and
use of fluorescence immunoaffinity imaging of exosome surface marker proteins.28,30,31
Here, we demonstrate this methodology for the high throughput and high purity isolation
of exomes directly from human plasma. In view of increasing recognition of exosomes as
potentially useful biomarkers of disease, our goal was to obtain pure exosome fractions
and to optimize their quantitative recovery from fresh human plasma specimens. In
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comparison to the conventional methods, the C-CP fiber HIC approach enables selective
isolation from minute volume plasma samples (20 μL) within ∼10 min chromatographic
cycles. Nanoparticle tracking analysis (NTA) results support the ability to harvest
structurally intact exosomes, with response functions from conventional HPLC absorbance
providing quantitative on-line detection. It is believed that this methodology of harvesting
exosomes from human plasma holds promise in both the clinical diagnostics and
fundamental biochemistry arenas.

Materials and methods
Plasma samples
Blood samples from healthy control patients were collected after obtaining written
informed consent to the study, which was approved by the IRB Committees of both the
Greenville Hospital System (Prisma Health) and Clemson University. Peripheral venous
blood was collected in vacutainer tubes with EDTA as the anticoagulant and processed
within 30 min of collection. Plasma samples were obtained by centrifugation for 5 min at
3000 g. Aliquots of plasma were maintained at −80 °C until use or further centrifuged to
isolate extracellular vesicles by the conventional protocols. Exosome “standards”
(lyophilized exosomes from human plasma of healthy donors), were purchased from
HansaBioMed Life Sciences (Tallinn, Estonia), and resuspended according to the supplier
with a projected density equivalence of 5.4 × 1012 particles mL−1. It must be emphasized
that these materials were not “certified” standards.
Hydrophobic interaction chromatography (HIC) method
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The PET C-CP fibers were produced by the Materials Science and Engineering
Department, Clemson University. All solvents were purchased from EMD (EMD
Millipore, Billerica, MA). Ammonium sulfate ((NH4)2SO4) and all other chemicals and
proteins were purchased from Sigma-Aldrich (St. Louis, MO). Deionized water (DI-H2O)
was secured from a Milli-Q water system. The chromatographic exosome separations were
performed on a Dionex Ultimate 3000 HPLC system, employing an LPG-3400SD
quaternary pump, and an MWD-3000 UV–vis absorbance detector (Thermo Fisher
Scientific, Waltham, MA). A Rheodyne model 8125 low-dispersion injector with 20 and
80 μL injection loops was used for sample injections.
The PET C-CP fiber microbore columns (column length: 50 mm, id: 0.76 mm
PEEK tubing, 450 fibers), prepared as described previously,32 were used for the exosome
separations. Columns of these dimensions have dynamic loading capacities of ∼5 × 1012
exosomes.33 After flushing the column with Buffer C (10 mM potassium phosphate buffer:
pH = 7.4), it was equilibrated with Buffer A (2.0 M (NH4)2SO4 solution dissolved in PBS;
pH = 7.4). As previously described in protein HIC methods development, appropriate
amounts of glycerol in the elution buffer demonstrate improved protein recoveries, while
maintaining their respective bioactivities versus use of ACN as an organic mobile phase
modifier.34 In addition, it has been shown that glycerol solutions are beneficial in
maintaining intact exosomes and cells for long-term storage.35 As such, a C-CP fiber HIC
method of exosome isolation has been developed, replacing the ACN with glycerol.36
Specifically, a 50% glycerol (v/v) solution prepared in PBS was employed as the elution
Buffer B. Buffer D (50% acetonitrile (ACN) v/v in DI-H2O) was applied for inter-analysis
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column washing and regeneration. A mobile phase flow rate of 0.5 mL min−1 and the HPLC
process presented in Table 6.1 were used for exosome isolation and column cleaning.
Employed here is a step-gradient HIC approach which provides higher general throughput,
with the solvent program depicted in Figure 6.1. Under the initial injection conditions of
2.0 M (NH4)2SO4 and 0% glycerol, small organic molecules and ionic species elute in the
injection peak, while latent plasma proteins and the desired exosomes are adsorbed to the
PET fibers. With the initial step to lower salt concentration and higher glycerol
Table 6.1 Gradient elution method (including column cleaning step) employed for HIC
isolation of plasma-derived exosomes on PET C-CP fiber columns.

composition (1 M (NH4)2SO4, 25% aqueous glycerol), proteins, having greater
hydrophobicity, elute as a band. Finally, reduction of the buffer to 0 M (NH4)2SO4 and
increasing the glycerol content to 50%, elutes the target exosomes. UV absorbance at
216 nm was monitored as a means of detecting the eluting species (proteins and exosomes).
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Based on the detector response reflecting their elution, purified exosomes were collected
post-column using a Foxy® R1 fraction collector (Teledyne ISCO, Lincoln, NE).
Nanoparticle tracking analysis (NTA)
NTA was performed at the Center for Nanotechnology in Drug Delivery,
University of North Carolina, Eshelman School of Pharmacy using a Nanosight (Malvern
Worcestershire, UK) NS500 equipped with a 532 nm laser and 565 nm long-pass cut off
fluorescent filter. Samples were diluted to a concentration between 1 × 108 and 5 × 108
particles mL−1 with 20 nm-filtered PBS. For each sample, particles moving under
Brownian motion were recorded on video five times, for 40 s each. Hydrodynamic
diameters were calculated using the Stokes-Einstein equation in a package incorporated in
the NTA system controls.

Results and discussion
HIC isolation of exosomes
In our previous report, exosomes derived from cell culture media were successfully
isolated using the PET C-CP fiber HIC separation, with the physical characteristics of size
distribution and shape morphology further confirmed via NTA, SEM and TEM analysis.20
In that case, an organic additive (30% v/v ACN in PBS) was applied in the elution buffer,
helping the separation quality and recovery of the hydrophobic exosomes. However, due
to the possibility of increased exosome aggregation and potential vesicle membrane
disruption, alternative options for elution buffer additives were investigated. As described
in research regarding protein separations using HIC, appropriate amounts of additives
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(such as glycerol, isopropanol, detergents, and chaotropic salts) in the elution buffer
demonstrate improved protein recovery, while maintaining their respective bioactivities.34
Su and co-workers found that an increase of 46.3% activity yield and 40% mass recovery
were achieved for protein HIC separations (Poros PE HIC column, Applied Biosystem)
when using 50% (v/v) glycerol in PBS as the elution buffer.35 It was also discovered that
glycerol addition during the elution process was necessary for correct protein structural
refolding and bioactivity maintenance as compared to the same parameters when PBS
elution buffer alone was utilized. In addition, Aimola et al. used a glycerol gradient to
isolate peripheral blood mononuclear cells (PBMCs) from adult peripheral blood, and
subsequent lactate dehydrogenase (LDH) assays revealed that glycerol was not cytotoxic
to the cells.37 Thus, the use of glycerol as the elution phase modifier was employed here.
In order to illustrate the concept of PET C-CP HIC separations for plasma-derived
exosome isolation, three samples were utilized; exosome-depleted bovine serum acting as
a blank control, commercial plasma-derived exosomes spiked into the exosome-depleted
bovine serum, and human plasma spiked into the exosome-depleted serum. Figure 6.1
shows the resulting chromatograms of the three samples, with the chromatographic
gradient program superimposed as a reference. First, pristine exosome-depleted bovine
serum was injected in order to establish a baseline chromatogram of the media components.
The detector response shows a sharp eluting peak from ∼2 to 4 min, likely composed of a
myriad of peptides, and proteins, reflecting a time profile which was observed previously,
as well as an injection peak at ∼0–1 min, composed of various salts and sugars.20 The
chromatogram obtained for the standard exosomes spiked into the serum, displays two
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Figure 6.1 PET C-CP fiber HIC chromatograms of pure bovine serum (blue line), a
50:50 mixture of pure exosome-depleted bovine serum spiked with a standard exosome
sample (red line), and a 50:50 mixture of pure exosome-depleted bovine serum spiked
with a human plasma sample (black line). Separations were performed with a mobile
phase flow rate of 0.5 mL min−1, 20 μL aliquot injections. Dashed lines depict the
program aspects of the 100% buffer A (2.0 M (NH4)2SO4 solution dissolved in PBS (green
line); pH = 7.4) and 100% buffer B (50% glycerol v/v dissolved in PBS) (black line).
major peaks, a large one between 2 and 4 min and a comparably smaller feature, reflecting
more strongly retained (more hydrophobic) species, with an elution time of ∼5–7 min; this
latter peak is attributed to the exosomes. In the case of the human plasma exosome-spiked
serum, the band eluting at ∼2–4 min is far more intense than the serum samples due to the
complexity of human plasma. That said, the latter band shows similar retention time and
shape features in comparison to the standard exosome-spiked bovine serum sample. For
comparison, the retention time of the first, undesired peak is 2.74 ± 0.02 min,
2.76 ± 0.02 min, and 2.74 ± 0.04 min respectively for the bovine serum alone, exosomespiked bovine serum sample, and human plasma-spiked bovine serum samples, while
equivalent elution times (5.78 ± 0.03 and 5.78 ± 0.01 min, respectively) are observed for
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the exosome fractions. While it cannot be ruled out that there may be some non-exosomerelated material in the latter elution peaks, the existence of “molecular”, non-vesicular (e.g.,
proteins) species of comparable hydrophobicity to exosomes would seem rather remote.
As noted, this is a major drawback in other exosome isolation methods. Studies are
currently underway in the laboratory to specifically quantify the purity of the exosome
isolate.31
Nanoparticle tracking analysis (NTA) is a widely accepted method for the
characterization and classification of extracellular vesicle (including exosomes)
concentrations and size distributions.35 Thus, analysis of the eluted exosome fractions from
the human plasma-derived exosomes provides evidence of the makeup of that eluent peak.
The centroid region of the exosome elution band was collected post-column from the
human plasma sample and sent for NTA along with the commercial exosome standard that
was used as a benchmark. The concentration and size distributions of both samples are
listed in Table 6.2 for comparison. (There are potential advantages to performing parallel
TEM sizing measurements, but at the same time the complexity of such measurements can
also lead to determinate errors. As such the method used by the commercial supplier was
employed.) According to the production sheet for the commercial standard,
ultracentrifugation and filtration were applied for the isolation of their product. As seen in
the table, the particles size distributions were very similar between the samples of distinctly
different isolation protocols (and origins). Histograms of the respective NTA size
distributions (included as Supplementary Material, Figure 6.1) each contained a prominent
fraction on the lower range of the size scale ranging from ∼90 to 160 nm, typically
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representing ∼70% of the total population. Beyond this, a minor, larger-sized fraction is
also seen in both distributions. Polydispersity is expected as exosomes in body fluids
originate from heterogeneous cell types; e.g. immune cells, platelets, endothelial cells, and
hepatocytes. The larger-size populations may also reflect proteins, exosome agglomerates,
and other classes of extracellular vesicles, including microvesicles. This size fraction may
also reflect the time-lag associated with sampling, packaging, and shipping of the materials
for NTA characterization. Performing NTA/SEM/TEM measurements immediately
following exosome isolation may help remediate any potential vesicle or protein
aggregation. Ultimately, there is high confidence in assigning this eluate fraction as being
composed of exosomes.
Table 6.2 NTA-determined exosome size characteristics of populations of HIC-isolated
exosomes from a human plasma sample and the commercial human plasma-derived
exosome sample.

These results suggest that the PET C-CP HIC method is effective at separating the
population of exosomes from other chemical species inherent in human plasma media.
Indeed, the presence of the broad concomitant elution bands in the HIC chromatograms
reflects the non-specificity and carryover of proteins, etc. in the purification process (i.e, a
single stage of ultracentrifugation here based on the commercial exosome product data
sheet) of the commercial exosome-spiked bovine serum sample. The HIC results prove that
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the exosome fraction can indeed be readily isolated from other undesirable components
within 10 min.
Practical evaluation of the PET C-CP fiber HIC method
The ability to consistently recycle columns after elution and washing steps is a key
attribute in terms of practical column lifetime. In many instances of bioprocessing, some
form of a clean-in-place (CIP) step is required, both to remove undesirable contaminants
such as “unrecovered” proteins and peptides in analytical separations and host cell proteins
in preparative antibody processing.23 In the case of porous media, contaminants may foul
the support phase leading to physical failure. In this study, the removal of media (plasma)
debris could be quite problematic, as no other sample pretreatment was applied. The ability
to maintain consistent, high separation efficiency and exosome recovery rates in order to
achieve high levels of purity and analytical quantification accuracy is challenging. Thus, a
post-elution wash buffer composed of 50% ACN (v/v in DI-H2O) was applied as mobile
phase D, to provide high solvent strength (Table 6.1).
Figure 6.2 demonstrates the efficacy of the developed human plasma-derived
exosome HIC isolation protocol. Shown are the overlapped chromatograms for 10
complete load/elute/wash cycles for 10 μL injections of the human plasma sample. As seen
in each case, three separate bands make up the chromatograms, including the non-retained
(e.g. salts), undesired biomolecules (peptides and proteins), and the target exosome species.
The consistency shown here is impressive in terms of the composite loading and recovery
steps, with the retention time of the exosome peak differing by only 0.76 %RSD and the
peak area by only 4.51 %RSD across the 10 replicates. The PET fiber column shows
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excellent column stability and separation reproducibility in the HIC mode when
incorporating the washing protocol. There is a slight increase in the background absorbance
across the chromatograms with increasing numbers of cycles. This trend is likely due to
non-complete removal of the glycerol elution solvent. Indeed, due to the high viscosity of
glycerol, the column backpressure increases throughout the separation cycles. As presented
in Supplementary Materials Fig. 6.2, there is a consistent increase in backpressure of
approximately 25% between the first and tenth separation cycles; while the change in
exosome recovery is inconsequential. In practical terms, considering the pressure
limitations of the PEEK tubing (3800 psi for 0.78 mm i.d.), each PET C-CP fiber column
should be capable of ∼30 exosome isolations with excellent precision in terms of
chromatographic efficiency and exosome recovery.

Figure 6.2 Chromatographs of 10 successive human plasma derived exosome isolation
cycles on the PET C-CP fiber column. Separations were performed as outlined in Table
6.1 with 10 μL injections.
Potential for plasma-derived exosome quantification
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Currently, NTA is the most common method for exosome quantification.38
However, it is an offline approach which involves several time-lag steps, including storage
and transportation, which may influence the results by virtue of aggregation or sample loss.
In order to make exosome retrieval easier to verify and potentially quantify, a simple online
and real-time measure of recovery is needed. In the context of the HPLC isolation step,
UV–vis absorbance at 216 nm is a viable approach, and has been confirmed by previous
studies.20 This is a common wavelength used in protein chromatography, and fortuitously,
the exosomes respond at this wavelength. Technically, what is registered as absorbance is
scattering of light by the vesicle bodies. As such, responses would be related to differences
in particle diameters and make-up, as well as concentration. The fact that the exosomes in
many assays would be derived from the same source minimizes such effects. To establish
a quantitative relationship between exosome concentration and the measured integrated
absorbance (peak area), eight different concentrations of the commercial human plasmaderived exosome standard were applied to generate a response curve. The integrated
absorbance values were extracted for the bands eluting between 5 and 7 min. The
concentration of the commercial exosome standard, measured here by NTA (Table 6.2),
was used in setting the “injected” values in the response curve. The amount of the undiluted
exosome standard within the 20 μL injection volume was 2.84 × 1010 particles
(1.42 ± 0.61 × 1012 particles mL−1 x 0.02 mL).
As shown in Figure 6.3, a direct proportionality exists between the integrated
absorbance values and the number of particles in the respective serial dilution samples,
suggesting quantitative recovery of exosomes via the C-CP fiber separation method. While

156

the robustness of the method as employed here requires far greater evaluation, the results
plotted in Fig. 6.3 represent a total of 24 injections (triplicates of 8 concentrations) of the
respective samples, without showing deleterious effects regarding the analytical recoveries
or precision. This suggests insignificant carryover or irreversible binding of the exosome
solutes. The derived linear response function is Y = 0.3001x + 8.462, with a correlation of
R2 = 0.997. Subsequently, an equivolume injection of the raw human plasma sample
yielded a value beyond the extent of the calibration data. Therefore, the injection volume
was reduced to 10 μL, yielding an average peak area of 82.20 mAU*min. Based on this
response, the number of exosomes in the elution peak was 2.46 × 1010 particles, or
equivalent to a concentration of 2.46 × 1012 particles mL−1. While many sources site
exosome densities of 1010 mL−1 as being typical, there are references to levels of 1012 mL−1
in human plasma.6,39 In order to confirm the accuracy of the quantitation, a 250 μL postcolumn fraction was collected from an initial 80 μL injection volume and submitted for
NTA measurement. As listed in Table 6.2, the concentration of that isolated exosome
sample was 6.25 × 1011 particles mL−1. Thus, the concentration in the original human
plasma is 1.95 × 1012 particles mL−1 (6.25 × 1011 particles mL−1 x 3.125, dilution factor),
which is quite consistent (within 20%, relative) to the value obtained from the calibration
function. Given the idiosyncrasies of the processes involved in obtaining the NTA
measurement, the slight differences between the absorbance- and NTA-determined
concentration values are relatively insignificant. Indeed, density differences of less than an
order or magnitude in many NTA determinations are considered within the measurement
error. Of course, in addition to UV–vis absorbance post-column quantification, one could
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also envision other LC-compatible detection methods. For example, multiangle light
scatter (MALS), which would also provide size information for the eluting particles, is
worthy of consideration.

Figure 6.3 Analytical response curves for separations of the designated concentrations of
the standard exosome solution. Separations were performed as outlined in Table 6.1,
with triplicate, 20 μL injections.

Conclusions
Current challenges in the study of exosomes under physiological or pathological
conditions lie with the standardization of protocols for exosome isolation from diverse
media, including body fluids and cell culture media. Several procedures and technological
solutions have been suggested to address the need for the isolation of exosomes (see Table
6.3). In this study, we have assessed the efficiency of the PET C-CP fiber HIC method for
exosome enrichment from the plasma of healthy donors. Techniques that allow the
isolation of these vesicles in a short time, while requiring small sample volumes, would be
valuable for clinical purposes. In comparison to other techniques, the HIC method used in
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Table 6.3 Comparison of exosome isolation methods for human plasma samples.

this work provides much shorter processing times (0.5 h or less for replicate uses), with
raw sample sizes of only 10 μL–20 μL of plasma. These aspects of clinical relevance are
also compared among the methods in Table 3. In addition, the C-CP HIC method shows
merit over the commercial exosome kits, including price ($5 per column) and reusability
(around 30 times). The price point may be such that single use protocols can be envisioned.
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Therefore, these results address many of the current challenges facing exosome isolation
protocols.
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CHAPTER SEVEN
FIBER-BASED HIC CAPTURE LOOP FOR COUPLING OF PROTEIN A AND SIZE
EXCLUSION CHROMATOGRAPHY IN A TWO-DIMENSIONAL SEPARATION OF
MONOCLONAL ANTIBODIES

Introduction
Clinically-applicable proteins, especially monoclonal antibodies (mAbs) have
become increasingly important in modern medicine.1,2 They constitute more than 30% of
total biopharmaceutical production and are the largest class of proteins under clinical trial.3
Monoclonal antibodies (mAbs) are proteins with high specificity for a target molecule
known as the antigen, making mAbs promising treatments for a variety of illnesses ranging
from cancer to inflammatory, infectious and cardiovascular diseases.4-6 In terms of further
differentiation, therapeutic antibodies occur in various forms of immunoglobulin G (IgGs),
with IgG1 and IgG2 being the most common subclasses.7
With the growing development of therapeutic mAbs comes the need for analytical
scrutiny towards the impurity components within the drug products.4,6,8 Due to the
increased implementation of Quality by Design (QbD) and Process Analytical Technology
(PAT) in drug manufacturing, monitoring and controlling quality attributes within a
predefined range during manufacture provides added consistency to product quality.9
Within the mAb production process, aggregation is one such quality attribute that affects
safety (side effects and immunogenicity) and efficacy (activity loss) issues in the final drug
products.2,10 Aggregate formation can be affected by variations in pH, temperature, and
dissolved oxygen within the bioreactor system, as well as the growth media
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components.11,12 Thus, monitoring and control of mAb aggregation is always of concern
during manufacturing, formulation, and stability testing.7,13-15
Due to the complexity of mammalian cell culture environments, analytical tools
that monitor mAb aggregation levels must be rapid and robust, as they impact the
production-release decision making process.16,17 Size exclusion chromatography (SEC) is
widely utilized in the industry to determine aggregation levels.17-19 It is easily implemented,
has relatively high throughput, and is robust enough to be validated for product lot
release.20,21 State of the art SEC column technology and ultra-high pressure liquid
chromatography (UHPLC) instrumentation yield mAb analysis times of less than 5 min.22
In the case of complex bioreactor samples, initial purification of the mAb product
from host cell proteins (HCPs), media components, genetic material, and other cellular
debris is required before quality testing by SEC and other purity tests.8,9 To quantify mAb
concentrations in culture media, an analytical protein A (ProA) immunoaffinity column is
typically applied to isolate the mAb from other media constituents.23,24 Optimally, the cell
culture supernatant can be directly loaded on the column (at pH ∼7.0), with the product
eluted from the column at low pH (pH ∼2.0–3.0).25,26 The elution from the ProA column
normally yields greater than 95% mAb recovery, with the concentration/mass of mAb
calculated based on response curves generated from standards.27,28 Having isolated the
mAbs in the ProA step, the percentage aggregation of the protein can be assessed by
subsequent SEC. Two-dimensional ProA–SEC methods have been described over the last
decade, providing mAb monomer and aggregation concentration levels in less than
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10 min.2,29,30 The primary benefits of this approach are reduced total analysis times in
comparison to traditional small-scale purification workflows followed by quality testing.31
The overall performance of the ProA-SEC method (not unlike other applications)
is limited by the band broadening in the first-dimension (1D) and the ability to inject
narrow bands onto the second-dimension (2D) column. 1D broadening of the mAb elution
peak is caused by the kinetically-slow affinity capture mechanism, coupled with slow
intraphase mass transfer rates in the typical porous, packed-bed support phases. Other
limitations in the coupling include elution and mAb exposure to low-pH solvents, low
recoveries in terms of the transfer of solute, temporal aspects in the sampling between
dimensions, and low overall recovery. Compromises exist between the volume and
concentration stored within the transfer valve loops and the integrity of the eventual 2D
chromatographic quality. There are two main methods to affect sampling for 2D-LC, with
compromises based on the ability to gain better time (and chemical) resolution at the
expense of sensitivity. In the first case, single heart-cutting, a sample loop whose volume
is equivalent to the expected solute elution volume from 1D is employed. By necessity,
solutes exiting 1D during the course of loop elution are not captured, passing to waste. The
more popular method of sampling is to operate in a multiple heart cutting mode, meaning
that the elution peak is captured into several smaller-volume fractions (loops), with those
usually analyzed in sequence.30,32 While in practice providing better resolution, previous
studies have shown that the degree of mAb aggregation increases appreciably as they are
exposed to low-pH 1D elution conditions as they are parked in the multiple injector
loops.10,33,34 In addition, low-pH exposure of mAbs results in small, but significant
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conformational changes.35 Thus the use of a single transfer loop in the single heart-cut
mode, or directly connecting the two columns and letting all of the ProA eluate to pass
through the SEC column, become the preferred options.17,36,37 Of course, the broad
“injection” bands and high sample loading (both volume and mass) of the latter approach
dramatically affect the SEC chromatographic performance, including resolution and
sensitivity.38 Ideal SEC volume loads correspond to between 5 and 10% of the total 2D
column volume. In practice, the use of a 2D injector loop which acts to capture and preconcentrate 1D eluates, and then introduce them as a focused plug onto the second
dimension would address many challenges presented in current ProA-SEC separations of
mAbs and other 2D separations.
This laboratory has placed appreciable efforts in developing a family of polymer
fibers, capillary-channeled polymers (C-CP), as stationary phases for high throughput
protein separations.39,40 C-CP fibers are extruded from commercial materials including
polypropylene (PP), polyester (PET), and nylon 6. The channels running along their length
inter-digitate in the column to form micrometer sized channels that facilitate highly
efficient protein separations at linear velocities of up to 100 mm s−1 with very low back
pressure (<1000 psi).40 The highly efficient fluid movement through the narrow channels
composed of non-porous C-CP fibers gives rise to favorable mass transfer rates.
Differences in native fiber chemistries, as well as facile surface modifications, provide a
platform for separations via reversed phase (RP), ion exchange (IEX), hydrophobic
interaction (HIC), and various affinity-based modalities.41-46 With regards to mAb
purification and quantification, ProA columns have been readily fabricated with C-CP
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fibers.45,47,48 Separations from buffer and cell culture media have been performed with high
efficiencies (elution peak widths of ∼5 s), with inter-day and intra-day precision of 3.1 and
3.5 %RSD respectively for a single column. Column-to-column variability was 1.3 and 6.6
%RSD for elution time and peak area, respectively.48
We describe the novel implementation of a 2D injector loop capture phase within
the ProA-SEC separation of mAbs. Specifically, a loop packed with PET C-CP fibers is
employed in an HIC mode to capture antibodies eluted from 1D ProA columns, with
subsequent introduction into a 2D SEC phase. The fiber phase provides facile release to the
2

D SEC column. Integral to the success of this approach is the ability to elute the mAbs

from the ProA columns efficiently under neutral-pH, HIC conditions (up to 1.6 M
ammonium sulfate). Two commercial ProA and an rSPA-modified C-CP fiber columns
were evaluated to test the efficacy of the approach. The chromatographic performance
(resolution and recovery) of the HIC fiber loop capture phase was compared to standard
open-loop approaches as well as the sole use of the SEC column to assess aggregation. It
is believed that the use of the fiber capture phase has substantial benefits in the application
at hand, as well as showing potential in other implementations of 2D-LC in the future.

Materials and methods
Chemicals and columns
HPLC-grade acetonitrile (ACN), and methanol (MeOH) were purchased from
EMD Millipore (Billerica, MA, USA). Phosphoric acid (85%) and hydrochloric acid (35%)
was purchased from Fisher Scientific (Pittsburgh, PA, USA). Potassium phosphate
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monobasic (KH2PO4) and sodium phosphate dibasic (Na2HPO4) were purchased from
Sigma Aldrich (St. Louis, MO, USA). Potassium chloride (KCl) and sodium chloride
(NaCl) was purchased from Fisher Scientific (Fair Lawn, NJ, USA). All aqueous solutions
were prepared with ultra-pure Milli-Q water (18.2 MΩ cm) obtained from a Millipore water
system (Billerica, MA, USA). Phosphate buffered saline (PBS) was prepared by dissolving
NaCl (8.18 g), Na2HPO4 (1.42 g), KCl (0.20 g) and KH2PO4 (0.24 g) in 1.0 L of Milli-Q
water. Tris buffer was prepared by dissolving 6.05 g of Tris base in 30 mL of H2O,
adjusting pH to 7.5 with 5 M HCl, and then adjusting the final volume to 50 mL with H2O.
IgG1 (Human Myeloma Plasma) at a stock concentration of 3.0 mg mL−1 was
purchased from Molecular Innovations (Novi, MI, USA). Raw bio-process IgGk1 sample
was obtained from the research laboratory of Professor Sarah Harcum, Department of
Bioengineering, Clemson University.
Two commercial protein A columns were employed in these studies. A POROS™
A 20 μm column (20 μm bead diameter, 2.1 × 30 mm) was purchased from Applied
Biosystems (distributed by ThermoFisher Scientific) and the TSKgel Protein A-5PW
column (20 μm bead diameter, 4.6 × 35 mm) was purchased from Tosoh Bioscience (King
of Prussia, PA, USA). Finally, an XBridge BEH 200 Å SEC column (3.5 μm bead diameter,
7.8 × 150 mm) was bought from Waters Corporation (Milford, MA, USA).
A C-CP fiber ProA column was also employed as the first dimension of the
separations.45,47,48 Earlier work demonstrated that the rSPA ligands immobilized on
polypropylene C-CP fibers provided not only their high binding specificity but also the
desired ∼3:1 IgG:protein A capture stoichiometry.45 Protein A derived from recombinant
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Staphylococcus aureus (rSPA) obtained from Syd Labs (Malden, MA, USA) at a
concentration of 49.4 mg mL−1 was diluted to 0.5 mg mL−1 in phosphate buffered saline
(PBS). The C-CP ProA columns were prepared by loading rSPA at a concentration of
0.5 mg mL−1 (∼1 × 10−5 M) at a flow rate of 0.5 mL min−1 for ∼10 min on the previouslypacked PP C-CP fiber column having dimensions of 0.76 mm i.d. x 100 cm.
The PET C-CP fiber microbore HIC loops were packed as described previously.40,49
The perimeter determined through electron micrographic imaging of cross-sectioned fibers
was 207.5 μm. Before packing, the desired amount of fiber was stretched on a dye fork.
After being rinsed with hot water, ACN, MeOH then Milli-Q water, the fibers were pulled
through polyether-ether-ketone (PEEK) tubing (30 cm), 0.76 mm inner diameter (IDEX
Health & Science LLC, Oak Harbor, WA, USA). In the case of the HIC capture loop (20 cm
long), the packing consisted of 720 native PET fibers, yielding an interstitial fraction ε i =
0.48 as determined using a uracil marker. This level of packing results in a loop void
volume of 47.2 μL.
Chromatographic procedure development
Single-dimension evaluations of the various columns were performed on a Dionex
Ultimate 3000 HPLC system (Thermo Fisher Scientific Inc., Sunnyvale, CA), consisting
of an LPG-3400SD pump, a WPS-3000TSL auto-sampler and a VWD-3400RS UV–Vis
absorbance detector, controlled under Chromeleon 7.0 software. Two-dimensional HPLC
experiments were performed on an Agilent 2D HPLC, consisting of 1D: 1260 binary pump,
1260 degasser, 1290 variable wavelength detector; 1290 valve drive, and 2D: 1290 high

170

speed pump, 1100 multiple wavelength detector. UV detection at both 216 and 280 nm
(4 nm windows) was used depending on the purpose of the measurement.
Protein A chromatography - In order to not bias the performance of the respective
1

D phases, a single method based on the commercial manufactures’ specifications was

employed. An adsorption buffer (buffer A, 1X PBS) at pH 7.4, and elution buffer (buffer
B) with 0.012 M hydrochloric acid at pH 2.0 were used. The instrumental method was as
follows: loading at 0.1 mL min−1 of buffer A (0–2.0 min), elution at 1.0 mL min−1 of buffer
B (2.0–4.0 min) and returned to buffer A for 4 min to re-equilibrate the ProA columns as
the flow rate was reduced from 1 mL min−1 to 0.1 mL min−1. A detection wavelength of
280 nm and sample injection volumes of 20 μL were used for all samples.
Size exclusion chromatography - Based on the manufacture’s specifications, the
mobile phase consisted of 150 mM NaCl and 50 mM Na2HPO4, pH adjusted to 6.8 with
HCl. The flow rate was 1 mL min−1, and the injection volume was 20 μL. The signal was
monitored by UV absorbance at 216 nm. Peaks were quantified by calculating relative peak
areas of high molecular weight (HMW), monomer, and low molecular weight (LMW)
species between the void and the inclusion volumes.12 HMW fractions are oligomer, trimer
and dimer species, while LMW fraction consists of protein fragments.50
2D-HPLC method coupling Protein A, HIC capture, and SEC - The instrumental
set-up includes three stationary phases in which a ProA column was used in combination
with a SEC column, with the HIC fiber loop applied for pre-concentration. Figure 7.1
presents a graphic illustration of the 2D valving (part no. G1170A) in the case of employing
the C-CP fiber capture loop in one of the two sampling positions, with the other consisting
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of a standard open injector loop. This arrangement generally allows for tandem volumebased peak (fraction) isolation within the sample loops.2 In standard 2D operation using
open sample loops, specific volume peak fractions are concurrently collected through rapid
automated switching of the fraction collection device using a standard, single heart-cutting
approach. Following the 1D elution step, 1X PBS is returned to the Protein A column for
re-equilibration. The 2D-LC fraction valve is switched to the position 2 in order to direct
the effluent flow from column to the waste, while changing the direction of flow from the
fraction valve to the 2D column. The impact of inserting the HIC fiber capture loop on the
HPLC operation is inconsequential as only ∼100 psi back pressure increase is observed
versus an open 80 μL sample loop for a 1 mL min−1 flow rate.

Figure 7.1 Schematic illustration of fraction collection/injector valve (Part no. G1170A)
positioning and solution flow paths in the capture and elution steps.
There are two modes of heart-cutting in commercial 2D-LC, differing essentially
by whether the start time or the end time of the capture is set. The choice between the two
depends very much on the degree of the ProA elution peak asymmetry (tailing) and the size
of capture loop utilized (automatically controlled by software). For the sake of conformity,
and most importantly for utilizing the integrating aspect of the fiber capture phase, end
point setting was employed, recognizing that for open loops this means that the designated
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volume captures the latter fraction of each evolving fraction. Finally, it must be noted that
the time scale for each of the plotted 2D SEC chromatograms is the total analysis time, as
both the protein A and SEC chromatograms start recording at the same time.

Results and discussion
Ammonium sulfate elution in protein A chromatography
The function of analytical ProA columns is to isolate IgG (IgG1-3) from complex
mixtures of spent media, host cell proteins, and DNA in as short of time as possible.51 High
throughput IgG purification and quantification is essential for subsequent SEC assessment
of product quality in terms of the levels of aggregation. Clearly, any implementation of
new elution modalities, as in the HIC capture loop here, must be pursued without
compromise to the IgG isolation efficiency.
IgG elution from analytical protein A columns is commonly achieved by dropping
the solvent pH to a value of ∼2. Conversely, HIC capture is driven by the concentration of
the antichaotropic salt (NH4)2SO4 in this case,52 in the injecting mobile phase. Therefore,
elution from the ProA column must be affected in the presence of the ammonium sulfate,
which will cause the proteins to “salt out” onto the PET fiber surfaces. The influence of
ammonium sulfate on the mAb elution characteristics was assessed by adding different
amounts of the salt to the acidic elution solvents. Thus, three mobile phases were used for
the experiments: A), 12 mM phosphate buffer, pH = 7.4, B) 12 mM HCl, pH = 2.0, and C)
2 M (NH4)2SO4, adjusted to pH = 2.0 with concentrated HCl. The relative composition of
the elution mobile phases B and C result in different (NH4)2SO4 concentrations while
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maintaining a solution pH = 2.0. Human IgG1 prepared in loading buffer A at a
concentration of 1 mg mL−1 was used as the test protein to evaluate IgG elution from the
three ProA columns.
In this one-dimensional evaluation, the respective ProA columns were operated
under the same conditions, based on the recommendations from the commercial versions;
yet not necessarily optimum for the fiber column. In this study, peak width, peak area and
retention time were compared across the different (NH4)2SO4 concentrations to assess
separation efficiency and recovery. Representative chromatograms of the IgG1 elution are
presented in Figure 7.2, with the quantitative figures of merit provided in Table 7.1. As the
concept of the HIC capture loop was first conceived as a method employing the rSPA CCP fiber phase, the corresponding data for that 1D phase is presented first, followed by the
two commercial ProA columns.
As shown in Fig. 7.2a (with details in Table 7.1 for triplicate experiments), the
elution of the neat IgG1 from the C-CP fiber ProA columns yields a very clean
chromatogram, with a sharp peak occurring at an elution time of ∼2.7 min. As detailed in
Table 7.1, neither the retention times nor the recoveries show appreciable variation with
the changes in elution solvent composition, from 0.6 – to 1.6 M (NH4)2SO4 at pH = 2.0.
Across the board, the elution times vary by less than 0.2% RSD, with the integrated signal
areas differing by only ∼1.2% RSD. The consistently sharp and narrow peak shapes are
highly beneficial for any 2D-LC processing. The nearly 99.5% IgG sample recovery across
these salt concentrations (vs. simple injection of the IgG without a column) suggests that
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Figure 7.2 Protein A chromatograms of commercial IgG sample eluted under various
ammonium sulfate concentrations. a) Protein A C-CP column, b) POROS A 20 μm
column, and c) TSKgel Protein A column. Mobile phase: Loading buffer (A), 1X PBS, pH
7.4, and elution buffer (B), varied (NH4)2SO4 concentration solution adjusted using
0.01 M hydrochloric acid at pH 2.0. Analyte: IgG1 sample (1.0 mg mL−1, 20 μL). Flow
rate: 0.1 mL min−1 buffer A 0–2.0 min, 1.0 mL min−1 buffer B 2.0–4.0 min and kept at
buffer A for 2 min for re-equilibration. Detection: 280 nm wavelength.
there is very minimal hydrophobic interaction between IgG molecule and the ProA C-CP
stationary phase.
The effects of the (NH4)2SO4 concentration on the eluted IgG peak for the
POROS™ A20 column are shown in Fig. 7.2b and detailed in Table 7.1. Some minor
qualitative differences seen between this column and the fiber one, most notably some
indication of the presence of unretained species (eluting with the void volume) and a
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Table 7.1 Influence of (NH4)2SO4 concentration on protein A chromatography elution
characteristics (n = 3). Absorbance measurements @ 280 nm.

diffuse band following the initial, sharp IgG band. This diffuse band may reflect some holdup of the buffer salts, leaching of the protein A ligand, or perhaps some IgG aggregation.
Upon introduction of salt to the elution buffer, there is a significant shift in the IgG elution
time (∼0.3 min shorter), beyond which the elution time continues to reduce with salt
concentration, though in a much less noticeable manner. It is interesting that the recoveries
(elution peak areas) increase upon addition of the salt. In terms of peak shape, the elution
peak under the no-salt conditions shows some sign of tailing, but addition of the (NH4)2SO4
provides better symmetry. This combination or responses implies that there may be ionic
contributions to the initial mAb capture. Upon addition of the salt, the recoveries remain at
∼91.5%. In all, the use of (NH4)2SO4 in the IgG elution solvent does not negatively impact
the ProA portion of the proposed 2D scheme.
To assess the potential universality of the acid/salt elution and subsequent HIC
capture phase, a second commercial column was evaluated. The chromatographic
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performance of the TSKgel Protein A-5PW (Tosoh Bioscience) column, shown in Fig. 7.2c
and Table 7.1, was the worst among the three ProA phases investigated. As seen in the
figure, increases in (NH4)2SO4 concentration in the elution buffer causes pronounced
reductions in the antibody recovery, with appreciable shifting of solute elution to later
times, with the growing prominence of a broad, diffuse elution peak at latter times. The
ratio between the column-free IgG peak area and the recovered total peak area decreases
continuously; down to ∼31%. Moreover, the IgG peak displays fronting and tailing issues,
suggesting some perturbation to the protein release mechanism in the presence of the salt.
The same trend in the shifting of IgG elution to shorter retention times, as in the case of
POROS™ A20 resins. It is not unreasonable to speculate that the presence of salt serves to
relieve some non-specific binding to the phase that may cause fronting. The causes for the
overall reduction in IgG recoveries remain unknown.
The concept of using an HIC capture phase in the proposed ProA–HIC–SEC
separations requires efficient elution under high-salt conditions. Of the ProA columns
tested, the C-CP fiber and POROS™ 20 fit the bill in terms of high IgG recoveries with
minimal sacrifices in chromatographic performance. One prominent difference between
the two is the constant elution time for the C-CP fiber column. The IgG bound to protein
A modified C-CP fibers elutes nearly instantaneously upon change to the acidic salt buffer.
As both of these columns employ the same rSPA ligand phase, any differences must be
related to the underlying supports; the extremely hydrophobic polypropylene fiber and
cross-linked polystyrene divinylbenzene. In the case of rSPA-modified C-CP fiber, nonspecific binding to the fiber surface was demonstrated to be very minimal.45,47,48 As to
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POROS™ A20, the process of hydrophilizing the polystyrene divinylbenzene surface is
proprietary information. Considering that added salt may impart some charge-shielding
effects, it is not unreasonable to suggest that the base support in POROS™ A20 may
contain residual charges which are masked in the presence of (NH4)2SO4. This may explain
the reduction in the elution time, even at its lowest concentration (100 mM).
Potential influence of ammonium sulfate concentration on IgG aggregation
As described in the literature, mAb aggregate formation is affected by pH changes,
temperature variations, sheer, and dissolved oxygen within the bioreactor system, as well
as media composition.36,53-55 Thus, it might be expected that increases in percentage
aggregation might be manifest under these HIC conditions. As such, a 1D experiment
wherein SEC is used to assess the effect of the ProA-HIC mobile phase eluate composition
was employed to assess potential perturbations to mAb aggregation.
To match the relevant ProA/HIC conditions, monomer and aggregate percentages
and recoveries were evaluated for 0 M–1.6 M concentrations of (NH4)2SO4 in a pH = 2
solution. IgG solutions were made up in the various solutions at a concentration of
1 mg mL−1 and allowed to sit for periods of 1–2 min prior to performing 20 μL injections.
This time frame is appreciably longer than the anticipated residence time in the injector
loop between 1D and 2D. Examples of the resulting 1D-SEC measurement chromatograms
are depicted in Figure 7.3, with the quantitative figures of merit presented in Table 7.2 (0 M
salt concentration represents the normal case of pH = 2 elution). Clearly seen in the
chromatograms are three connected peaks, representing the trimer, dimer, and monomer
forms of IgG, respectively. The combination of trimer and dimer are treated as the total
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Figure 7.3 SEC chromatograms of commercial IgG samples prepared in acidic media
with varied (NH4)2SO4 concentrations. Analyte: IgG1 sample (1.0 mg mL−1, 20 μL). SEC
buffer: 50 mM NaH2PO4 and 150 mM NaCl, pH 6.8. Flow rate: 1.0 mL min−1. Detection:
216 nm wavelength.
aggregates. The peak appearing at a retention time of ∼8 min is due to the (NH4)2SO4 salt
making up the injection phase. The respective chromatograms are qualitatively similar,
with the most obvious difference lying in the increase from 0.6 to 0.8 M (NH4)2SO4, where
the extent of aggregation increases by only ∼3%; there are no significant changes at higher
salt concentrations. As seen in Table 7.2, the absorbance responses for the aggregate and
monomer fractions increase slightly at higher salt concentrations. However, when
comparing the aggregate percentage data, the ratio between aggregate and monomer is
virtually unchanged, implying that the (NH4)2SO4 concentrations typical of HIC do not
stimulate the IgG aggregation formation in the 1-min exposure time. In our case, we did
not see additional aggregation induced by the sulfate, perhaps due to the short exposure
time. This is probably an effect that mAb specific and worthy of evaluation in each case.
In fact, the changes in salt concentrations do not perturb the retention times or the widths
of the monomer peaks, thus there is no indication of negative consequences of injecting
mAbs from the HIC elution matrix solution. When thinking about potential trade-offs
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between the waste of higher salt concentrations and improved HIC in-loop capture
efficiency, a ProA elution buffer consisting of 1.4 M (NH4)2SO4 (pH = 2.0) was applied in
the composite ProA–HIC–SEC experiments.
Table 7.2 1D-SEC peak characteristics (n = 3) of IgG samples prepared in different
(NH4)2SO4 concentration solutions. Absorbance measurements @ 216 nm. SEC
conditions: column: Waters XBridge BEH 200 Å SEC column, buffer: 150 mM NaCl and
50 mM Na2HPO4, flow rate: 1.0 mL min−1.

Comparison between C-CP fiber-packed and standard open tube injectors
Having established the compatibility of the HIC elution solvent in terms of 1D
recoveries from the C-CP fiber and POROS ProA phases and confirmation of a lack of
perturbation in terms of aggregation, the properties of the capture/injection loops were
evaluated. In the case of using standard, open tube injectors, the loop size has opposing
effects; sensitivity versus temporal resolution. Large loops yield high mass recoveries
(though diluted in concentration), but limit 1D sampling resolution in the introduction of
wider injection plugs into 2D. In order to assess the potential benefits of using the fiberbased HIC loop, the PET C-CP fiber loop (47.2 μL void volume), and 40, 60 and 80 μL
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stainless steel open sample loops were compared for eluted IgG sample capture/injection.
Larger open-tube loops would result in volume overload and extremely wide injections
onto the SEC column.
While an inverse salt gradient is typically applied to elute proteins from mildly
hydrophobic stationary phases in the HIC modality, a higher throughput is achieved by use
of a step function reduction of the salt content, the same is true for mAb elution from the
HIC capture loop. In the present approach, proteins eluting from the ProA column at
∼1.4 M (NH4)2SO4 salt are captured onto the fibers, while the SEC buffer (150 mM NaCl
and 50 mM NaH2PO4) serves as the injection solvent to that phase. Essentially, a 1.4 - to 0 M (NH4)2SO4) step serves as the injection initiator. The same sequence in solvent changes
was employed in the case of the open-tube loops.
To illustrate the utility of the HIC capture approach, the C-CP fiber and POROS
ProA phases were each employed in the ProA–HIC–SEC evaluation of injection
characteristics. Figure 7.4a depicts representative 2D SEC elution chromatograms for the
cases of the three open loops and the C-CP fiber capture loop. Clearly shown across Fig.
7.4 chromatograms are dramatic changes in the qualitative and quantitative IgG elution
characteristics. Based on the 1D elution conditions, the primary IgG component elutes in a
∼110 μL volume, so in all instances the collection volume of the respective loops is
exceeded, meaning that for the open loops, true cuts are being taken while the entire IgG
eluate volume passes through the fiber loop. As would be expected, the relative peak areas
increase with the size of the open loops, but not in direct proportion to the 2:3:4 size ratio
due to the near-Gaussian distribution of 1D-eluting peak. An additional complication is
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due to the fact that mAb aggregates tend to elute in latter portions of the ProA peak. Thus,
the fractional amount of aggregates is a function of the loop volume. In the case of the fiber
capture loop, the recovery reflects the passage and collection of the entire ∼110 μL 1D
elution volume, with triplicate injection variability of ∼0.2 %RSD. Interestingly, the
percentage aggregation is seen to increase, following the monomer recoveries. In this case,
as is inferred qualitatively in the chromatograms, the increasing values reflect better sample
recovery in the case of the fiber loop. In this way, the HIC capture loop presents a more
accurate reflection of the aggregate composition. As a final consideration, it had been
expected that the size of the open-tube loops might affect the SEC separation efficiency.
As the data in Table 7.3 reflect, though, there is no significant difference in the either the
retention times or monomer peak widths for the different loop sizes. By the same token,
the enhanced recovery of the fiber phase does not bring along any coincident sacrifices in
2

D separation quality.

Figure 7.4 2D SEC chromatograms commercial IgG samples using different sample
loops; 40, 60, 80 μL open tube loops and a C-CP fiber HIC capture loop. Protein A
column formats a) C-CP fibers and b) POROS A 20 μm. Analyte: IgG1 sample
(1.0 mg mL−1, 20 μL), 1D Loading buffer: 1X PBS, pH 7.4, Elution buffer: 1.4 M
(NH4)2SO4 with HCl, pH 2.0. 2D buffer: 50 mM NaH2PO4 and 150 mM NaCl, pH 6.8.
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The commercial POROS™ A 20 μm column was applied in the same experiment
to further assess the potential applicability of the HIC capture loop. Representative
chromatograms are plotted in Fig. 7.4b for comparison with the C-CP ProA phase, with
quantitative figures of merit reported in Table 7.3b. In the case of the packed bed ProA
column, the elution volume of the IgG is ∼130 μL under the manufacturer’s suggested
operating conditions. As can be seen in Fig. 7.4 and Table 7.3, the dependence of the SEC
Table 7.3 Comparison of collection sample loops on SEC peak characteristics. a) C-CP
proA and b) POROS A columns. Absorbance measurements @ 216 nm. SEC conditions:
column: Waters XBridge BEH 200 Å SEC column, buffer: 150 mM NaCl and 50 mM
Na2HPO4, flow rate: 1.0 mL min−1.

chromatograms on the capture loop identity are virtually the same between the two ProA
columns, suggesting a universal benefit in applying HIC loop between the ProA and SEC
dimension. What is consistently true in comparing the C-CP fiber and commercial phase
data is the greater overall recovery from the former. For the open-loop injectors, this is
easily explained as each loop is collecting a greater fraction of the IgG elution volume.
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Thus, the integrating aspect of this approach, as opposed to the heart-cutting of the liquid
phase, is a practical advantage.
As a further characterization of the method robustness, 10 consecutive ProA–HIC–
SEC assays were performed using the fiber ProA column and the commercial IgG sample.
No clean in place (CIP) steps were performed in either chromatographic dimension. The
respective 2D SEC chromatograms are presented in Figure 7.1 of Supplementary Material.
For these separations, the precision of the IgG monomer recoveries (peak areas) was ∼0.5
%RSD with the SEC elution retention times varying by ∼0.2 %RSD.
Quantitative comparison of IgG recoveries for the standard protein A–SEC and protein A–
HIC–SEC approaches with 1D SEC
Linearity and reproducibility of response functions is an important parameter when
developing new assay with potential applications to product quality control. In the case of
the combined ProA–HIC–SEC method, there are essentially two cases of comparison. The
first is the raw recoveries that are realized versus the direct injection of pure antibody onto
the SEC column, with the second being the conventional case of ProA-SEC where an open
tube injector is employed. To test the linearity of ProA–HIC–SEC assay, the recovery of
monomer and aggregate species were determined as a function of injected protein
concentration. A serial dilution from 1 mg mL−1 down to 50 μg mL−1 (being representative
of typical analytical scale separations) was performed using a stock IgG solution. In all
instances, a 20 μL injection was employed. In the case of the conventional 2D arrangement,
the largest (80 μL) open loop was used to deliver the greatest sample volume to the SEC
column.
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Calibration data for the monomer and aggregate species are presented in Table 7.4
for the case of the solely SEC separation, conventional ProA-SEC with an open loop
injector, and the ProA–HIC–SEC methods for the two ProA phases; C-CP fibers and
POROS™ A20. In the ideal case, injection of pure antibody onto the SEC column should
give the best response sensitivity (slope) as well as the most correct representation of the
degree of aggregation. The addition of the ProA step might result in some losses in that
sensitivity; either through lower column recovery or poor inter-dimensional transfer
efficiency. It would be anticipated that the integrating nature of the HIC capture step should
lend itself to more ideal recoveries (like SEC itself) with similar percentages of
aggregation.
Table 7.4 Analytical response characteristics obtained for IgG monomers and
aggregates solely SEC, and conventional (open loop) proA-SEC, and new proA–HIC–
SEC methods using a) C-CP proA and b) POROS A columns. Range of concentrations
50–1000 μg mL−1. Absorbance measurements @ 216 nm. In all instances, a 20 μL
injection was employed. In the case of conventional 2D arrangement, the largest (80 μL)
open loop was used to couple the two dimensions.
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A strong linear correlation (R2 ≥ 0.998) exists between the injected IgG
concentration and the eluting SEC integrated peak area for the monomer in all of the assays.
Using the singular SEC column response as the baseline, there are lower levels of recovery
when either of the ProA columns are used as 1D or an open transfer loop is employed.
There is a higher monomer recovery in the case of the C-CP phase, where ∼11% greater
yields are observed than for the commercial ProA phase. (It was confirmed experimentally
that neither of the ProA phases was operating under overload conditions.) The recoveries
are returned to the ideal (only SEC) levels when the HIC capture phase is incorporated,
with variability of the recoveries varying by <2 %RSD for the triplicate injections. Thus,
it is clear that while the 80 μL loop does not have any inherent concern regarding recovery
from the loop, there is the limitation of not capturing the entirety of the IgG plug from the
1

D ProA columns, resulting in lower sensitivity (slope) in that case versus the HIC capture

phase.
Similarly, a high degree of correlation (R2 ≥ 0.997) to linearity is evident for each
assay for the aggregate peak area recoveries versus sample concentration. However, the
conventional ProA-SEC assays underestimate the absolute aggregate levels measured by
traditional size exclusion by approximately 21 and 35% (based on the slopes), respectively,
using the ProA C-CP and POROS™ A20 columns (Table 7.4). It appears that the 1D
separations (without HIC capture) clearly effect the aggregate content based on the peak
area loss. It is important to keep in mind that the antibody exits the ProA columns at very
low pH, and is essentially parked in that solvent within the open loop until injection to the
SEC column, and indeed through the entire SEC step. The observed drop in aggregation
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could be the result overall protein loss, or as suggested by Schofield et al. weak nonspecific
binding interactions between aggregates and the silica beads making up the size
exclusion.29 It has been shown that if the pH of the mobile phase is lower than ∼5.0 (more
specifically, below the pI of the protein), a significant drop in SEC resolution is
observed.56,57 A recent publication by Lemmerer et al. describing a similar ProA-SEC assay
also reported a drop in the relative levels of aggregates as well.31 Furthermore, several
authors have hypothesized that the cause behind this effect is an increase in protein – matrix
interactions (versus protein-protein) at lower pH.17,58,59 As presented in Table 7.4, the
percentage aggregation when using the HIC capture phase is experimentally no different
than the 1D SEC case. Thus, any residual ill-effects of the low-pH conditions are alleviated
by using HIC as the mAb exposure to that environment is halted at the capture step.
Quantitative comparison of the bio-process IgGk1 sample between discrete protein A and
SEC separations, standard protein A–SEC and protein A–HIC–SEC approaches
One of the major obstacles precluding the development of at-reactor quality control
strategies for biopharmaceuticals is the lack of real-time measurement capability. Product
quality and properties may go through changes during the transfer and storage periods prior
to analysis.10 Building up a robust assay which provides real time measurement is optimal;
integrated ProA-SEC should provide a means to this end. The supernatant derived from an
in-house, research CHO cell line sample was applied to study the practical efficacy of the
ProA–HIC–SEC method. The fresh CHO cell product used here, versus the aged, freezerstored commercial IgG used to acquire Fig. 7.3, Fig. 7.4 data clearly reflects less
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aggregation. The SEC chromatogram of the raw supernatant (no ProA step) is included as
Fig. 7.2 of Supplementary Material.
In this study, raw IgG sample was obtained from the lab-made cell line bioreactor
and stored at −80 °C before usage. Two different strategies were evaluated for consistency
of results: 1) ProA purification and fraction collection first on the 1D HPLC instrument
followed (discretely) by SEC (1D HPLC), ProA-SEC (2D-LC), and ProA–HIC–SEC (2DLC), and 2) direct analysis using integrated ProA-SEC and ProA–HIC–SEC methods. Due
to the differences between the standalone 1D and 2D systems (including absorbance cells
and flow path lengths), only the aggregation percentage (which is the ultimate metric in
the experiments) was calculated for comparison.
In strategy 1, the commercial POROS A 20 μm column was applied to purify the
raw cell line IgG solution on the 1D HPLC instrument using the consistent separation
conditions (injection: 80 μL volume in PBS, pH = 7.4, elution: HCl, pH = 2.0). The IgG
fraction collection initiation time was determined with four different collection time widths
(from the same start point) used to equate with different 2D open-loop volumes. Fractions
were immediately quenched with Tris buffer (pH = 7.5) to minimize aggregation prior to
SEC analysis. Figure 7.5a presents representative SEC chromatograms for the different
fraction windows/volumes. Clearly, the retention characteristics (times and peak widths)
of the aggregates and monomers do not change with the fraction size, but there are clear
differences in the relative recoveries between the two species-types. The table of peak areas
and aggregation percentages (the average of triplicate injections) reflect the obvious greater
recoveries will the larger ProA fractions, but also reinforce the fact that aggregates tend to
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elute in the latter portions of the IgG band. This supports the previous results (Fig. 7.4)
using open loops and the integrating nature of HIC fiber loop capture. This also explains
why aggregation percentages may be skewed in single heart-cutting modes as practitioners
typical collect the centroid of the eluting peak to obtain the greatest sensitivity.2,29
As a comparison, the ProA purified IgG sample (1.0 min collection width, 80 μL
injection volume) was tested with both the ProA-open loop-SEC and ProA–HIC–SEC
methods. Ideally, these two methods would yield the same aggregate percentage as the
1.0 min window data of Figure 7.5a and 5.97%. As shown in Fig. 7.5b., the aggregation
percentage for the open-loop ProA-SEC method is approximately one-half of the expected
value, with the data from the HIC-capture loop being very close to the target values; 5.42
vs. 5.97% aggregation. This, approximately 10% reduction may reflect some amount of
reduced recovery from the fiber surfaces as aggregate molecules are more hydrophobic
than monomer species.3,10
Ultimately, the final affirmation of the developed ProA–HIC–SEC method is the
recovery of comparable percentage aggregation metrics as are currently obtained using the
distinct ProA and SEC separations. For this determination, raw samples of the in-house
IgG supernatants (20 μL injection volume) were processed without sample pretreatment
other than passage through the 0.45 μm filter. As seen in Fig. 7.5c, while the SEC
chromatograms are qualitatively similar, the quantitative results are different in two ways.
Consistent with the previous comparisons, the monomer recovery realized with the use of
the HIC phase is somewhat better than the open-loop case; attributed to the integrating
nature of the fibers versus the 80 μL heart cut. More significantly, the HIC-capture process
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Figure 7.5 Comparison of SEC chromatograms of fresh CHO cell supernatants using
different process. (a) Analyte: in-house CHO cell line IgGk1 sample. Protein A loading
buffer: 1X PBS, pH 7.4, Elution buffer: HCl, pH 2.0. SEC buffer: 50 mM NaH2PO4 and
150 mM NaCl, pH 6.8. (b) Analyte: Purified IgGk1 sample from (a). 1D Loading buffer:
1X PBS, pH 7.4, Elution buffer: 1.4 M (NH4)2SO4 with HCl, pH 2.0. 2D SEC buffer:
50 mM NaH2PO4 and 150 mM NaCl, pH 6.8. (c) Analyte: in-house CHO cell line IgGk1
sample. 1D Loading buffer: 1X PBS, pH 7.4, Elution buffer: 1.4 M (NH4)2SO4 with HCl,
pH 2.0. 2D SEC buffer: 50 mM NaH2PO4 and 150 mM NaCl, pH 6.8.
yields aggregate percentages that are in line with the discrete 1D methodology, 5.66 vs.
5.97%. Again, the relative amount of observed aggregation is underestimated by
approximately a factor of 2 in the open-loop case, versus the baseline method. Here again
with attribute this phenomenon to incomplete fraction collection and the open-loop parking
of the faction in the acidic media. In conclusion, the new ProA–HIC–SEC assay ProA and
SEC methods, saving time and labor, and decreasing the possibility of sample
contamination and degradation. In addition, the efficacy of the ProA step is validated in

190

the cell supernatant case by the fact that there is no evidence of host cell protein carryover
into 2D, as confirmed by the lack of additional SEC peaks. This fact is clearly demonstrated
as well when comparing the product SEC chromatogram in Fig. 7.5c with that of the raw
supernatant in Fig. 7.2 of Supplementary Material.

Conclusions
A novel approach to using a hydrophobic capture phase as the injection loop in a
2D-LC platform has been described. In this work, polyester capillary-channeled polymer
(C-CP) fibers were used as a HIC capture phase between protein A and size exclusion
chromatography separations in a 2D-HPLC workflow to analyze mAbs. The HIC capture
loop replaced the typical open loop used in heart-cutting 2D-HPLC. To capture the mAb
on the C-CP HIC loops, the ProA elution needed to be performed with molar levels of
ammonium sulfate. This procedure was successfully demonstrated using one commercial
ProA phase as well as a C-CP fiber-based ProA column. The primary benefit of the HIC
capture loops was the ability to capture all of the mAb during ProA elution to ensure
complete coverage of the all forms of the antibody. This was shown by the higher recovery
and percent of aggregates detected when using the HIC loop, which more closely matches
the 1D SEC results. In the normal case, parking in the open loop may also result in extended
exposure to acidic media, and thus reduction of the apparent level of aggregation.
Additionally, the ProA–HIC–SEC separation was performed on harvested cell culture fluid
(HCCF) samples in less than 10 min, versus the standard method of ProA purification,
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buffer quenching, and subsequent SEC analysis to determine purity sequentially over the
course of hours.
The concept of incorporating a chromatographic phase in the fraction collection
loops of a 2D-HPLC platform holds a great deal of merit. The key enabling features for the
use of C-CP fibers in this way are the high permeability and rapid solid-solution mass
transfer characteristics of the phase. To that end, there may be opportunities for
improvement in loop performance based on tuning of its dimensions and packing
characteristics. The use of standard, high-porosity bead media would suffer from higher
backpressures and broad injection characteristics into the 2D separation stage. While not of
concern in mAb characterization, use of the fibers could serve as a means of analyte
preconcentration prior to 2D separations. In addition to HIC, reversed-phase or ionexchange mechanisms could be applied on the neat fiber surfaces. Alternatively, surface
modifications could be readily employed to affect various immunoaffinity or other capture
modalities, adding yet another level of chemical selectivity without the need for additional
stages of chromatographic hardware (pumps, detectors, etc.).
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CHAPTER EIGHT
SUMMARY AND FUTURE WORK
This dissertation work summaries several applications using C-CP fibers for protein
to monoclonal antibodies and exosomes separation. Polypropylene C-CP fibers employed
in microbore format have demonstrated excellent efficiency for protein separations that
improves with mobile phase linear velocity. A full parametric evaluation was performed
for protein mixtures, including variations in column length, interstitial fraction, gradient
rate, and volume flow rate using UV-vis absorbance detection. Besides, the loading effects
on protein separation using polypropylene C-CP fiber stationary phase were measured.
Several parameters and assumptions about overloading theory were evaluated and
confirmed using BSA as the model protein, with varied sample mass and volume and
mobile phase condition. Of the methods employed, the area height approach yielded the
best representations of the various effects. It is notable that in the case of C-CP fiber
columns, increased mobile phase flow rates and column length result in increased loading
capacity. This is attributed to the more favorable mass transfer rates at higher flow rates,
also resulting in better peak shape (less tailing) and symmetry. Two different shaped C-CP
fibers, the well-characterized eight-channeled PP4 and newly developed trilobal PPY, have
been compared to determine the potential of the later fiber as an improved stationary phase
in biomacromolecule separations. The basic structure of PPY fibers suggests the capacity
to affect greater packing densities with increased channel uniformity than realized with the
PP4 fibers. Smaller, more uniform-sized, PPY fibers, will lead to further improved packing
homogeneity as the variability in the microchannel structure decreases. At the same time,
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we demonstrate the direct coupling of C-CP fibers separations with ESI-MS for the
determination of proteins in a urine matrix.
In contrast to reversed-phase liquid chromatography, HIC is less detrimental to
potential changes in protein structures and is therefore more commonly used in industrial
scale purification as well as on the bench scale when the conformational integrity of the
protein is important. High separation efficiency and loading capacity using native PET CCP fibers as the stationary phase in an HIC mode was demonstrated for the first time.
Model parameters and correlation coefficients show near-perfect fitting with the
Freundilich equation (across all loading concentrations) and the Langmuir equation (for
low - medium concentrations) for preparative loading/elution process. A full parametric
evaluation was performed for model protein mixtures, including variations in salt
concentration, organic modifier, solvent pH, flow rate and gradient rate. In terms of organic
modifiers, acetonitrile (ACN) and isopropanol (IPA), best separation efficiency was found
when using ∼15 – 20% of ACN. The combination of a non-porous polymer surface of the
fiber phases and high column permeability yields very efficient mass transfer
characteristics, as exhibited by narrowing of peak widths with increases in mobile phase
linear velocity. Besides, the efficiency of the PET C-CP fiber HIC method for exosome
enrichment from the plasma of healthy donors has been assessed. Techniques that allow
the isolation of these vesicles in a short time, while requiring small sample volumes, would
be valuable for clinical purposes. In comparison to other techniques, the HIC method used
in this work provides much shorter processing times (0.5 h or less for replicate uses), with
raw sample sizes of only 10 μL–20 μL of plasma. Besides, a novel approach to using a
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hydrophobic capture phase as the injection loop in a 2D-LC platform has been described.
In this work, a HIC capture phase was installed between protein A and size exclusion
chromatography separations in a 2D-HPLC workflow to analyze mAbs. The primary
benefit of the HIC capture loops was the ability to capture all of the mAb during ProA
elution to ensure complete coverage of the all forms of the antibody. This was shown by
the higher recovery and percent of aggregates detected when using the HIC loop, which
more closely matches the 1D SEC results. In the normal case, parking in the open loop may
also result in extended exposure to acidic media, and thus reduction of the apparent level
of aggregation. Additionally, the ProA–HIC–SEC separation was performed on harvested
cell culture fluid (HCCF) samples in less than 10 min, versus the standard method of ProA
purification, buffer quenching, and subsequent SEC analysis to determine purity
sequentially over the course of hours.
For additional hydrodynamic study on C-CP fibers, it would be interesting to see
the effect that temperature would have on C-CP fiber column separations since our group
have never operated the experiment using column temperature control oven. A further
reduction in back pressure would be expected, but it would also be interesting to see the
resolution, peak shape and retention time, as the solvation strength should increase with
temperature. Future studies regarding pH effects on HIC protein separation should address
extremes in pH range, such as below 5 or above 8. Along those lines, protein
conformational changes, denaturation, and aggregation will be evaluated. Besides the use
of single electrolytes, multicomponent electrolyte mixtures may be used as an additional
tool. Ultimately, the use of C-CP fiber phases operating in an HIC mode will be evaluated
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as the second-dimension separation phase in two-dimensional LC (2D-LC) separations.
Here, high velocity separations coupled with rapid gradient rates and short re-equilibration
times of the fiber surfaces could be used to appreciable advantage. For example, new
comprehensive 2D-HPLC (RP X RP, SCX X RP, HIC X RP) method of intact protein
separation, wherein polypropylene capillary-channeled polymer (C-CP) fibers are applied
in the second dimension (2D), should be developed and optimized. The use of the C-CP
fibers was anticipated to provide operational benefits over commercial phases, including
rapid cycling and operation at lower backpressures. The ability to operate C-CP fiber
columns at high linear velocities (>100 mm sec-1 at < 1500 psi) without sacrifice in protein
resolution is certainly beneficial toward their use specifically in

2

D. Following

optimization, the 2D performance of the C-CP fiber column should be compared to
commercial, packed-bed columns commonly employed in 2D-LC. As the solvents
employed in RP chromatography are friendly to mass spectrometry (ESI) detection, each
of these methods could be coupled in comprehensive 2D-LC-MS as would be applied in
top-down proteomics.
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APPENDICES
Appendix A
Supporting Information for Chapter Three

Figure A-1: Column back pressures equating to volume flow rates of 0.1-0.8 mL min-1 for methanol,
acetonitrile, and water solvents. a) i = 0.616 PP4 column and b) i = 0.405 PPY column. From this data
column permeability was calculated using Darcy’s Law, and reported for each solvent in Table 3.2.

202

Figure A-2: Comparison of chromatograms as a function of protien loading mass a) PP4 column and b)
PPY column. Conditions: injection volume = 20 µL, flow rate = 0.5 mL min-1, 15 min gradient (0.1%
aqueous TFA to 100% ACN + 0.1% TFA,).

203

Table A-1. Comparison of critical pair separation performance for PPY and PP4 columns as a
function of mobile phase flow rate.*

* -

For the sake of clarity, tr, w0.5, and As values are presented as rounded values, while the Rs values
are those computed by the chromatographic data system.

Table A-2. Comparison of critical pair separation performance for PPY and PP4 as a function of
gradient rate.*

* -

For the sake of clarity, tr, w0.5, and As values are presented as rounded values, while the Rs values
are those computed by the chromatographic data system.
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Table A-3. Comparison of derived resolution values for protein pairs in the six-protein mixture. All
separations performed on under identical conditions: injection volume = 5 µL, flow rate, 0.6 mL min-1, 20
min gradient (0.1% aqueous TFA to 100% ACN + 0.1% TFA,).
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Appendix B

Supporting Information for Chapter Five
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Figure B-1. Experimentally determined dynamic binding capacities and adsorption isotherm fits for
lysozyme loading on PET C-CP fibers with fits to Langmuir and Freundlich isotherm models.
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Figure B-2. HIC chromatograms at various isopropanol additive percentages in the elution buffer. Analytes:
1) ribonuclease A, 2) lysozyme, 3) α-chymotrypsinogen A and 4) transferrin (0.25 mg mL -1, 5 µL each).
Loading buffer: 2 M (NH4)2SO4 solution, elution buffer: 10 mM PBS with organic additive, gradient rate:
10% mobile phase B min-1, flow rate: 0.5 mL min-1, absorbance detection: 216 nm).
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Figure B-3. HIC chromatograms at various mobile phase pH values. Analytes: Ribonuclease A, Lysozyme
and α-chymotrypsinogen A (0.25 mg mL-1, 5 µL each), Loading buffer: 1.8 M (NH4)2SO4 solution, elution
buffer: 10 mM PBS with 15% ACN, gradient rate: 10% mobile phase B min -1, flow rate: 0.5 mL min-1,
absorbance detection: 216 nm.
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Table B-1. Peak characteristics for three-protein (ribonuclease A, α-chymotrypsinogen A and
lysozyme) separations as a function of gradient rate (% mobile phase B increase per minute).
Constant flow rate of 0.5 mL min-1 (40 mm s-1).
Peak Width
(w1/2, min)
Gradient
Rate
(%B
min-1)
16.67
12.5
10
6.67
5

Retention Time
Difference (∆t, min)

Resolution (Rs)

Ribo A

Lyso

Chymo

Ribo A:
Lyso

Lyso:
Chymo

Ribo A:
Lyso

Lyso:
Chymo

0.155
0.193
0.233
0.307
0.407

0.106
0.131
0.158
0.218
0.289

0.095
0.120
0.148
0.218
0.276

0.717
0.918
1.13
1.66
2.21

0.655
0.874
1.11
1.71
2.36

3.24
3.34
3.41
3.73
3.75

3.85
4.11
4.28
4.63
4.93

Table B-2. Peak characteristics for three-protein (ribonuclease A, α-chymotrypsinogen A and
lysozyme) separations as a function of solvent volume flow rate. Constant gradient rate of
10% mobile phase B min-1.
Peak Width (w1/2, min)

Retention Time Difference
(∆t, min)

Resolution (Rs)

Flow rate
(mL min-1)

Ribo A

Lyso

Chymo

Ribo A:
Lyso

Lyso:
Chymo

Ribo A:
Lyso

Lyso:
Chymo

0.2

0.301

0.206

0.197

1.08

1.11

2.51

3.25

0.3
0.4
0.5
0.6

0.231
0.217
0.205
0.204

0.174
0.162
0.156
0.154

0.156
0.146
0.141
0.141

1.09
1.11
1.13
1.15

1.12
1.13
1.14
1.14

3.18
3.46
3.69
3.79

4.00
4.33
4.53
4.56
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Appendix C
Supporting Information for Chapter Six

Figure C-1. Size distribution of exosomes measured by NTA. (Top) Isolated exosome from human plasma;
(Bottom) Commercial exosome standard.

210

Figure C-2. Backpressure readings corresponding to the first and tenth separations corresponding to the
chromatograms presented in Figure 6.2 of the main manuscript, inclusive of all of the operational functions
presented in Table 6.1 of the main manuscript.
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Appendix D
Supporting Information for Chapter Seven

Figure D-1. Overlap of ten continuous Protein A (C-CP column) – HIC – SEC measurements. Analyte:
IgG1 sample (1.0 mg mL-1, 20 µL), 1D Loading buffer: 1X PBS, pH 7.4, Elution buffer: 1.4 M (NH 4)2SO4
with HCl, pH 2.0. 2D buffer: 50 mM NaH2PO4 and 150 mM NaCl, pH 6.8.
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Figure D-2. SEC chromatogram of raw CHO cell line-derived IgG (20 µL). SEC buffer: 50 mM NaH2PO4
and 150 mM NaCl, pH 6.8. Flow rate: 1.0 mL min-1. Detection: 216 nm wavelength.
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